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Abstract: Obwohl die Grössenzunahme eine augenfällige Eigenschaft der Entwicklung darstellt, ist über
die Mechanismen, welche das Wachstum von Zellen, Geweben und ganzen Organismen steuern, er-
staunlich wenig bekannt. Um mehr Licht in die Wachstumskontrolle zu bringen, wurde ein genetischer
Ansatz im Modellorganismus Drosophila melanogaster gewählt. Eine Mutagenese verfolgte das Ziel, Gene,
deren Produkte wachstumsfördernd oder -hemmend wirken, zu identifizieren. Zu diesem Zweck wurden
Mosaiktiere generiert, deren Köpfe grösstenteils homozygot für zufällige Mutationen waren, während die
Körper heterozygot blieben. Das Auftreten von unnatürlichen Kopfgrössen erlaubte eine Selektion von
Mutationen in Genen, die eine Rolle in der Wachstumskontrolle spielen. Von Fliegen mit kleineren Köpfen
(sogenannten Pinheads) kann erwartet werden, dass sie eine wachstumsfördernde Genfunktion beein-
trächtigt haben, während grössere Köpfe auf einen Defekt in einem wachstumshemmenden Gen hinweisen.
Eine detaillierte Komplementationsanalyse mit den gefundenen Allelen hat gezeigt, dass das Rückgrat
des Signaltransduktionswegs des Insulinrezeptors mehrfach getroffen worden ist. Mehrere Allele in den
Genen, die für den Insulinrezeptor, für die katalytische Untereinheit der Lipidkinase PI3K sowie für die
Serin/Threonin-spezifische Proteinkinase Akt (auch Proteinkinase B genannt) kodieren, wurden aufgrund
des resultierenden Pinhead-Phänotyps gefunden. Dies belegt eindrücklich die Wichtigkeit dieses Signal-
transduktionswegs in der Wachstumskontrolle. Zusätzlich konnten weitere, teilweise unbekannte Gene
identifiziert werden, die einen positiven oder negativen Einfluss auf das Wachstum ausüben. Spezielle
Aufmerksamkeit wurde der Charakterisierung eines Gens gewidmet, welches für das Fliegenhomologe der
kleinen GTPase Rheb kodiert. Mittels detaillierter Epistasie-Analyse konnte Rheb zweifelsfrei in einem
genetischen Netzwerk unterhalb von den Tumorsuppressorgenen Tsc1/2 (Tuberous Sclerosis Complex
1/2) sowie oberhalb von TOR (Target of Rapamycin) und S6K (ribosomale Protein S6 Kinase) eingeord-
net werden. Dieser Befund wurde durch biochemische Experimente unterstützt, welche eine Abhängigkeit
der S6K-Aktivität von Rheb demonstrieren. In Mittelpunkt des zweiten Teils der vorliegenden Arbeit
steht das Proto-Onkogen Akt. Die Proteinkinase Akt trägt am NH2-terminalen Ende eine Pleckstrin-
Homologie (PH) Domäne, welche mit hoher Affinität an Phosphatidylinositole bindet, die an der D3
Position phosphoryliert sind (PI(3,4)P2 und vor allem PI(3,4,5)P3, kurz PIP3). Bei Aktivierung der Sig-
nalkaskade steigt die Konzentration des sekundären Botenstoffes PIP3 in der Zellmembran an, wodurch
sich Akt an die Membran anlagert, wo es durch zwei folgende Phosphorylierungsschritte aktiviert wird.
Durch den Einsatz von neuen Mutationen im Gen, welches für Drosophila Akt kodiert, konnten die
phänotypischen Auswirkungen einer verminderten Akt Aktivität während der Entwicklung untersucht
werden. Die Ergebnisse von zahlreichen Studien an Zellkulturen von Säugern haben auf eine wichtige
anti-apoptotische Funktion von Akt hingewiesen. Deshalb mag es erstaunen, dass der Verlust der Akt
Funktion während der Entwicklung von Drosophila keinen programmierten Zelltod auslöst. Vielmehr
wachsen die betroffenen Zellen äusserst langsam, und Tiere mit beeinträchtigter Akt Funktion erreichen
das Adultstadium mit beträchtlicher Verspätung und weisen eine deutlich reduzierte Körpergrösse auf,
die aufgrund von weniger und kleinerern Zellen zustande kommt. Interessanterweise können Fliegen ohne
die Funktion des Tumorsuppressorgens PTEN überleben, wenn sie in Akt eine Mutation tragen, welche
die Affinität der PH Domäne für PIP3 vermindert. Diese überlebenden Tiere demonstrieren zwei wichtige
Befunde: Die Aktivierung der Proteinkinase Akt scheint das einzige kritische Ereignis zu sein, das durch
den Funktionsverlust von PTEN bewirkt wird. Und zweitens kann gefolgert werden, dass PTEN keine
weiteren Funktionen als die Dephosphorylierung von PIP3 ausübt. Despite the fact that increase in size is
one of the most obvious features of development, relatively little is known about the mechanisms at work
to ensure proper growth at the levels of the cell, the tissues and the whole organism. A genetic approach
in the model organism Drosophila melanogaster was initiated to shed light on the regulatory network
governing growth. To identify genes involved in growth regulation, an unbiased screen for mutations that
either stimulate or inhibit growth was performed. The rationale of the screen was to generate mosaic
flies consisting of heads largely homozygous for randomly induced mutations on heterozygous bodies. By
screening for head size abnormalities in such animals, mutations in genes involved in growth control could
be selected for. Flies with heads of reduced size (so-called pinheads) can be expected to carry a lesion in
a growth-promoting gene, whereas bigger than normal heads are indicative of loss of a growth-restricting
gene function. A detailed complementation analysis with the obtained alleles revealed that the backbone
of the signal transduction cascade initiated by the insulin receptor was hit many times. Multiple mu-
tations in the genes encoding the insulin receptor (Inr), the catalytic subunit of the lipid kinase PI3K
(Dp110), and the serine-threonine kinase Akt (also called protein kinase B, PKB) were recovered by
virtue of the resulting pinhead phenotype, demonstrating the outstanding importance of this signaling
pathway in the control of cellular growth. In addition, mutations in a number of novel genes that either
promote or dampen growth were identified. Special emphasis was put on the characterization of the gene
encoding the Drosophila homolog of the small GTPase Rheb (Ras homolog enriched in brain). By means
of a detailed epistasis analysis, Rheb could be unequivocally placed downstream of the tumor suppressor
genes Tsc1/Tsc2 (Tuberous Sclerosis Complex 1/2) and upstream of TOR (target of Rapamycin) and S6K
(ribosomal protein S6 kinase), a finding that was further substantiated by the biochemical demonstration
that the activity of S6K critically depends on Rheb. A second part of this thesis deals specifically with the
role of a key component of the insulin receptor signaling pathway, the proto-oncogene Akt (or PKB). Akt
is a serine- threonine protein kinase carrying an NH2-terminally located pleckstrin homology (PH) domain
that binds with high affinity to D3-phosphorylated phosphatidylinositols (PI(3,4) P2 and PI(3,4,5)P3).
Upon signaling activity, the concentration of the second messenger PIP3 in the plasma membrane raises,
thereby recruiting Akt to the membrane where it is activated by two subsequent phosphorylation steps.
Using novel protein variants, the phenotypic consequences of impaired Akt function during Drosophila
development were investigated. Whereas numerous studies of Akt function in mammalian cell culture
systems have implicated this kinase as a key player in the protection from apoptosis, loss of Drosophila
Akt function did not trigger programmed cell death. Cells devoid of Akt function rather grew very slowly,
and animals with reduced Akt function emerged with a substantial delay and displayed dramatically re-
duced body size due to fewer and smaller cells. Most importantly, animals completely lacking the tumor
suppressor PTEN were rescued by a mutation in Akt that specifically lowers the affinity of its PH domain
for PIP3. Two lessons can be learnt from these rather unexpected survivors. First, activation of Akt is
the critical event caused by the loss of PTEN function. Second, the only essential function that PTEN
performs is to dephosphorylate PIP3.
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7Summary
Despite the fact that increase in size is one of the most obvious features of
development, relatively little is known about the mechanisms at work to ensure
proper growth at the levels of the cell, the tissues and the whole organism. A genetic
approach in the model organism Drosophila melanogaster was initiated to shed light
on the regulatory network governing growth. To identify genes involved in growth
regulation, an unbiased screen for mutations that either stimulate or inhibit growth
was performed. The rationale of the screen was to generate mosaic flies consisting
of heads largely homozygous for randomly induced mutations on heterozygous
bodies. By screening for head size abnormalities in such animals, mutations in genes
involved in growth control could be selected for. Flies with heads of reduced size (so-
called pinheads) can be expected to carry a lesion in a growth-promoting gene,
whereas bigger than normal heads are indicative of loss of a growth-restricting gene
function. A detailed complementation analysis with the obtained alleles revealed that
the backbone of the signal transduction cascade initiated by the insulin receptor was
hit many times. Multiple mutations in the genes encoding the insulin receptor (Inr),
the catalytic subunit of the lipid kinase PI3K (Dp110), and the serine-threonine kinase
Akt (also called protein kinase B, PKB) were recovered by virtue of the resulting
pinhead phenotype, demonstrating the outstanding importance of this signaling
pathway in the control of cellular growth. In addition, mutations in a number of novel
genes that either promote or dampen growth were identified. Special emphasis was
put on the characterization of the gene encoding the Drosophila homolog of the small
GTPase Rheb (Ras homolog enriched in brain). By means of a detailed epistasis
analysis, Rheb could be unequivocally placed downstream of the tumor suppressor
genes Tsc1/Tsc2 (Tuberous Sclerosis Complex 1/2) and upstream of TOR (target of
Rapamycin) and S6K (ribosomal protein S6 kinase), a finding that was further
substantiated by the biochemical demonstration that the activity of S6K critically
depends on Rheb.
A second part of this thesis deals specifically with the role of a key component of the
insulin receptor signaling pathway, the proto-oncogene Akt (or PKB). Akt is a serine-
threonine protein kinase carrying an NH2-terminally located pleckstrin homology
(PH) domain that binds with high affinity to D3-phosphorylated phosphatidylinositols
(PI(3,4)P2 and PI(3,4,5)P3). Upon signaling activity, the concentration of the second
messenger PIP3 in the plasma membrane raises, thereby recruiting Akt to the
membrane where it is activated by two subsequent phosphorylation steps. Using
novel protein variants, the phenotypic consequences of impaired Akt function during
Drosophila development were investigated. Whereas numerous studies of Akt
function in mammalian cell culture systems have implicated this kinase as a key
player in the protection from apoptosis, loss of Drosophila Akt function did not trigger
programmed cell death. Cells devoid of Akt function rather grew very slowly, and
animals with reduced Akt function emerged with a substantial delay and displayed
dramatically reduced body size due to fewer and smaller cells. Most importantly,
animals completely lacking the tumor suppressor PTEN were rescued by a mutation
in Akt that specifically lowers the affinity of its PH domain for PIP3. Two lessons can
be learnt from these rather unexpected survivors. First, activation of Akt is the critical
event caused by the loss of PTEN function. Second, the only essential function that
PTEN performs is to dephosphorylate PIP3.
9Zusammenfassung
Obwohl die Grössenzunahme eine augenfällige Eigenschaft der Entwicklung
darstellt, ist über die Mechanismen, welche das Wachstum von Zellen, Geweben und
ganzen Organismen steuern, erstaunlich wenig bekannt. Um mehr Licht in die
Wachstumskontrolle zu bringen, wurde ein genetischer Ansatz im Modellorganismus
Drosophila melanogaster gewählt. Eine Mutagenese verfolgte das Ziel, Gene, deren
Produkte wachstumsfördernd oder -hemmend wirken, zu identifizieren. Zu diesem
Zweck wurden Mosaiktiere generiert, deren Köpfe grösstenteils homozygot für
zufällige Mutationen waren, während die Körper heterozygot blieben. Das Auftreten
von unnatürlichen Kopfgrössen erlaubte eine Selektion von Mutationen in Genen, die
eine Rolle in der Wachstumskontrolle spielen. Von Fliegen mit kleineren Köpfen
(sogenannten Pinheads) kann erwartet werden, dass sie eine wachstumsfördernde
Genfunktion beeinträchtigt haben, während grössere Köpfe auf einen Defekt in
einem wachstumshemmenden Gen hinweisen. Eine detaillierte
Komplementationsanalyse mit den gefundenen Allelen hat gezeigt, dass das
Rückgrat des Signaltransduktionswegs des Insulinrezeptors mehrfach getroffen
worden ist. Mehrere Allele in den Genen, die für den Insulinrezeptor, für die
katalytische Untereinheit der Lipidkinase PI3K sowie für die Serin/Threonin-
spezifische Proteinkinase Akt (auch Proteinkinase B genannt) kodieren, wurden
aufgrund des resultierenden Pinhead-Phänotyps gefunden. Dies belegt eindrücklich
die Wichtigkeit dieses Signaltransduktionswegs in der Wachstumskontrolle.
Zusätzlich konnten weitere, teilweise unbekannte Gene identifiziert werden, die einen
positiven oder negativen Einfluss auf das Wachstum ausüben. Spezielle
Aufmerksamkeit wurde der Charakterisierung eines Gens gewidmet, welches für das
Fliegenhomologe der kleinen GTPase Rheb kodiert. Mittels detaillierter Epistasie-
Analyse konnte Rheb zweifelsfrei in einem genetischen Netzwerk unterhalb von den
Tumorsuppressorgenen Tsc1/2 (Tuberous Sclerosis Complex 1/2) sowie oberhalb
von TOR (Target of Rapamycin) und S6K (ribosomale Protein S6 Kinase)
eingeordnet werden. Dieser Befund wurde durch biochemische Experimente
unterstützt, welche eine Abhängigkeit der S6K-Aktivität von Rheb demonstrieren.
In Mittelpunkt des zweiten Teils der vorliegenden Arbeit steht das Proto-Onkogen
Akt. Die Proteinkinase Akt trägt am NH2-terminalen Ende eine Pleckstrin-Homologie
(PH) Domäne, welche mit hoher Affinität an Phosphatidylinositole bindet, die an der
D3 Position phosphoryliert sind (PI(3,4)P2 und vor allem PI(3,4,5)P3, kurz PIP3). Bei
Aktivierung der Signalkaskade steigt die Konzentration des sekundären Botenstoffes
PIP3 in der Zellmembran an, wodurch sich Akt an die Membran anlagert, wo es
durch zwei folgende Phosphorylierungsschritte aktiviert wird. Durch den Einsatz von
neuen Mutationen im Gen, welches für Drosophila Akt kodiert, konnten die
phänotypischen Auswirkungen einer verminderten Akt Aktivität während der
Entwicklung untersucht werden. Die Ergebnisse von zahlreichen Studien an
Zellkulturen von Säugern haben auf eine wichtige anti-apoptotische Funktion von Akt
hingewiesen. Deshalb mag es erstaunen, dass der Verlust der Akt Funktion während
der Entwicklung von Drosophila keinen programmierten Zelltod auslöst. Vielmehr
wachsen die betroffenen Zellen äusserst langsam, und Tiere mit beeinträchtigter Akt
Funktion erreichen das Adultstadium mit beträchtlicher Verspätung und weisen eine
deutlich reduzierte Körpergrösse auf, die aufgrund von weniger und kleinerern Zellen
zustande kommt. Interessanterweise können Fliegen ohne die Funktion des
Tumorsuppressorgens PTEN überleben, wenn sie in Akt eine Mutation tragen,
welche die Affinität der PH Domäne für PIP3 vermindert. Diese überlebenden Tiere
demonstrieren zwei wichtige Befunde: Die Aktivierung der Proteinkinase Akt scheint
das einzige kritische Ereignis zu sein, das durch den Funktionsverlust von PTEN
bewirkt wird. Und zweitens kann gefolgert werden, dass PTEN keine weiteren
Funktionen als die Dephosphorylierung von PIP3 ausübt.
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Introduction
No life without growth. Every living being needs to grow, at least during a certain
period of its existence. Even the simplest single-celled organisms require growth for
their duplication. They have to attain a certain size before dividing and thereby giving
rise to two daughter cells. In multicellular organisms, the growth of a multitude of
cells must be highly orchestrated to guarantee the proper development of tissues,
organs, and complex bodies. Growth can be seen as an accumulation of biomass. It
is reflected in the multiplication of cells of a certain size. The number of cells is
determined by the relative rates of proliferation and cell death (Conlon and Raff,
1999). Traditionally, research in the growth control field focussed mainly on the
regulation of the cell division cycle. Considerable advances in our understanding of
the cellular cell cycle machinery have resulted from these efforts. In the 1990s, the
role of programmed cell death as a means of constraining tissue size got
appreciated. A plethora of recent studies has contributed to unraveling the tangled
web of cellular suicide pathways. The regulation of a cell’s biosynthesis capacity, the
basis for cellular growth, has received little attention until recently. Two elegant
studies in Drosophila resulted in the revival of the long-known concept of
predominance of growth over cell cycle progression (Neufeld et al., 1998; Weigmann
et al., 1997). By manipulating the cell cycle length during larval wing development, it
could be convincingly demonstrated that neither acceleration nor retardation of the
cell cycle progression did influence net growth. These findings undoubtedly caused a
shift in the central issues of growth control. A main challenge will be to uncover the
signaling pathways that control the rate of biosynthesis in accordance with the
environmental conditions. The goal of the present thesis was to take a genetic
approach in elucidating this regulatory framework in the model organism Drosophila
melanogaster, with a special emphasis on the role of signaling downstream of the
insulin receptor.
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Signal transduction pathways and growth control
An overview on some signaling pathways that contribute to the regulation of growth
is depicted in:
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Over the past 25 years, the genetic control of cell size has
mainly been addressed in yeast, a single-celled organism.
Recent insights from Drosophila have shed light on the
signalling pathways responsible for adjusting and maintaining
cell size in metazoans. Evidence is emerging for a signalling
cascade conserved in evolution that links external nutrient
sources to cell size.
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Abbreviations
dMyc Drosophila Myc
dS6K Drosophila p70 S6 kinase
IGF insulin-like growth factor
Inr insulin receptor
IRS insulin receptor substrate
MAPK mitogen-activated protein kinase
PIP3 phosphatidylinositol 3,4,5 trisphosphate
PI3K phosphoinositide 3-kinase
PKB protein kinase B
PTEN phosphatase and tensin homologue
RTK receptor tyrosine kinase
TOP terminal oligopyrimidine tract
TOR target of rapamycin
uORF upstream open reading frame
Introduction
During metazoan development, cells undergo dramatic
changes in size and shape, yet each of the diverse cell types
attains a characteristic size upon differentiation, indicating
that cell size must be under tight genetic control. Some
determinants of cell size have been known for decades.
First, the size of a cell critically depends on its DNA con-
tent. A correlation between the number of chromosome
sets and cell size has been demonstrated in organisms as
diverse as yeast, Drosophila, salamanders and mice [1–5].
Furthermore, during development, many animal and plant
species generate large specialised cell types that are poly-
ploid as a consequence of several rounds of endoreplication.
In nematodes, polyploidization of hypodermal cells con-
tributes significantly to body-size control [6]. Second, cell
size is strongly influenced by the environment. Under
adverse nutritional conditions, for example, yeast cells
divide at a smaller size than they normally do [1]. This cor-
relation also holds true for multicellular organisms such as
Drosophila [7,8]. Another determinant of cell size is tem-
perature: laboratory fruit flies are bigger when reared at low
temperature owing to an increase in cell size [9–12].
Despite the long-standing interest in the phenomenon of
cell-size control, the underlying genetic networks are still
poorly understood. Elegant experiments in yeast pio-
neered genetic analysis in this area and revealed the
predominance of cellular growth (equating to an increase
in mass) over the cell-cycle machinery [13–15]. Whereas
blocking cell-cycle progression does not impede cellular
growth, interfering with general biosynthesis results in cell
cycle arrest. Conversely, mutations that accelerate the cell
cycle do not promote growth but rather result in progres-
sively smaller cells. The issues of how cellular growth is
regulated and how a cell senses the critical size at which it
should divide have remained largely unresolved.
The aim of this review is to highlight recent advances from
genetically amenable model organisms in understanding
the signalling pathways governing cellular growth and the
mechanisms that co-ordinate growth with cell division. 
Signal transduction pathways controlling growth
The past year has seen an unprecedented wealth of stud-
ies on growth regulation in the fruit fly Drosophila
melanogaster. Figure 1 depicts the various signalling path-
ways that are currently attracting considerable attention.
Insulin receptor signalling in Drosophila
Flies lacking the function of Chico, a homologue of the
human insulin receptor substrates 1–4 (IRS1–4), are small
as a result of a reduction in both cell number and size
[16••]. Cells mutant for chico grow more slowly than het-
erozygous cells and are smaller throughout development.
The analysis of mutations in other components of the
insulin receptor (Inr) signal transduction cascade has
revealed strikingly similar phenotypes. For example, het-
eroallelic combinations of Inr alleles result in small flies
with fewer and smaller cells [16••,17,18]. Furthermore,
cells devoid of the lipid kinase PI3K show a pronounced
impairment of growth and a reduction in size whereas
overexpression of a wild-type or of an activated version of
the catalytic subunit of PI3K stimulates cellular growth,
resulting in bigger cells [19,20••]. PTEN is a lipid phos-
phatase that antagonises the activity of PI3K. Loss of
Drosophila PTEN (dPTEN) function results in enhanced
growth and larger cells [21••–23••]. Conversely, overex-
pression of dPTEN reduces cell number and cell
size [21••–23••].
The balance of PI3K and PTEN activities determines the
level of the second messenger PIP3. What might be the
effectors of PIP3 in Drosophila growth control?
Overexpression studies suggest that the serine/threonine
kinase Dakt/PKB plays a critical role downstream of PI3K.
As has been shown for PI3K, overexpression of Dakt/PKB
in clones increases cell size without affecting cell number
[24•]. Accordingly, loss of Dakt/PKB function results in
impaired growth and small cells ([24•]; H Stocker,
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E Hafen, unpublished data). Flies homozygous for hypo-
morphic Dakt/PKB alleles resemble chico mutant flies
(H Stocker, E Hafen unpublished data). Furthermore,
cells lacking dPTEN function grow to a normal size in a
background with reduced Dakt/PKB activity [23••].
Phosphorylation of the ribosomal protein S6 by S6 kinase
(S6K) leads to an increase in the translation of 5′ TOP (ter-
minal oligopyrimidine tract) mRNAs that largely encode
components of the translational apparatus such as riboso-
mal proteins [25]. As S6K activity can be regulated by
PI3K in mammals (reviewed in [26]), mutations in dS6K
might be expected to yield similar phenotypes as muta-
tions in other components of the Inr/PI3K pathway.
Indeed, flies lacking dS6K function are viable, develop
slowly and are small [27••]. Remarkably, the size reduction
is caused exclusively by a decrease in cell size [27••].
Nutrition and growth control
Starvation of larvae phenocopies the small-size phenotype
associated with mutations in the Inr signalling pathway
[7,8], suggesting that this signalling relays information on
the availability of nutrients to every single cell. But what
are the ligands that control the activity of the insulin
receptor and how is their expression regulated? The
essentially complete Drosophila genome sequence [28] has
revealed the presence of at least seven insulin-like pep-
tides. Interestingly, overexpression of one such peptide
produces bigger flies with more and bigger cells
(W Brogiolo, E Hafen, unpublished data).
It is worth noting that a highly conserved Inr pathway also
operates in the nematode Caenorhabditis elegans to control
lifespan and an alternative larval stage, called the dauer
larva, in response to suboptimal food conditions [29–31].
However, there are two major differences in how the Inr-sig-
nalling pathway is used in the fly and the nematode.
Whereas Inr signalling acts in a cell-autonomous fashion in
Drosophila, it is required only in a subset of neurons in C. ele-
gans [32]. Furthermore, no effects of Inr signalling on cell
size have been reported in the nematode. Nevertheless, it is
tempting to speculate that the evolutionarily ancient func-
tion of Inr signalling is to coordinate development with
nutritional conditions. The discrepancies between C. elegans
and Drosophila could be a consequence of the underlying
developmental mechanisms. In contrast to the fly, the organ
and body size of the nematode do not rely on growth and
proliferation of precursor tissues, but rather emerge as a
result of a strict developmental programme (cell lineage).
The regulation of protein synthesis in response to the
availability of nutrients is likely to represent a fundamen-
tal mechanism of growth control in all eukaryotes. In yeast,
the TOR proteins play a key role in this process. Upon
nutrient deprivation, yeast cells downregulate TOR func-
tion which results in a dampening of translational activity
as well as an induction of autophagy [33]. The Inr sig-
nalling pathway may contribute to the control of TOR
activity in multicellular eukaryotes. In fact, in Drosophila.
cells devoid of TOR function grow poorly (S Oldham,
E Hafen, unpublished data).
Inr signalling in vertebrates
The paramount importance of insulin and the insulin-like
growth factors (IGFs) in mammalian growth control is well
documented (reviewed in [34]). Mice lacking any one of
either IGF-I, IGF-II, IGF1 receptor, Inr, IRS1 or IRS2 have
a reduced body size. Moreover, the cell cycle is dramatically
prolonged in embryonic fibroblasts derived from Igf1 receptor
knockout mice [35], as in flies with reduced Inr signalling
activity ([27••]; H Stocker, E Hafen, unpublished observa-
tions). However, only recently have studies in mice
investigated the effects of IGF signalling on cell size. Such an
analysis of igf-I knockout mice has revealed a reduced muscle
fibre size in the diaphragm [36]. Consistently, treatment of
myotubes with IGF-I results in hypertrophy, and this effect
can be mimicked by expression of activated Akt/PKB [37].
Furthermore, modulating the activity of PI3K during heart
development affects both cell and organ size [38•].
Myc functions in growth control
Whereas numerous functions in mammalian cell 
proliferation control have already been ascribed to the
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Figure 1
Schematic representation of signalling pathways controlling cellular
growth (protein synthesis) in Drosophila. This network contributes to
the control of protein synthesis. The transcriptional regulation of dMyc
as well as the control of dTOR activity remain enigmatic. Cellular
growth might be coupled to the cell-cycle machinery via Cyclin E;
however, Myc probably also acts directly on cell-cycle components.
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proto-oncogene c-myc [39], recent experiments in
Drosophila suggest additional direct roles in growth control.
The mutation diminutive, which results in a reduced body
size and slender bristles, is caused by a defect in Drosophila
Myc (dMyc) [40,41]. The study of additional mutations
revealed that whereas only cell size is reduced in adult flies
homozygous for one hypomorphic allele, the cell-size
reduction is accompanied by a decrease in cell number in a
more severe mutation [42••]. dMyc-overexpressing cells are
substantially larger than wild-type ones, independent of the
cell-cycle phase [42••]. The suggested growth-promoting
capacity of Myc recently received strong support by two
studies demonstrating a similar role in B cells [43•,44•].
How might Myc exert its growth-enhancing function?
Among the proposed Myc targets, there are a number of
genes involved in translational control and metabolism
[45–48]. Notably, the mRNA cap-binding protein
eIF4E — a key regulator of translational initiation [49] —
contains two Myc-binding sites in its promoter [50].
Furthermore, the only bona fide Myc target gene in
Drosophila, pitchoune, encodes a DEAD box RNA helicase
that may be involved in ribosome biogenesis [51].
Ras-MAPK signalling
In model organisms, Ras-MAPK signalling has been pre-
dominantly associated with promoting changes in cell fate
during development. Cells that are homozygous mutant for
partial loss-of-function mutations in various components of
the Ras-MAPK signal transduction cascade, however, also
grow poorly and stay small [52]. This observation has now
been complemented by a study on the growth-enhancing
function of Ras [53••]. As for dMyc, expression of activated
Ras augments cellular growth and increases cell size.
Interestingly, Ras appears to upregulate dMyc at a post-
transcriptional level, consistent with the previous finding
that Ras enhances Myc protein stability in vertebrate tis-
sue-culture cells [54]. A growth-promoting activity of Ras
has also been described in mice, where Ras hyperactivity
causes cardiac hypertrophy (reviewed in [55]).
Gigas — a cell size mutation affecting ploidy
The Drosophila gene gigas encodes a homologue of the
human tumour suppressor gene TSC2 (tuberous sclerosis
complex gene 2), a putative exchange factor for the small
GTPase Rap1. Cells that are mutant for gigas are very large,
possibly as a consequence of endoreplication [56]. Despite
their increased size, they are capable of differentiating
properly, as are the giant cells in human hamartomas
caused by the lack of one copy of TSC2 [56].
NF1 — a component of the humoral control?
All the above-mentioned growth regulators act in a strictly
cell-autonomous manner. In contrast, in mutants for the
Drosophila homologue of the tumour suppressor NF1 (neu-
rofibromatosis type 1), the cell-size reduction is
non-autonomous. Whereas the wing cells are smaller in
homozygous mutant flies, mutant cells are of normal size
when surrounded by heterozygous cells [57]. Expression of
activated Protein Kinase A suffices to restore wild-type cell
size in homozygous mutant flies [57]. As NF1 is also
required for the proper response to certain neuropeptides
and for learning [58,59], it is conceivable that NF1 acts in
the nervous system to regulate expression of unknown hor-
mone(s) which, in turn, coordinate growth.
Coupling of cell growth to cell-cycle progression
Insights from yeast
In the Drosophila mutants discussed above, reductions in
cell size are paralleled by a decreased growth rate (with the
possible exception of NF1). This raises the issue of how cell
proliferation is linked to growth — that is, how does a cell
sense the critical size at which it has to initiate cell division?
Genetic analyses in yeast have shed light on some basic
mechanisms. In the budding yeast Saccharomyces cerevisiae, a
growth-sensing mechanism operates during late G1 phase
(START). Translational control of the G1 cyclin Cln3 is
achieved by means of an upstream ORF (uORF) in the 5′
leader sequence which ensures that Cln3 fails to accumulate
under poor growth conditions. As Cln3 acts at the top of a
hierarchy of genes controlling the START transcriptional
programme, translational regulation of this very unstable
protein could serve as a growth sensor [60,61]. Furthermore,
the influence of ploidy on cell size has been investigated at
the level of transcription in S. cerevisiae [62•]. A microarray-
based analysis of gene expression in isogenic strains that
varied only in ploidy showed a relative repression of the G1
cyclins Cln1 and Pcl1 in cells with high ploidy. As expres-
sion levels of G1 cyclins determine the passage through
START, ploidy-dependent repression of G1 cyclins may
explain why cells with more chromosome sets pass through
START at a larger size.
In contrast, mitotic control links growth to the cell cycle in
wild-type cells of the fission yeast Schizosaccharomyces pombe.
The rate-limiting component for G2–M progression, the
phosphatase Cdc25, appears to be translationally controlled
in a manner very analogous to Cln3 in S. cerevisiae ([63•] but
see also [64,65]). Under normal conditions, G1–S size control
is cryptic in S. pombe because cells are already larger than the
threshold size after completion of mitosis. The analysis of
cig1, cig2 and puc1 triple mutant cells, however, revealed the
importance of these G1 cyclins in G1–S size control [66]. 
Co-ordination of growth and cell cycle in Drosophila
Are similar control mechanisms to those in yeast at work in
multicellular organisms? Again, recent experiments in
Drosophila provide some answers. Cyclin E and String, a
Cdc25 homologue, are rate-limiting components in G1–S and
G2–M progression, respectively [67,68]. Overexpression of
Cyclin E shortens G1 phase but leads to a concomitant
increase in G2 phase length. Conversely, overexpression of
String reduces G2 while prolonging G1 [69]. Therefore G1–S
and G2–M progression appear to be controlled in a different
manner, and reducing the length of one gap phase of the cell
cycle results in a compensatory extension of the other. To
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accelerate the cell cycle, both gap phases need to be short-
ened, for example by co-expression of Cyclin E and String
[69]. A similar effect can be achieved by overproduction of
the transcriptional regulator E2F. In both cases, cell size
decreases as cell-division rate rises, leaving total growth
(clonal size) constant [69]. These experiments elegantly
demonstrated the inability of cell-cycle acceleration to stim-
ulate growth, as is the case in yeast. 
Studying the cell-cycle profiles of the various growth
mutants has enabled a further dissection of the link between
cellular growth and cell-cycle progression. Cells with
reduced Inr signalling activity (e.g. overexpressing dPTEN
or mutant for dS6K) show a considerable increase in cell-
cycle length, yet their cell cycle profiles look surprisingly
normal [23••,27••]. Hence, all the phases of the cell cycle are
proportionally extended. Conversely, augmenting cellular
growth (e.g. by overexpression of PI3K, dMyc or activated
Ras) shortens G1 phase but is insufficient to override G2-M
control [20••,42••,53••]. As for overexpression of Cyclin E,
cell-cycle acceleration requires co-expression of String.
Since the string gene bears extensive cis-regulatory
sequences that respond to various developmental cues
[70,71], string is an attractive candidate to couple patterning
signals to cell-cycle progression [42••,53••].
How does the G1–S control respond to cellular growth? By
analogy to S. cerevisiae, one might expect a G1 cyclin to be
tightly controlled at the translational level. Indeed, Cyclin
E fulfils the criteria for a growth sensor. First, Cyclin E lev-
els are rate-limiting for G1–S progression [67,69]. Second,
the 5′ region of the cyclin E mRNA contains several
uORFs, comparable to cln3 [72]. As Cyclin E is unstable,
accumulation to a threshold level requires high translation-
al activity. Third, increasing growth rate by overexpression
of either Myc or activated Ras results in an upregulation of
Cyclin E protein [53••].
Reducing translational efficiency, however, does not always
equate with cell-size reduction in Drosophila. Mutations in
ribosomal proteins — known as Minutes, reviewed in [73] —
that impair ribosome biogenesis and slow down
development do not appreciably reduce cell size
[27••,69,73]. The role of S6K may be key in understanding
this apparent inconsistency. By selectively promoting the
translation of 5′ TOP mRNAs encoding ribosomal proteins
and other components of the translational apparatus, S6K
activity contributes to prevent the accumulation of cell-
cycle regulators until the cell has reached an appropriate
size [74]. Whereas translation is globally decreased in
Minute mutants, non-ribosomal protein mRNAs would be
preferentially translated in cells devoid of dS6K. This could
allow a cell-cycle regulator to accumulate relatively rapidly,
resulting in cell division at a smaller size [74]. A schematic
representation of this model is shown in Figure 2.
The emerging picture of a growth-sensing G1–S control and
a patterning-dependent G2–M control is attractive but
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Figure 2
Model for growth-dependent G1–S control. (a) If the availability of
nutrients is not limiting, cells exiting mitosis first focus on
replenishing the ribosome pools. High levels of Inr and S6K activity
lead to selective translation of 5′ TOP mRNAs required for ribosome
biogenesis. The sizer protein (possibly Cyclin E in Drosophila)
accumulates poorly in this initial phase but rises rapidly as soon as
the full translational capacity is achieved. (b) Mutations in genes
encoding ribosomal proteins (Minutes) impair the general
translational efficiency. Hence, the rate of increase in biomass is
reduced and cell-cycle length is prolonged. The completion of
ribosome biogenesis, however, is still a prerequisite for the
accumulation of the sizer protein: thus, cells progress through the
cell cycle at the same critical size. (c) As Inr and S6K activities are
low under adverse nutritional conditions, ribosomal protein mRNAs
are no longer preferentially translated: thus, accumulation of the
sizer protein commences earlier and reaches the critical
concentration at a smaller cell size. The same scenario applies to
mutations reducing Inr signalling activity. In addition, a similar
mechanism might control G2–M progression.
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incomplete. Although it can explain the phenotypes associ-
ated with growth stimulation (e.g. by overexpressing dMyc
or activated Ras), it cannot account for the proportional
extension of all cell-cycle phases in cells with impaired
growth rates (e.g. mutant for dS6K or overexpressing
dPTEN, respectively). Therefore, we propose the exis-
tence of a growth-dependent G2–M control that remains
cryptic during normal development but becomes apparent
once the translational capacity of a cell drops below a cer-
tain threshold. This two-step mechanism would be
reminiscent of size control in fission yeast where the mitot-
ic control is composed of a ‘sizer’ and a ‘timer’ [64].
Concluding remarks
Recent experiments in genetically tractable model organisms
are helping to unravel the mechanisms that control cellular
growth and how it is co-ordinated with cell-cycle progression.
In particular, a well-conserved signalling pathway leading
from the insulin receptor to the translational machinery has
been identified on the basis of Drosophila growth pheno-
types. This pathway has been subject to extensive
biochemical characterisation in mammalian cells but it
remains unclear whether genetic manipulation of Inr sig-
nalling in mammals results in cell-size phenotypes
comparable to those observed in Drosophila. The cell-size
issue has possibly received too little attention to date, and it
may also be more difficult to study cell size in mammalian
tissues. Alternatively, cell size could be more rigorously con-
trolled in mammals. The large differences in body size
observed in mammals (such as mice and elephants) are main-
ly the result of varying cell number [75], whereas cell size
contributes significantly to body-size variations between
Drosophila species [76]. Cellular growth and cell division rate
may be more tightly coupled in mammals than in flies, ren-
dering the distinction between growth control and cell-cycle
control more difficult to analyse. Drosophila may, therefore,
be a particularly well-suited model system for establishing
the basic mechanisms of cell size and growth control.
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The insulin receptor signal transduction pathway
Because of its central role in the regulation of glucose homeostasis, the signaling
pathway downstream of the insulin receptor (IR) has attracted numerous researchers
for several decades. The current literature provides a wealth of information about its
components with respect to development, physiology and disease in mammals. In
the following sections, I shall try to briefly summarize the current picture of IR
signaling. For a more detailed description, the reader is referred to recent review
articles (Birnbaum, 2001; Pessin and Saltiel, 2000; Saltiel and Kahn, 2001; Saltiel
and Pessin, 2002; Shepherd et al., 1998; Vanhaesebroeck et al., 2001; Virkamaki et
al., 1999; White, 2003).
The ligands
The family of insulin-like hormones in mammals comprises at least nine members
(ten in humans), with insulin being the most prominent one. Insulin is synthesized in
the ß-cells of the islets of Langerhans in the pancreas as pre-pro-insulin and gets
subsequently processed (cleavage of signal peptide, removal of C-chain). The
mature hormone consists of two polypeptide chains (A- and B-chain) covalently
linked by two disulfide bonds. The physiological consequences of insulin action are
described below (Insulin signaling and diabetes mellitus).  Insulin-like growth factors
(IGF-I and IGF-II) are mainly produced by the liver and are key mediators of the
growth hormone signal (see IGF signaling downstream of growth hormone). In
addition, IGF-I has been shown to exert a neuroprotective function in both the CNS
and PNS (Zheng et al., 2000). Insulin-3 (also called Leydig insulin-like hormone)
plays an important role during testicular descent by regulating growth and
differentiation of the embryonic gubernaculum (Nef and Parada, 1999). Relaxin has
been implicated in growth and remodeling of reproductive tissue and has therefore
been viewed as a pregnancy hormone (Sherwood et al., 1993), but recent data
suggests additional functions for relaxin (Bathgate et al., 2003; Dschietzig and
Stangl, 2003; Masterson et al., 2004; Samuel et al., 2004). Another member of the
relaxin family (termed H3 relaxin in humans and M3 relaxin in mice, respectively)
was identified based on sequence homology (Bathgate et al., 2002). In contrast to
relaxin, which is exclusively expressed in the ovary, it is produced in the brain,
suggesting a different (yet to be analyzed) function. The roles of the other insulin-like
peptides, termed insulin-4, -5, and -6, remain elusive.
It is conceivable that the action of those ligands can be either enhanced or
counteracted by molecules that physically bind the ligand(s) and promote or prevent
a productive interaction with the receptor(s). In the case of the IGFs, a family of
binding proteins (IGFBPs) that share sequence homologies over the entire length
could be identified (Rosenzweig, 2004). Interestingly, IGFBP-7 (also called IGFBP-
related protein 1 or Mac25) deviates in its COOH-terminus and was shown to bind
IGF with low affinity only. Instead, it is able to bind insulin with high affinity, thereby
inhibiting the binding of insulin to its receptor (Yamanaka et al., 1997). Several
studies suggest that it can act as a tumor suppressor (Burger et al., 1998; Kato,
2000; Komatsu et al., 2000).
The receptors
The insulin receptor (IR) is a heterotetrameric protein with two α- and two ß-subunits
connected via disulfide bonds. Whereas the α-subunits are localized extracellularly
and are bound by the ligand(s), the ß-subunits contain a membrane-spanning
domain and an intracellular tyrosine kinase domain. Upon ligand binding, the
inhibition of the kinase activity of the ß-subunit by the α-subunit gets relieved, which
leads to transphosphorylation of the ß-subunits and to the phosphorylation of cellular
substrates (see below).
The IGF-I receptor (IGF-IR) and the insulin receptor-related receptor (IRR) belong to
the same subfamily of receptor tyrosine kinases and can form functional hybrids.
Genetic analyses in mice demonstrated considerable complexity and redundancy in
the ligand/receptor interactions (Efstratiadis, 1998). Whereas IGF-I binds exclusively
to IGF-IR, IGF-II could be shown to signal through both the IGF-IR and IR (Louvi et
al., 1997). Both the IR and the IGF-IR are required for pre- and postnatal growth.
Whereas mice lacking IR function die within four days after birth because of severe
ketoacidosis (Accili et al., 1996; Joshi et al., 1996), IGF-IR mutant mice are reduced
in size and die at birth due to respiratory failure (Liu et al., 1993). The growth deficit
is aggravated by simultaneous loss of both receptors (Louvi et al., 1997). By
contrast, the loss of the orphan receptor IRR, which is highly expressed in pancreatic
ß-cells, does not result in developmental or metabolic abnormalities (Kitamura et al.,
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2001). Recently, Nef and co-workers discovered an unexpected role for the insulin
receptor tyrosine kinase family (Nef et al., 2003). XY mice that are mutant for all
three receptors fail to develop male gonads and display a complete female
phenotype, probably due to a lack of Sry expression. These findings implicate insulin
signaling in male sex determination.
Besides binding to IGF-IR and IR, IGF-II interacts with yet another receptor, IGF-IIR.
IGF-IIR displays no homology with receptor tyrosine kinases. It rather corresponds to
a mannose 6-phosphate receptor and serves as a sink for IGF-II. Interestingly, IGF-
IIR is expressed only from the maternal allele in mice. Mutants inheriting a targeted
allele from their mother display an overgrowth phenotype (135% of normal
birthweight) and usually die perinatally. The overgrowth correlates with an increased
concentration of IGF-II and is completely suppressed by a mutation in either IGF-II or
IGF-IR (Ludwig et al., 1996). Mouse embryos lacking both the IGF-IR and the IGF-
IIR develop normally (Ludwig et al., 1996).
The receptors for the other insulin-like peptides probably do not belong to the family
of receptor tyrosine kinases. Recently, the orphan G-protein coupled receptor LGR7
could be identified to be the physiological receptor of relaxin (Hsu et al., 2002;
Krajnc-Franken et al., 2004; Sudo et al., 2003). However, other G-protein coupled
receptors were also shown to bind relaxin (Hsu et al., 2002; Liu et al., 2003a; Liu et
al., 2003b). Furthermore, insulin-3 signals through the G-protein coupled receptor
LGR8/GREAT (Bogatcheva et al., 2003; Ferlin et al., 2003; Kumagai et al., 2002).
The IRS proteins
There is a growing list of intracellular substrates of the insulin/IGF-I receptor tyrosine
kinases that link the receptors to signal transduction cascades. Four of the known
substrates share sequence homologies and belong to the family of insulin receptor
substrate (IRS) proteins (Lee and White, 2004; White and Yenush, 1998; Yenush
and White, 1997). IRS family members are characterized by NH2-terminal pleckstrin
homology (PH) and phosphotyrosine binding (PTB) domains. Binding to the activated
receptor occurs through the interaction of a PTB-binding site (the phosphotyrosine
motif NPXY) in the juxtamembrane region of the IR/IGF-IR with the PTB domain of
IRS. The IRS proteins also possess a number of phosphotyrosine motifs. The
phosphorylated tyrosines in the IRS proteins and in other substrates such as Cbl,
Shc, APS and Gab-1 provide docking sites for proteins containing SH2 (Src-
homology type 2) domains. The SH2 domain proteins often act as adapter
molecules, for instance the p85 regulatory subunit of class 1A phosphatidylinositol-3
kinase (PI3K), or the Grb2 adapter that bridges to the nucleotide exchange factor of
the small GTPase Ras. Other SH2 proteins have enzymatic activities like the
proteintyrosine phosphatase SHP2 or the non-receptor tyrosine kinase Fyn.
The network of receptors, substrate and adapter molecules is thought to link insulin
receptor activity to three main signal transduction pathways: to the PI3K-Akt pathway
(see below), the Ras-MAPK pathway (via Grb2/Shc), and the CAP/Cbl pathway that
results in the activation of the G protein TC10 (Chiang et al., 2001; Watson et al.,
2001).
Knockout analyses for the IRS proteins revealed complementary rather than
redundant functions. Whereas mice lacking IRS-1 exhibit a growth retardation
phenotype as well as insulin resistance in peripheral tissues (Araki et al., 1994;
Tamemoto et al., 1994), IRS-2 knockout mice display insulin resistance both in the
periphery and the liver and a decrease in β-cell mass (Kido et al., 2000; Withers et
al., 1998), which leads to the development of type 2 diabetes mellitus (see below). In
contrast, mice lacking either IRS-3 or IRS-4 do not show severe abnormalities in
growth and metabolism (Fantin et al., 2000; Liu et al., 1999).
The second messenger PIP3
The main branch of signaling downstream of the IR/IGF-IR involves the lipid kinase
phosphatidylinositol-3-OH kinase (PI3K) (Leevers et al., 1999). Its regulatory subunit
(p85) binds via the SH2-domain to phosphotyrosine motifs in IRS proteins, thereby
recruiting the catalytic subunit (p110) to the plasma membrane. Alternative ways of
PI3K activation include direct binding of p85 to receptor tyrosine kinases and the
interaction of p110 with GTP-loaded Ras (Rodriguez-Viciana et al., 1994). Although
protein serine kinase activity of PI3K has been reported (Carpenter et al., 1993;
Dhand et al., 1994), its principal enzymatic activity consists in the phosphorylation of
phosphoinositides at the D3 position (Stephens et al., 1993). Phosphatidylinositol-
(3,4,5)-trisphosphate (PIP3) is the major product of PI3K and serves as a second
messenger to mediate the signal initiated by IR/IGF-IR activity.
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The PIP3 concentration is regulated by the activities of PI3K and of the counteracting
lipid phosphatase PTEN (phosphatase and tensin homolog on chromosome 10)
(Maehama and Dixon, 1998; Maehama and Dixon, 1999). The loss of PTEN in
immortalized mouse embryonic fibroblasts or in embryonic stem cells results in a 2-3
fold increase in the PIP3 concentration (Stambolic et al., 1998; Sun et al., 1999).
Interestingly, PTEN is a tumor suppressor that is frequently mutated in a variety of
human cancers (Simpson and Parsons, 2001), demonstrating the paramount
importance of IR/IGF-I signaling in the regulation of growth. Whether PTEN also
possesses protein phosphatase activity is still under debate. At least in vitro,
dephosphorylation of focal adhesion kinase (FAK) and Shc by PTEN was
demonstrated (Gu et al., 1999; Tamura et al., 1998).
The effectors of PIP3
The best-characterized PIP3 binding motif is the PH domain (Vanhaesebroeck et al.,
2001). A variety of signaling proteins contain PH domains and are potentially
regulated by the interaction with PIP3 (Leevers et al., 1999). The lipid second
messenger PIP3 provides a means to recruit signaling proteins to the plasma
membrane, a key step in the regulation of many enzymes. Maybe the best-studied
example of activation based on the PIP3-mediated membrane localization is the
activation of Akt. Akt is a proto-oncogene composed of an NH2-terminally located PH
domain, a central serine-threonine protein kinase domain, and a COOH-terminal
regulatory tail. Upon rising PIP3 concentrations, Akt associates with the plasma
membrane by virtue of binding to PIP3 via its PH domain. Once at the membrane,
Akt is phosphorylated by phosphoinositide-dependent kinase 1 (PDK1) at threonine
308 (in Akt1) in the T-loop and by another phosphoinositide-dependent kinase of
unknown nature (tentatively called PDK2) at serine 473 near the COOH-terminus.
Both phosphorylation events are needed to ensure full Akt kinase activity. Hooking
Akt to the membrane results in its constitutive activation (Andjelkovic et al., 1997),
demonstrating that (i) the membrane localization is the rate limiting step in the
activation of Akt and that (ii) PDK1 (and probably also PDK2) are already localized to
the membrane. Oncogenic activation of Akt involves the same mechanism: v-Akt is
fused to the viral gag protein (p15, p12, and truncated p30) that is myristoylated at its
NH2-terminus and targeted to the plasma membrane. One focus of recent studies
was the identification of Akt substrates. The growing list of proteins that can be
phosphorylated by Akt includes the metabolic enzymes GSK3 and 6-phosphofructo-
2-kinase; a number of genes involved in survival signaling such as BAD and the
Forkhead family transcription factors FKHR, FKHRL1, and AFX; the serine kinase
mammalian target of rapamycin (mTOR), endothelial nitric oxide synthase (eNOS),
BRCA1, I-κB kinases (IKKs), and Raf (reviewed in (Scheid and Woodgett, 2001)).
Consistent with the molecular nature of these substrates, Akt has been primarily
implicated in anti-apoptotic signaling (Datta et al., 1999) and in metabolic regulation
(Lawlor and Alessi, 2001).
The activating kinase PDK1 also carries a PH domain. Because it displays a higher
affinity for PIP3 as compared to that of Akt, PDK1 is supposedly localized to the cell
membrane even under nonstimulated conditions. PDK1 phosphorylates AGC kinases
including Akt, S6K, SGK, Rsk, PKC isoforms, and PKA. In embryonic stem (ES) cells
lacking PDK1 function, phosphorylation of the T-loop motif in Akt, S6K, and Rsk no
longer occurred, whereas other AGC family members (namely PKA, MSK1, and
AMPK) still were phosphorylated (Williams et al., 2000).
In addition to the kinases Akt and PDK1, a variety of signaling proteins have been
postulated to interact with PIP3 via PH domain: Btk family tyrosine kinases, guanine
nucleotide exchange factors for the Rho and Arf families of small GTPases, and
PLCγ (Leevers et al., 1999). Therefore, raising PIP3 levels is believed to elicit a
plethora of cellular responses.
Insulin signaling and diabetes mellitus
In healthy humans, the plasma glucose concentration is kept within the range of 4-7
mM. Insulin is a key player in the metabolic control of glucose homeostasis. Upon
high glucose concentration, the islet ß-cells of the pancreas secrete insulin, which
promotes the uptake of glucose in muscle and fat cells, stimulates the synthesis of
lipids and glycogen, and counteracts lipolysis, glycogenolysis and gluconeogenesis.
All these activities contribute to a reduction of the blood glucose level.
Diabetes mellitus is characterized by elevated plasma glucose levels. Three types of
diabetes mellitus can be distinguished. Type 1 or insulin-dependent diabetes mellitus
(IDDM) results from a deficit in insulin production due to an autoimmune destruction
of the ß-cells. It accounts for roughly 10% of the patients. In a subset, the ß-cells are
21
still present, but they are impaired in glucose-stimulated insulin release because of
one of several autosomal dominant mutations that lead to ß-cell dysfunction. This
form of diabetes is called maturity onset diabetes of the young (MODY). Most
diabetes patients (about 90%) suffer from type 2 or non-insulin dependent diabetes
mellitus (NIDDM). The hallmark of type 2 diabetes is the peripheral insulin resistance
(i.e. the target tissues such as muscle cells and adipocytes get progressively less
responsive to insulin). Initially, the system compensates for the reduced response to
insulin by increasing the production of the hormone (hyperinsulinemia), but
eventually the ß-cells fail to secrete enough insulin to maintain normal blood glucose
concentrations. Type 2 diabetes is a multifactorial disease and shows a strong
correlation with obesity.
A series of knockout mice were generated to enhance the understanding of the
mechanisms underlying diabetes (Nandi et al., 2004; Terauchi and Kadowaki, 2002).
Whereas mice lacking the functions of IR, IRS-2 or Akt-2 did develop a disease
related to type 2 diabetes, knockout mice for p85 (a regulatory subunit of PI3K), IRS-
1, IRS-3, IRS-4, Akt1, or GLUT4 did not (Saltiel and Kahn, 2001). Diabetes is
ameliorated in obese animals by knockouts for the phosphatases PTP1B and SHIP2.
The picture got even more complex when tissue-specific knockout mice were
analyzed. Surprisingly, mice lacking the IR in the muscle tissue displayed normal
glucose tolerance. However, the concentrations of free fatty acids were increased in
these animals. Removal of IR function from fat tissue did not affect glucose
tolerance, too. Liver-specific IR knockout resulted in impaired glucose tolerance,
decreased insulin clearance, and hyperinsulinemia. Mice without IR activity in the
islet β-cells exhibited defects in the glucose stimulated insulin secretion. Finally, a
brain specific IR knockout yielded a complex phenotype, including increased food
intake, mild adiposity, insulin resistance, hypertriglyceridaemia, and reduced fertility
(reviewed in (Kitamura et al., 2003; Kulkarni and Okada, 2002; Saltiel and Kahn,
2001)). Thus, the analysis of knockout models demonstrated the existence of a
complex regulatory network that governs metabolic control.
IGF signaling downstream of growth hormone
Growth hormone (GH) is produced by the pituitary and is a major regulator of
postnatal growth. The somatomedin hypothesis postulates that GH (somatotropin)
induces hepatic expression of a circulating hormone (somatomedin), which in turn
elicits responses in the target tissues. There is a large body of evidence for an
endocrine role of IGF-I downstream of GH in growth control. First, mice lacking IGF-I
are reduced in size (Baker et al., 1993; Liu et al., 1993). Second, circulating IGF-I is
diminished in the absence of GH (Lupu et al., 2001). Third, whereas the growth of
mice lacking GH can be improved by administration of IGF-I, mice without functional
IGF-I remain unresponsive to GH (Liu and LeRoith, 1999). These findings are
compatible with the GH-IGF-I axis proposed by the somatomedin hypothesis.
Whereas IGF-I is essential for normal growth throughout development, the role of
IGF-II is confined to embryonic growth (DeChiara et al., 1990). Therefore, only IGF-I
is a candidate somatomedin. Double mutant mice lacking both GH and IGF-I remain
extremely small (only 17% of normal body weight), indicating that the GH-IGF-I axis
is a main contributor to growth control (Lupu et al., 2001).
The somatomedin hypothesis, however, is challenged by a series of experimental
findings. The phenotype of mice lacking both GH and IGF-I is clearly distinct from
that of IGF-I nullizygotes, demonstrating the existence of both independent and
overlapping functions (Lupu et al., 2001). Consistently, the expression of IGF-I
outside the liver is only in part, if at all, dependent on GH (Lupu et al., 2001).
Furthermore, liver-specific conditional knockouts of IGF-I were reported to display a
normal growth behavior (Sjogren et al., 1999; Yakar et al., 1999). Despite strongly
reduced IGF-I concentrations in the serum, the body size of these mice remained
unaffected. However, as the ablation of IGF-I was incomplete in these studies, a
growth-promoting role of circulating IGF-I cannot be ruled out.
In order to reconcile the apparently contradictory findings, a four-component model
was proposed (Lupu et al., 2001). The endocrine function of hepatic IGF-I
(component 1) reflects the overlapping activity of GH and IGF-I. Some of the
extrahepatic production of IGF-I also depends on GH (component 2). In addition,
both GH and IGF-I exert independent extrahepatic functions (components 3 and 4).
Insulin receptor signaling in model organisms
The signal transduction cascade headed by the insulin receptor has been
considerably well conserved during evolution. In the model organism Caenorhabditis
elegans, insulin receptor signaling regulates development and aging (Finch and
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Ruvkun, 2001; Guarente and Kenyon, 2000; Guarente et al., 1998). A large family of
37 insulin-like peptides with largely unknown functions has been discovered (Pierce
et al., 2001). An insulin receptor-like tyrosine kinase is encoded by the daf-2 gene.
Interestingly, the requirement for this receptor is non-autonomous and confined to
the nervous system (Apfeld and Kenyon, 1998; Wolkow et al., 2000). Signaling
downstream of DAF-2 resembles the signaling cascade of mammals: activation of
the PI3K AGE-1 results in increasing PIP3 concentrations, which in turn activates
PDK-1 and the two Akt-like kinases (AKT-1 and AKT-2). The signal is counteracted
by DAF-18, a PTEN ortholog that presumably dephosphorylates PIP3. The Akt
kinases phosphorylate and inactivate the Forkhead family transcription factor DAF-
16. As daf-16 mutations are completely epistatic over daf-2, age-1, and akt-1/akt-2,
the negative regulation of DAF-16 appears to be the crucial outcome of insulin
receptor signaling in C. elegans.
The exploration of insulin receptor signaling in the fruitfly Drosophila melanogaster
was initiated by studies on the function of the single insulin receptor ortholog (Chen
et al., 1996; Fernandez et al., 1995). Subsequently, Sally Leevers pioneered the
growth control research in the Hafen laboratory by an overexpression analysis on
PI3K (Leevers et al., 1996). The discovery and characterization of Chico, the fly
ortholog of the IRS proteins (Bohni et al., 1999), set the stage for further dissection of
this versatile signaling pathway. The work presented here is embedded in this
context.
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Results
Most data of this thesis have been presented in several publications that will be
displayed in the following sections.
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2ABSTRACT
In order to identify growth-regulating genes, we generated tissue-specific mosaics for
newly induced mutations on the right arm of the 3rd chromosome and scored them for
size differences in the head and the eyes, the organs where mitotic recombination
was forced to occur by the expression of flp recombinase during development.
Mutations in genes encoding components of the insulin signaling pathway, namely
the insulin receptor (Inr), the lipid kinase PI3K, and the serine/threonine kinase
Akt/PKB, were obtained based on a characteristic pinhead phenotype. Two
complementation groups yielding very similar phenotypes correspond to the genes
encoding the small GTPase Rheb (Ras homolog enriched in brain) and the adaptor
molecule Lnk, respectively. Furthermore, alleles of MASK, RhoGAP, nicastrin and an
unknown gene (CG2747) were identified due to the resulting head size reduction.
Among the mutations resulting in an opposite (bighead) phenotype, we found alleles
of the tumor suppressor genes Tsc1, lats/warts and salvador. Mutation in the gene
that codes for the fly homolog of C-terminal Src kinase (CSK) also fell into this class.
We further isolated mutations in crumbs and Hairless because they significantly
increased the size of the mutant eyes. Finally, we report the identification of Epsin-
like protein (ELP) as a candidate locus for a bighead complementation group.
3INTRODUCTION
Most of the efforts to unravel the control of growth of multicellular organisms have
been spent in elucidating the mechanisms of the cell cycle machinery. Only recently
elegant studies in Drosophila have reminded us of the predominant role of cellular
growth (accumulation of mass) over cell cycle progression (NEUFELD et al. 1998;
WEIGMANN et al. 1997), a fact that had been demonstrated in the single-celled yeast
over two decades ago (NURSE 1975). The gene networks governing cellular growth
have attracted considerable attention since then. Especially the role of the insulin
receptor signaling pathway in the cell-autonomous control of growth during
Drosophila development has been studied in great detail (GAROFALO 2002;
GOBERDHAN and WILSON 2003; STOCKER and HAFEN 2000; WEINKOVE and LEEVERS
2000). Interestingly, larvae lacking the function of the insulin receptor or of one of its
downstream signaling components specifically in the eye imaginal disc (the tissue
giving rise to the adult eye and the head capsule) will develop small heads and eyes
on otherwise normal bodies (BOHNI et al. 1999; BROGIOLO et al. 2001). These so-
called pinhead flies prompted us to exploit the generation of tissue-specific mosaics
to systematically screen for mutations that would affect growth either positively
(resulting in a pinhead) or negatively (resulting in a big head). The ey-flp system
developed by Barry Dickson (NEWSOME et al. 2000) turned out to be suitable since it
leads to phenotypes that are easy to score and that do not seem to affect the viability
of the mosaic flies.
Here we describe our effort to isolate novel growth-affecting mutations on the right
arm of the 3rd chromosome. We report the isolation of ten growth promoting and eight
growth inhibiting complementation groups.
4MATERIALS AND METHODS
Fly stocks
To generate tissue-specific mosaics, we made use of the ey-flp system described in
(NEWSOME et al. 2000). The deficiencies used in the mapping procedure are listed in
Tables 1 and 2. The following mutations were used for complementation analyses:
Inr5545 (FERNANDEZ et al. 1995), Dp110A (WEINKOVE et al. 1999), dAkt1 (STAVELEY et
al. 1998), crb2, H1, Tsc1 (TAPON et al. 2001), and lats (XU et al. 1995).
Screening of mosaic flies
Males carrying FRT sites on the right arm of chromosome 3 were fed with 33mM
EMS according to standard protocols and crossed to females of the genotype y w ey-
flp; FRT82 w+ cl3R3/TM6B y+. cl3R3 is a recessive cell-lethal mutation that has been
generated on the FRT82 w+ chromosome (NEWSOME et al. 2000). Half of the F1
progeny was of the genotype y w ey-flp/+ or Y; FRT82 */FRT82 w+ cl3R3 and was
scored for eyes and heads of abnormal size. Positives were re-crossed to y w ey-flp;
FRT82 w+ cl3R3/TM6B y+ to check for germline transmission. Of the 50000 flies
screened approximately 1000 showed size-defects of the head, whereof 390 stable
lines could be established.
Mapping of the mutations
For each complementation group, one representative allele was mapped meiotically
based on the phenotype. The markers used were: mini-w+ (cytological position 87E),
w+ (90E), and y+ (96E). The rough map position was confirmed and refined by
complementation analysis using deficiencies (where available). Fine-mapping was
done by assessing the frequency of recombination between alleles and nearby P-
element insertions. The P-elements used for the mapping are listed in Tables 1 and
2.
5RESULTS
Mutations in components of the insulin receptor signaling pathway impair cellular
growth in a cell-autonomous fashion (BOHNI et al. 1999; BROGIOLO et al. 2001;
VERDU et al. 1999; WEINKOVE et al. 1999). Clones of mutant cells bear a severe
growth disadvantage and remain small compared to their wild-type sister clones. If
mitotic recombination is forced to occur by the constant supply of flp recombinase
and the sister clone gets eliminated by means of a cell-lethal mutation, these clones
can, however, cover substantial fractions of whole organs. Driving the expression of
the flp recombinase under the control of eyeless regulatory sequences results in the
formation of tissue-specific clones in the eye imaginal disc solely. In combination with
a cell-lethal mutation on the homologous chromosome, this system allows to
generate eyes and head capsules largely composed of cells that are homozygous
mutant for the gene of interest (NEWSOME et al. 2000). Such mosaic flies that lack the
function of the IRS homolog Chico or of the insulin receptor (Inr) specifically in the
descendants of the eye imaginal disc show a very characteristic phenotype. While
their bodies are of normal size, their eyes and heads are dramatically reduced
(BOHNI et al. 1999; BROGIOLO et al. 2001). We wished to identify mutations in growth-
modulating genes based on similar phenotypes. To this end, males carrying target
sites for the flp recombinase near the base of the right arm of the 3rd chromosome
(FRT82) were subjected to EMS mutagenesis and crossed to females that brought in
four elements: the source of the recombinase (ey-flp), FRT sites at the corresponding
position, a dominant eye marker (w+) and a cell-lethal mutation (cl3R3). In the mosaic
flies of the F1 generation, the effects of homozygosity for newly induced mutations on
3R could be observed in the heads and the eyes. The presence of homozygous
mutant tissue could easily be visualized by the loss of the pigment marker w+
resulting in white eye tissue.
We scored 50000 mosaic flies for size defects and recovered 321 mutations giving
rise to smaller eyes and 69 mutations leading to bigger eyes. The mutations were
further classified based on whether they primarily affect the number or the size of
individual ommatidial units, or both (Figure 1). Subsequently, extensive
complementation analyses were initiated within these classes, and a total of 18
complementation groups could be established.
6Class S1: Reduction of both cell number and cell size
Ey-flp clones for mutations in Inr or in chico cause a pinhead phenotype due to fewer
and smaller cells. The differentiation of various cell types, however, is not affected.
Therefore, albeit much reduced in size, such eyes have a normal appearance and a
smooth surface. We classified all phenotypes with similar characteristics as S1. Eyes
that also showed a reduction in both cell number and cell size but displayed a rough
eye surface were scored as S2 mutations. The roughness could be due to the
mutation responsible for the size defect. Alternatively, it could be caused by an
unrelated second-site mutation. Since we could not a priori distinguish between these
possibilities, we treated the S1 and S2 classes similarly.
We could establish six complementation groups in the S1/S2 class (Table 1, Figure
2B-E). As the genes encoding the three core components of the Inr signaling
cascade (Inr, Dp110/PI3K, Akt/PKB) all map to 3R, we tested whether we isolated
novel alleles by complementation analysis with already existing alleles. Indeed, we
found 48 alleles of Inr, 19 alleles of Dp110/PI3K and 13 alleles of Akt/PKB. These
high numbers of alleles argue that the screen was very efficient and that saturation
was probably reached.
S1A is comprised of 10 alleles that gave rise to very similar pinhead phenotypes as
mutations in Inr signaling components. It was meiotically mapped close to the
centromere, and subsequent SNP mapping lead to the identification of Rheb as the
affected gene (STOCKER et al. 2003).
S1B, a large complementation group consisting of 26 alleles, was roughly mapped to
the cytological region 95. Using deficiencies with breakpoints in this interval, the
candidate region could be further refined to 95D11 – 95F7. We tested P-element
insertions in 95D – 95F and found that line l(3)S005343 (DEAK et al. 1997) fails to
complement two representative alleles of S1B. By remobilizing the P-element in
l(3)S005343 we could confirm a causal relationship between the insertion and the
non-complementation with S1B (30 out of 38 w- revertants did complement S1B).
Interestingly, two alleles of S1B that showed a less pronounced pinhead phenotype
in ey-flp clones survived in trans to l(3)S005343, but the resulting adults were clearly
reduced in size. The insertion site of l(3)S005343 was determined by the plasmid
rescue technique. The P-element lies 2 kb upstream of the gene encoding MASK
(Multiple ankyrin-repeats, single KH domain) that has recently been identified in a
screen for enhancers of a phenotype caused by a dominant negative form of the
7phosphatase Corkscrew (SMITH et al. 2002). MASK encodes a large protein with up
to 23 ankyrin repeats, two putative nuclear localization signals (NLS) and a KH
domain.
The four alleles of complementation group S1F are very special in that they give rise
to small adults in all heteroallelic combinations. The cytological map position of S1F
based on phenotypic meiotic mapping is 96D – 96F. S1F alleles fail to complement a
P-element insertion in the gene encoding Lnk, an adaptor protein with a PH- and an
SH2-domain.
Class S3: Reduction of cell size
In contrast to the S1 class, pinheads of the S3 class contain a roughly normal
number of ommatidia. The size defect, therefore, is primarily due to a reduction in cell
size (provided that the ommatidial units are properly built). We could establish three
complementation groups belonging to class S3 (Table 1, Figure 2F-H). S3A is
represented by seven alleles and could be localized to the numbered divisions 84/85
by phenotypic meiotic mapping. As this region has been subjected to extensive
genetic analyses, a number of deficiencies with well-defined breakpoints allowed a
subdivision of the interval defined by the genes doublesex and puckered. S3A could
be placed to 84E8-12 because of non-complementation with Df(3R)dsx21 and
complementation with Df(3R)dsx15 and Df(3R)dsx43. In addition, S3A alleles failed
to complement l(3)84Ee that had been isolated in a screen for lethal mutations in
84D-E. Complementation group l(3)84Ee is represented by a single allele that was
isolated among 2386 lines (BAKER et al. 1991). The number of alleles from both
screens point to a rather small gene. However, we were able to identify molecular
lesions in CG2747 that encodes a huge protein of unknown function and without any
discernible motif (two isoforms of 2165 and 2117 amino acids, respectively). It
remains to be determined whether the lesions found in CG2747 are causally related
to the pinhead phenotype of S3A.
S3B and S3C consist of ten alleles each. Classical meiotic mapping and subsequent
fine mapping enabled us to narrow down the candidate regions to 84D-E and 88C-E,
respectively (Table 1). The candidate region for S3C could be further refined by SNP
mapping, and subsequently mutations in RhoGAP88C were identified. The gene
affected by the S3B alleles remains to be determined.
8Class S4: Reduction of cell number
A small number of pinheads were characterized by the dramatically reduced number
of ommatidia that appeared to be of normal size. Most of these mutations could not
be classified into complementation groups. Two mutations, however, failed to
complement each other as well as two mutations of the Ras-like class. Characteristic
of Ras-like mutations is a pinhead phenotype without homozygous mutant tissue in
ey-flp clones. This phenotype emerges because the mutant cells are able to progress
through the cell cycle (albeit at a reduced rate) but are bound to die as soon as they
should initiate differentiation into the different cell types (HALFAR et al. 2001). It is
conceivable that mutations of the S4 class represent hypomorphic alleles of the Ras-
like class. The S4A complementation group could be mapped to the letter division
96B. SNP mapping allowed identifying nicastrin as the affected gene (NAIRZ et al.
2002).
Taken together, 153 of the 321 pinhead mutations could be assigned to ten
complementation groups. The genes associated with nine of these complementation
groups could be determined. Whereas a growth-promoting role of Inr, Dp110/PI3K
and Akt/PKB has already been shown, we identified MASK, Rheb and Lnk as novel
growth regulators.
In addition to the pinhead mutations, our screen yielded a total of 69 mutations that
resulted in increased size of the eyes and the head. We applied analogous criteria to
subdivide these mutations into big head classes (Table 2).
Class B1: Increase in cell number and cell size
The mutations resulting in an increased eye field due to more and slightly bigger
ommatidia defined three complementation groups. Unexpectedly, we found that two
of the complementation groups correspond to the previously described genes crumbs
and Hairless, respectively (Figure 3B,C). crumbs encodes a transmembrane protein
with EGF- and laminin A-repeats which plays a role in the biogenesis of adherens
junctions and in the maintenance of apical membrane identity (GRAWE et al. 1996;
TEPASS 1996; TEPASS et al. 1990; WODARZ et al. 1995). The relatively high number
of crumbs alleles isolated in our screen (13) is consistent with the large size of the
9coding region (Crumbs consists of 2139 amino acids). Three alleles of the B1 class
failed to complement Hairless that encodes a negative component of the Notch
signal transduction cascade (BANG et al. 1991; BANG and POSAKONY 1992; MAIER et
al. 1992). Hairless has been shown to bind to Suppressor of Hairless (Su(H)) and
thereby antagonizing its DNA-binding activity (BROU et al. 1994). The haplo-
insufficient phenotype of Hairless (loss of the humeral bristles) is also evident in the
newly isolated alleles.
Another complementation group that also encompasses three alleles (B1E) was only
recently identified and was mapped to the cytological region 87F-88B.
Class B3: Increase in cell size
12 mutations displayed a dramatic increase in cell size, whereas the number of
ommatidia appeared to be only slightly increased (Figure 3D). This phenotype is very
reminiscent of the consequences of loss of PTEN function (GAO et al. 2000;
GOBERDHAN et al. 1999; HUANG et al. 1999). The tumor suppressor PTEN is a lipid
phosphatase that antagonizes the activity of PI3K. Therefore, the mutants of the B3
class are likely to code for negative regulators of Inr signaling. We found that all 12
mutations belong to a single complementation group that maps to 95D11 – 95F15.
An obvious candidate gene, the fly homologue of the tuberous sclerosis gene Tsc1,
lies in 95E4-5 (ITO and RUBIN 1999). Recently, three groups reported that mutations
in Tsc1 result in phenotypes indistinguishable from those observed in our screen
(GAO and PAN 2001; POTTER et al. 2001; TAPON et al. 2001). In fact,
complementation analysis confirmed that B3 corresponds to Tsc1.
Class B4: Increase in cell number
Mutations belonging to four complementation groups resulted in a hyperproliferative
phenotype. The supernumerary ommatidia caused the formation of folds that gave
the eyes a tumerous appearance (Figure 3E-H). The four alleles of complementation
group B4B could be correlated with the tumor suppressor gene lats/warts (JUSTICE et
al. 1995; XU et al. 1995). lats/warts encodes a serine/threonine kinase that has been
implicated in the regulation of cdc2 (TAO et al. 1999).
The localization of the largest complementation group of the B4 class (B4A, nine
alleles) could be narrowed down to the interval 94D1 – 94D10-13, which corresponds
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to about 150 kb. We were able to detect lesions in CG13831 that corresponds to the
recently identified salvador gene (KANGO-SINGH et al. 2002; TAPON et al. 2002).
salvador encodes a WW-domain protein that binds to Lats/Warts (TAPON et al. 2002).
Complementation group B4C consists of three alleles and could be placed to 86E6 –
86E19 by meiotic mapping followed by complementation with deficiencies. We
identified three lethal P-element insertions in this interval that failed to complement
B4C. The analysis of the insertion sites by plasmid rescue revealed that all three P-
elements reside within gene CG17309. There exist two classes of ESTs for CG17309
that result from the usage of two different upstream exons. All P-insertions lie in the
first intron with respect to the more abundant transcript and upstream of the
transcriptional start site of the rarer transcript, respectively. The protein encoded by
CG17309 shares extensive homologies to C-terminal Src kinase (CSK) in its C-
terminal half (SH2 domain and tyrosine kinase domain), but its N-terminus lacks any
homologies to other proteins in the database.
The four alleles of B4D map to 94A in close proximity to the P-element insertion
l(3)L3560. Using the SNP mapping technique, we identified mutations in CG31170.
CG31170 codes for a protein of 633 amino acids with an N-terminal ENTH (epsin N-
terminal homology) domain. Therefore, we named CG31170 Epsin-like protein (ELP).
In summary, 52 of the 69 big head mutations fall into eight complementation groups.
Interestingly, we could identify mutations in two genes, crumbs and Hairless, which
had been studied in great detail before without revealing a role in growth control. The
isolation of alleles of the tumor suppressor genes lats/warts and dTsc1 is less
surprising. Furthermore, we identified a novel protein with strong homologies to CSK.
The gene mutated in the bighead complementation group B1E remains to be
determined.
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DISCUSSION
Growth is a central aspect of life, and its regulation and coordination poses a major
problem to all multicellular organisms. To gain insight into the signaling networks
governing growth, it is of outstanding importance to discover the genes involved in
growth control. This can be achieved by identifying mutations that will affect proper
growth control in genetically amenable model systems. We wished to determine all
genes involved in the regulation of growth in Drosophila melanogaster by screening
for mutations affecting the size of particular organs, the head and the eyes. This
study describes the growth-modulating mutations that we identified on the right arm
of the 3rd chromosome.
Screening for growth mutation faces two major limitations. First, most mutations are
expected to be strictly recessive, i.e. the loss of one copy will not alter the size of the
organism. In order to check the consequences of homozygosity for such mutations, a
F2 screen would be required. The amount of work associated with an F2 screen,
however, would not allow screening the genome to saturation. Second, it is
conceivable that the complete loss of growth-modulating genes might result in
lethality, thereby excluding these genes from detection in an F2 screen. To
circumvent these problems, we decided to generate tissue-specific mosaics. The ey-
flp technique (NEWSOME et al. 2000) allowed us to screen flies with largely
homozygous heads on otherwise heterozygous bodies in the F1 generation. The
proportions of the mutant eyes and head relative to the normal-sized thorax served
as indicator for growth defects. Since the fly head is dispensable for viability, we
could even detect mutations that cause lethality in the homozygous state.
The mutations we found could affect growth in many ways. They might (a) interfere
with the patterning of the organ, (b) directly regulate cellular growth (= accumulation
of biomass), (c) influence the survival of the mutant cells or (d) any combination of
these possibilities. Our primary interest was directed to the class of mutations that
exclusively impinge on cellular growth. To avoid patterning or apoptosis mutants, we
decided to selectively screen for flies with eyes of abnormal size but rather normal
morphology. We discarded all flies that either showed morphological anomalies of
the eyes (altered shape, scars, loss of ommatidial structure etc) or that did not carry
homozygous mutant cells (some exceptions will be discussed below).
12
The observed size differences could be due to changes in cell size, cell number, or
both. We used these criteria to subdivide the growth mutations into several
phenotypic classes (Table 1). How do the different phenotypes arise? Previous
studies have shown that impaired cellular growth caused by a deficit in Inr signaling
results in a reduction of both cell number and cell size without affecting patterning.
Therefore, we would expect all mutations impairing Inr signaling strength to fall into
class S1. Interestingly, mutations in the gene encoding the Drosophila homologue of
ribosomal S6 kinase (p70 S6K) give rise to adult flies that are reduced in size due to
smaller cells solely (MONTAGNE et al. 1999). It is unclear, however, whether such a
mutation would give rise to a S3 pinhead. In the case of dS6K, tissue-specific
mosaics failed to produce pinheads, probably as a consequence of the stability of the
protein (J. Montagne, personal communication). Alternatively, mutations in the S3
class could reflect a primary defect in cell size measurement. This would imply that
the organ size is determined relative to the cell size (otherwise the organ would reach
a normal size by adding more cells). An opposite phenotype is observed in class S4
(mutant eyes that consist of fewer cells of apparently normal size). This defect cannot
simply be caused by blocking cell cycle progression, because in such a case the
heterozygous cells that did not undergo mitotic recombination would compensate for
the slowly dividing homozygous mutant cells and take over the majority of the eye
tissue. The phenotype could arise as a consequence of a failure of the mutant cells
to differentiate (comparable to the situation in clones of cells mutant for Ras, (HALFAR
et al. 2001)) or as a result of a block in the eye development program (e.g. disturbed
progression of the morphogenetic furrow). Since we tried to exclude mutants
affecting eye development, we only kept the lines that showed a clearly reduced
head size indicative of growth deficits.
The bighead mutants were classified accordingly. In contrast to mutations in
positively acting components of the Inr signaling cascade, tissue-specific mosaics for
a negatively acting component, the tumor suppressor gene PTEN, primarily affect
cell size but only moderately increase cell number. Mutations in genes counteracting
Inr signaling can therefore be expected to fall into class B3. Bigheads with more (and
slightly larger) ommatidia (class B1) could arise from an aberrant definition of the eye
field. Even if they were not a direct consequence of stimulated cellular growth, they
might tell us a lot about how the size of an organ gets determined. Finally, bigheads
of class B4 were chosen despite the fact that they display abnormal eye morphology
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because the phenotype was suggestive of massive overproliferation (and therefore
overgrowth).
Ordering the 390 growth mutations into complementation groups represented a major
task. The superficial classification of the mutations upon visual inspection proved to
be very helpful for the complementation analyses. First, we tested the strongest
mutations within each class against each other. Second, a representative member of
every complementation group was crossed to the whole collection of growth
mutations. This procedure yielded ten complementation groups in the pinhead class
and nine complementation groups in the big head class.
To map the mutations, we applied the following strategy: (1) The mutations were
mapped relative to three dominant markers based on the phenotype. This quick
method provided us with a rather rough map position. Since the mapping relied on
the phenotype and not on other criteria such as lethality, we could avoid problems
with background mutations. Furthermore, composite phenotypes (e.g. rough
pinheads caused by more that one mutation on 3R) became immediately evident. (2)
We made use of deficiencies to confirm and to further refine the map position. (3)
Nearby P-element insertions were chosen for the fine mapping. The distance
between the mutation and the dominant marker of the P-element was determined by
the frequency of recombinant chromosomes having lost both the dominant marker
and the mutation (as assessed by the loss of lethality over another allele of the same
complementation group). (4) The closest P-elements are selected for SNP mapping.
This technique makes use of normally occurring single nucleotide polymorphisms
between different strains that serve as molecular markers to determine the sites of
recombination very precisely. SNPs in fragments of up to 1000 bp can easily be
detected by duplex HPLC (DHPLC) that exploits the changes in the melting behavior
of DNA caused by mismatches (NAIRZ et al. 2002).
We were able to clarify the identity of nine growth promoting and of seven growth
inhibiting genes so far. As expected, mutations in components of the Inr signal
transduction pathway turned up in the S1 class. In total, we isolated 48 novel Inr
alleles, 19 mutations in the gene encoding the catalytic subunit of PI3K (Dp110) and
13 alleles of Akt/PKB. These numbers show a clear correlation with the length of the
corresponding proteins (Inr: 2146 amino acids, Dp110/PI3K: 1088 amino acids,
Akt/PKB: 611 amino acids). Furthermore, in the light of the high number of alleles we
feel confident that the right arm of the 3rd chromosome has been screened to
saturation.
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Mutations in all the three central components of Inr signaling have been described
before. Whereas a number of Inr alleles have already been analyzed (BROGIOLO et
al. 2001; CHEN et al. 1996; FERNANDEZ et al. 1995), the only available loss-of-
function mutation of Dp110/PI3K is a synthetic null allele (a small deficiency
combined with a genomic rescue construct for the neighboring gene,
Hairless)(WEINKOVE et al. 1999). It will therefore be interesting to determine the
molecular lesions in the novel Dp110/PI 3K alleles and to correlate them with the
phenotypic strength. One special allele (5W3) should provide us with a particularly
useful tool for further studies on growth regulation and other aspects of Inr signaling
because it represents a temperature-sensitive mutation. While it is fully viable over a
deficiency at 18°C, it behaves like a strong loss-of-function allele at 25 °C.
Temperature-shift experiments have already revealed that the female sterility
associated with Inr signaling mutations is reversible (data not shown). Two mutations
in Akt/PKB have been reported previously, but the data concerning the phenotypic
analysis have remained somewhat confusing (SCANGA et al. 2000; STAVELEY et al.
1998; VERDU et al. 1999). In contrast to Inr and chico, mutants in Akt/PKB were
claimed to affect cell size solely. In a study presented elsewhere, we clearly
demonstrate that flies homozygous mutant for a hypomorphic allele of Akt/PKB are
reduced in size owing to fewer and smaller cells. In the screen described here, we
isolated at least six additional hypomorphic alleles of Akt/PKB that were viable in
combination with the null allele dAkt1. All these combinations resulted in small flies
with a significant reduction in both cell size and cell number (data not shown).
Three additional complementation groups belonging to class S1 were established. It
is conceivable that the affected gene products also play a role in Inr signaling. In fact,
S1A and S1F turned out to correspond to Rheb and Lnk, respectively. The
characterization of Rheb was described elsewhere (STOCKER et al. 2003). It encodes
a small GTPase of the Ras superfamily. Epistasis analysis placed it in the TOR
branch downstream of Inr signaling, between the Tsc1/2 complex and TOR. Several
studies demonstrated that Tsc2 acts as the GTPase activating protein (GAP) of
Rheb, thereby establishing a direct link from the Tsc1/2 tumor suppressor complex to
Rheb (GARAMI et al. 2003; INOKI et al. 2003; TEE et al. 2003; ZHANG et al. 2003).
Lnk is the only Drosophila homolog of three members of a family of adaptor
molecules, consisting of Lnk (HUANG et al. 1995), APS (YOKOUCHI et al. 1997) and
SH2-B (KOTANI et al. 1998). The hallmark of these family members is the presence of
a pleckstrin homology (PH) domain, a Src homology type 2 (SH2) domain, and
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tyrosine phosphorylation sites that form Grb2 docking sites. APS and SH2-B directly
interact with and are phosphorylated by the insulin receptor (AHMED and PILLAY
2001; AHMED et al. 1999; AHMED et al. 2000; HU et al. 2003; KOTANI et al. 1998).
Knockout mice have been generated to get insight into the function of the three
family members. Whereas mice lacking Lnk are viable and show relatively mild
defects in B cell regulation (TAKAKI et al. 2000), APS-/- animals display increased
insulin sensitivity (MINAMI et al. 2003). Mice devoid of SH2-B are slightly growth-
impaired and have underdeveloped genital organs (OHTSUKA et al. 2002). The
phenotypes of double and triple knockout mice remain to be determined. In light of
the biochemical data on the mouse homologs, we assume that Drosophila Lnk
bridges between the Inr and downstream effectors such as PI3K and, possibly,
Drk/Grb2. Therefore, Lnk could play a role that is partially redundant with the function
of the IRS homolog Chico. In fact, whereas chico and Lnk single mutants are viable
and reduced in size, chico Lnk double mutants are lethal. This could explain why
chico is the only non-essential core component of Inr signaling described so far.
Another possibility is that Lnk mediates Inr signaling via Drk-Ras. Whereas the Inr
loss-of-function phenotype did not reveal any sign of reduced Ras-MAPK activity,
overexpression of an activated Inr resulted in MAPK phosphorylation (BROGIOLO et
al. 2001). Whether this crosstalk requires Lnk function needs to be investigated.
The screen revealed a growth promoting function for MASK. The presumptive gene
product carries up to 23 ankyrin repeats (depending on the prediction program and
the stringency used), two putative nuclear localization signals and a well-conserved
KH-domain. Whereas ankyrin repeats have been shown to form reactive surfaces
that primarily mediate protein-protein interactions (SEDGWICK and SMERDON 1999),
the KH domain is supposed to bind RNA (SIOMI et al. 1994). It was first identified in
the hnRNP K protein (KH = hnRNP K homology). The Drosophila genome encodes
27 proteins with KH domains, whereof 18 proteins possess a single KH domain
(LASKO 2000). They fulfill a variety of cellular functions ranging from prevention of
nuclear export of a specific mRNA (NABEL-ROSEN et al. 1999) to the intracellular
localization of mRNAs (DESHLER et al. 1998; HAVIN et al. 1998; ROSS et al. 1997). A
prominent member of the KH domain protein family, the human fragile-X associated
protein (FMRP), also has a homologue in Drosophila (CG6203; (LASKO 2000)) and is
thought to shuttle between the nucleus and the cytoplasm (FENG et al. 1997b). Its
association with large mRNP particles and ribosomes is suggestive of a role in
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translational control (CEMAN et al. 1999; FENG et al. 1997a). The Drosophila P-
element somatic inhibitor (PSI), a protein with four KH domains, is a member of the
RNA-binding protein complex that mediates the tissue-specific alternative splicing of
the P-element transposase mRNA. Interestingly, mutations in bancal that encodes a
Drosophila homologue of hnRNP K lead to a reduction in appendage size owing to
fewer cells (CHARROUX et al. 1999). High levels of bancal expression, on the other
hand, result in programmed cell death (CHARROUX et al. 1999). Thus, correct levels
of bancal expression seem to be crucial for normal development. Consistent with this
notion, Bancal appears to negatively regulate its own expression (CHARROUX et al.
1999). The variety of functions exerted by KH-domain containing proteins renders
functional predictions difficult. Recently, MASK has been isolated as a putative
component of Ras-MAPK signaling (SMITH et al. 2002). The function of MASK,
however, remains elusive.
Among the mutations in growth inhibiting genes, we were most interested in the B3
class because the phenotypes associated with these mutants are very similar to
those obtained with PTEN alleles. We therefore speculate that B3 alleles represent
mutations in genes counteracting Inr signaling. All 12 alleles of class B3 formed a
single complementation group, indicating that there is only one locus on 3R that
genetically behaves like PTEN. Our mapping results pointed to the Drosophila
homologue of the tumor suppressor gene Tsc1 as the likely candidate because
mutations in gigas that encodes the homologue of Tsc2 display similar phenotypes
(ITO and RUBIN 1999). Indeed, in the course of our work three other groups reported
that mutations in Tsc1 result in growth phenotypes comparable to PTEN mutants,
and that they genetically interact with mutations in the Inr signaling cascade (GAO
and PAN 2001; POTTER et al. 2001; TAPON et al. 2001). Tuberous sclerosis complex
(TSC) is a dominant disorder characterized by the occurrence of hamartomas in
many organs (reviewed in CHEADLE et al. 2000). These hamartomas are growths
consisting of differentiated but disorganized cells, and they frequently contain giant
cells. A causal relationship between inherited TSC and mutations in two genes,
TSC1 and TSC2, has been demonstrated (VAN SLEGTENHORST et al. 1997). TSC1
encodes a protein of 1164 amino acids, hamartin, containing two putative coiled-coil
domains near its C-terminus. TSC2 codes for an 1807 amino acid protein called
tuberin that also contains predicted coiled-coil domains as well as a putative
GTPase-activating protein (GAP) domain. The two proteins have been shown to
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interact physically via their coiled-coil domains (NELLIST et al. 1999; PLANK et al.
1998; VAN SLEGTENHORST et al. 1998). Mutations in either gene result in the same
clinical manifestations, presumably because they disrupt the formation of a functional
complex. All the 152 reported TSC1 mutations from human patients as well as the
four mutations in the fly homologue of TSC1 lead to a truncation of the protein. It will
be interesting to determine whether other kinds of mutations can be found among the
12 alleles isolated in our screen. Genetic analysis has revealed a function of the TSC
complex in the negative regulation of TOR (GAO et al. 2002; RADIMERSKI et al. 2002).
Consistently, the target of the GAP activity of Tsc2, the small GTPase Rheb, acts
upstream of TOR.
The two genes that we found to be mutated in the complementation groups B1A and
B1D were less expected. crumbs  codes for a transmembrane protein with a huge
extracellular domain containing 30 EGF- and four laminin A-type repeats,
respectively. It has been shown to exert a crucial function in the formation of
adherens junctions and in the establishment of apical polarity of epithelial cells
(GRAWE et al. 1996; WODARZ et al. 1995). Loss of Crumbs function results in
complete degeneration of all ectodermally-derived epithelia during embryogenesis.
Crumbs forms complexes with the PDZ-domain protein Discs lost (Dlt) (BHAT et al.
1999). A function for Crumbs in imaginal disc development has not been described
yet.
Hairless encodes a protein that antagonizes the DNA-binding activity of Suppressor
of Hairless and thereby counteracts Notch signaling. It is known that the function of
Hairless is required only in a subset of Notch-mediated developmental decisions,
especially in the development of the peripheral nervous system (SCHWEISGUTH and
LECOURTOIS 1998). Recently, a growth-promoting role for Notch signaling during eye
development has been suggested. It appears that Notch activity is required along the
equator to define the size of the eye field, which in turn triggers the proliferation of
undifferentiated cells of the eye primordium (CHAO et al. 2004; CHO and CHOI 1998;
DOMINGUEZ and DE CELIS 1998; KENYON et al. 2003; PAPAYANNOPOULOS et al. 1998).
If Hairless acted in this process to restrict Notch activity, loss of Hairless function
might result in an expansion of the eye field, which could account for the big head
phenotype. A similar role for Notch signaling in organ growth control has also been
observed in the leg imaginal disc (DE CELIS et al. 1998; RAUSKOLB and IRVINE 1999).
It is tempting to speculate that in crumbs mutants, Notch signaling gets somehow
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intensified. It will be interesting to identify the remaining gene of the same class B1
and to test whether it also modulates Notch signaling strength.
Mutants of class B4 are special in that they lose the normal epithelial organization of
the eyes. They tend to form huge folds that are reminiscent of tumors. Since they
obviously cause massive overgrowth, we decided to further characterize these
mutants although they do not meet all our criteria. Complementation group B4B
turned out to correspond to the tumor suppressor gene lats/warts. This gene had
previously been identified based on the phenotype in clones of mutant cells (apical
hypertrophy of imaginal epithelial cells, (JUSTICE et al. 1995; XU et al. 1995)). It
encodes a serine/threonine kinase related to cAMP-dependent kinases. Mammalian
homologues of Lats/Warts have also been reported (HORI et al. 2000; TAO et al.
1999; YABUTA et al. 2000). Human Lats1 was shown to complex with Cdc2 early in
mitosis, thereby excluding the binding of CyclinA and inhibiting the kinase activity of
Cdc2 which results in G2/M arrest (TAO et al. 1999; XIA et al. 2002; YANG et al.
2001). Besides other defects in the endocrine system, lats1 knockout mice develop
soft-tissue sarcomas and are highly sensitive to carcinogenic treatments (ST JOHN et
al. 1999). Mouse embryos lacking Kpm/Lats2 exhibit overgrowth in restricted tissues,
and lats2-/- MEFs acquire a growth advantage and display genomic instability
(MCPHERSON et al. 2004). The tumor suppressor gene lats/warts, therefore,
exemplifies the value of the model system Drosophila to discover growth-regulating
genes that are also relevant to tumorigenesis in humans.
Our screen yielded a novel tumor suppressor gene coding for a protein that shares
strong homologies with C-terminal Src kinase (CSK) in its C-terminal half. The
protein carries highly conserved SH2 and tyrosine kinase domains, but no SH3
domain. Since the N-terminal half does not show significant homologies to other
proteins, it is likely that the regulation of the tyrosine kinase activity is achieved in a
way different to the regulation of Src by CSK. The similarity of the phenotypes
suggests that Lats/Warts and the novel tyrosine kinase might act in the same
process(es). Indeed, Stewart and co-workers identified CSK mutations as dominant
modifiers of lats-dependent phenotypes (STEWART et al. 2003). CSK is able to
phosphorylate Lats at a conserved C-terminal tyrosine, and this phosphorylation is
required for normal Lats function (STEWART et al. 2003).
The complementation group displaying the strongest overproliferation phenotype,
B4A, corresponds to the salvador gene. Salvador, a WW-domain containing protein,
restricts proliferation and promotes apoptosis (KANGO-SINGH et al. 2002; TAPON et al.
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2002). These effects are, at least in part, mediated by the regulation of Cyclin E and
DIAP1 expression, respectively (TAPON et al. 2002). Interestingly, Salvador is
evolutionarily conserved, and mutations in the human ortholog, hWW45, were
discovered in three cancer cell lines (TAPON et al. 2002). Recently, the
serine/threonine kinase Hippo, the ortholog of human MST1 and MST2 kinases, was
found as a novel member of the Hippo-Salvador-Warts signaling cassette (HARVEY et
al. 2003; PANTALACCI et al. 2003; UDAN et al. 2003; WU et al. 2003). Hippo binds to
and phosphorylates Salvador, thereby forming a physical and functional complex with
Salvador and Warts (WU et al. 2003). It is also evolutionarily conserved, since the
human ortholog is capable of rescuing the Drosophila mutation (WU et al. 2003).
Therefore, it is tempting to speculate that the Hippo-Salvador-Warts complex might
act as a tumor suppressor in humans.
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Concluding remarks
We attempted to identify all growth-modulating genes on the right arm of
chromosome 3 by screening tissue-specific mosaics for size abnormalities. We
ended up with a reasonable number of complementation groups for both the growth
stimulating and growth inhibiting genes. The identification of the affected genes has
provided evidence for both the specificity of the screen and the relevance of the
mutants that were found. Thus, we feel confident that our strategy to search for
growth-modulating mutations in the model organism Drosophila is a valuable tool to
identify and characterize novel genes that will hopefully contribute to our
understanding of human cancer.
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FIGURE LEGENDS
Figure 1 Schematic representation of phenotypic classes.
All the growth-modulating alleles have been classified according to their primary
defect (reduction in number of ommatidia, reduction in size of ommatidia, or both).
“S” stands for “small” (i.e. pinhead mutations), “B” indicates “big” (i.e. bighead
mutations). Single arrow signifies moderate change, two arrows indicate severe
change.
Figure 2 Phenotypes of pinhead mutations.
Scanning electron micrographs of mutant heads displaying a size reduction. Each
complementation group is represented by an allele of average strength. (A) wild-type,
(B) Inr, (C) Akt, (D) Rheb, (E) MASK, (F) S3A, (G) S3B, (H) RhoGAP88C. Anterior is
to the left.
Figure 3 Phenotypes of bighead mutations.
Scanning electron micrographs of heads with increased size. One representative
allele is shown for each complementation group. (A) wild-type, (B) Hairless, (C)
crumbs, (D) Tsc1, (E) salvador, (F) lats/warts, (G) CSK, (H) ELP. Anterior is to the
left. Note the almost complete loss of interommatidial bristles in (B).
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Rheb is an essential regulator of S6K in controlling cell
growth in Drosophila
Hugo Stocker1, Thomas Radimerski2, Benno Schindelholz3, Franz Wittwer1, Priyanka Belawat1, Pierre Daram3,
Sebastian Breuer3, George Thomas2 and Ernst Hafen1
Understanding the mechanisms through which multicellular organisms regulate cell, organ and body growth is of relevance to
developmental biology and to research on growth-related diseases such as cancer. Here we describe a new effector in growth
control, the small GTPase Rheb (Ras homologue enriched in brain). Mutations in the Drosophila melanogaster Rheb gene were
isolated as growth-inhibitors, whereas overexpression of Rheb promoted cell growth. Our genetic and biochemical analyses
suggest that Rheb functions downstream of the tumour suppressors Tsc1 (tuberous sclerosis 1)/Tsc2 in the TOR (target of
rapamycin) signalling pathway to control growth, and that a major effector of Rheb function is S6K.
A growing number of studies in genetically tractable model organ-
isms, such as D. melanogaster, have greatly enhanced our understand-
ing of growth regulation. From these efforts, two highly conserved
signalling pathways dedicated to the control of growth have emerged,
namely the insulin receptor (InR)/phosphatidylinositol-3-OH kinase
(PI(3)K) and TOR pathways1,2. Recent studies have also shown that
these two pathways interact, although the mechanisms by which they
communicate are the subject of controversy3,4. In addition, each path-
way seems to be modulated by distinct tumour suppressor genes,
PTEN (phosphatase and tensin homologue deleted in chromosome
10) and TSC1/TSC2, respectively5,6. Whereas it is clear that PTEN con-
strains PI(3)K signalling by dephosphorylation of phosphatidylinosi-
tol-3,4,5-triphosphate (PtdInsP3)
7, the mechanism by which TSC1
and TSC2 counteract TOR signalling remains elusive. Importantly,
TSC2 possesses a putative GTPase-activating protein (GAP) domain,
which has been shown to increase the intrinsic GTPase activity of the
small GTPases Rap1 and Rab5 (refs 8, 9). Here, we present genetic and
biochemical data from Drosophila suggesting a novel role for the small
GTPase Rheb in the TOR/S6K signalling pathway.
To identify growth-regulating genes, we performed two comple-
mentary screens for loss- and gain-of-function mutations, respec-
tively. In the loss-of-function screen, we discovered a novel
complementation group of ten alleles that impair cell and organ
growth. The ethylmethane sulphonate (EMS)-induced mutations
were identified on the basis of reduced head size of mosaic animals
consisting of heads largely made up of homozygous mutant cells and
bodies containing heterozygous cells (compare Fig. 1a with Fig. 1b).
This phenotype is reminiscent of mutations in InR signalling compo-
nents. The heads of mutant flies were largely made up of homozygous
mutant cells and bodies containing heterozygous cells (Fig. 1a), a phe-
notype reminiscent of mutations in InR signalling components10,11.
Genetic mapping of two representative alleles and subsequent testing
of candidate open reading frames identified alterations in the gene
CG1081 in seven alleles. CG1081 encodes a small GTPase most closely
related to mammalian Rheb12 (Supplementary Information, Fig. S1a).
Therefore, we named this complementation group Rheb.
The gain-of-function screen for genes that stimulate growth when
overexpressed resulted in the identification of an EP element in the
Rheb locus (EP 50.084). EP-mediated overexpression of Rheb in the
developing eye substantially increased eye size (Fig. 1c). We generated
six additional Rheb loss-of-function alleles by imprecise excision of EP
50.084. Whereas all combinations of the EMS-induced Rheb alleles
were lethal, some hetero-allelic combinations of EMS-induced alleles
and EP excision alleles were viable and resulted in flies of reduced size
(Supplementary Information, Fig. S1b). The size reduction was
caused by a decrease in cell number (3–11%), as well as in cell size
(9–14% in wing cells, more than 20% in eye cells as judged by omma-
tidial size). In addition, the small flies eclosed with a delay of at least
one day and the females had rudimentary ovaries and were sterile (Fig.
1d). Thus, the surviving Rheb mutant flies display all the hallmarks of
impaired InR signalling activity, resembling flies lacking the insulin-
receptor substrate (IRS) protein Chico10.
A more severe reduction in Rheb function (in heteroallelic combi-
nations of Rheb mutations) was lethal at late larval or early pupal
stages. Mutant larvae and pupae were consistently smaller (Fig. 1e, f),
although the phenotype was variable. Interestingly, the size reduction
was more pronounced in the endoreplicative larval tissue than in the
imaginal discs (Fig. 1g–j), similarly to the larval phenotype of TOR
mutants13,14. Staining of DNA in salivary glands and fat body cells
demonstrated a severe deficit in endoreplication (Fig. 1j).
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The behaviour of Rheb mutant cells was studied during develop-
ment by means of mitotic recombination. Clones of cells homozygous
for EMS-induced Rheb alleles grew poorly and were consistently
smaller than their corresponding sister clones (Fig. 2a). When pro-
vided with a proliferative advantage (by means of the Minute tech-
nique), Rheb mutant cells still failed to cover large regions of the
imaginal discs. Instead, the resulting clones typically displayed elon-
gated shapes with thin extensions (Supplementary Information, Fig.
S2a). A possible explanation for this unusual phenotype may reside in
their attempt to minimise contact with other mutant cells. To our
knowledge, this phenomenon has not been previously described in the
context of growth-regulating genes. Despite this abnormal behaviour,
Rheb mutant cells differentiate properly into adult structures. For
example, analysis of clones in the adult eye revealed the presence of
extremely small photoreceptor cells of otherwise normal structure and
arrangement in the mutant tissue (Fig. 2b). The size reduction pheno-
type is strictly cell-autonomous. Taken together, the characterisation
of the mutant phenotypes demonstrates that Rheb is required for
proper growth regulation in a cell-autonomous manner.
Next, we examined whether overexpression of Rheb is sufficient to
promote growth. The effect of overexpressing Rheb during develop-
ment through the use of the EP 50.084 line and two independent UAS-
Rheb lines was monitored in marked clones in imaginal discs and in
the adult eye. All the lines yielded qualitatively similar results, with the
EP line consistently showing the strongest effects. Clones overexpress-
ing Rheb in the wing imaginal disc attained a substantially larger size
when compared with control clones (Fig. 2c). This enlargement is
caused by a significant increase in cell size (a 48% increase in area cov-
ered per cell). In contrast, the cell doubling time remained unchanged
in cells expressing Rheb versus control cells (10.5 h versus 10.8 h).
Consistent with the size effect in the imaginal discs, cells expressing
Rheb in differentiating cells posterior to the morphogenetic furrow
(under the control of GMR regulatory sequences) resulted in enlarged
but fully differentiated photoreceptor cells (a 66% size increase of the
a b c
d e f
g h i
200 µm 200 µm
j
Figure 1 Growth defects caused by Rheb mutations. (a–c) Phenotypes that
resulted in the identification of Rheb alleles. Shown are SEMs of female fly
eyes taken at the same magnification. EMS-induced Rheb loss-of-function
alleles were identified on the basis of the pinhead phenotype in mosaic
animals with largely homozygous mutant heads, as shown in a. A
comparison with a control eye, as shown in b, demonstrates the marked size
reduction. An EP-element driving Rheb expression was isolated as a gain-of-
function mutation promoting overgrowth in the eye, as shown in c. (d)
Ovaries of viable Rheb7A1/Rheb44.1 females (bottom) are markedly reduced
in size when compared with control ovaries (top). (e, f) Phenotype of a pupal
lethal heteroallelic combination (Rheb7A1/Rheb26.2). The size range of
mutant larvae (e, middle and right) is shown in comparison with a control
larva (left). Whereas the smaller mutant larvae die, the larger mutant larvae
arrest development at the early pupal stage. A corresponding pupa (f, right)
is clearly smaller than the control pupa (left). (g–j) Size defects of imaginal
discs and salivary glands in larvae of a pupal lethal heteroallelic
combination (Rheb3M2/Rheb26.2). Whereas the size reduction of mutant
imaginal discs is roughly proportional to the larval size (g, control; h,
mutant), the salivary glands are more severely reduced (compare j to control
gland in i). DAPI staining (blue) shows a strong endoreplication deficit in
Rheb mutant salivary glands. Membranes are stained with an anti-lin7
antibody (red).
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Figure 2 Clonal analysis of Rheb function. (a) Loss-of-function clones in the
wing imaginal disc are consistently smaller than their corresponding twin
clones. A clone of cells homozygous mutant for Rheb2D1 (marked by the
absence of GFP) is only about half the size of its twin spot (bright green
staining). Nuclei are labelled by DAPI staining (shown in red). The reduced
clone size is accounted for by fewer and smaller cells (n = 10, P = 0.00038
for cell number, P = 0.00126 for cell size). (b) Tangential sections through
compound eyes reveal that cells homozygous mutant for Rheb3M2 (marked
by the lack of pigments) are able to differentiate into the various cell types
of the eye. The size of the mutant cells, however, is greatly reduced (as
reflected by a 72% reduction in rhabdomere area in tangential sections). A
mosaic ommatidium containing a single mutant photoreceptor cell (inset,
asterisk) demonstrates the cell-autonomy of the size reduction. (c) Flp-out
clones of Rheb-expressing cells in the wing imaginal disc attain a
significantly larger size. Clones 40 h after induction and marked by GFP
expression are shown (top: control, bottom: expressing Rheb). The increase
in clonal area is caused by larger cells (n = 20, P = 0.00002), whereas the
number of cells is not significantly altered (P = 0.087). (d) Expression of
Rheb during eye development results in an enlargement of photoreceptor
cells.Cells expressing Rheb under GMR-control are marked by the absence
of pigmentation. Cell-autonomy of the size increase is demonstrated by a
single Rheb-expressing photoreceptor cell (asterisk) in a mosaic
ommatidium (inset). (e–h) The effects of Rheb expression in endoreplicative
larval tissues under normal conditions (e, g) and under amino-acid
deprivation (f, h). Cells expressing Rheb (labelled with GFP, arrows in lower
panels) under normal nutrient availability in salivary glands (e) and fat body
cells (g) display only a mild size increase. In larvae starved for amino acids,
however, Rheb expression exerts strong effects on both cell size and DNA
ploidy. In salivary glands (f), Rheb-expressing cells display a several fold
increase in size and contain much more DNA (stained with DAPI, lower
panels) than non-expressing neighbouring cells, but they do not reach
normal size and ploidy. In the fat body cells (h), expression of Rheb reverts
the starvation phenotype completely. Size, DNA content, and appearance
(amount of vesicles) of these cells are indistinguishable from non-starved
cells. Membranes are visualised with an anti-lin7 antibody staining (red).
Separate DAPI staining is shown in lower panels (blue).
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rhabdomeres; Fig. 2d). As in the case of the loss-of-function clones, the
size alteration was cell-autonomous. Thus, Rheb is sufficient to pro-
mote cellular growth.
As both InR and TOR signalling have been implicated in the
response to nutrient availability15,16, we asked whether overexpression
of Rheb would promote growth even under starvation conditions. It
has been shown that depriving larvae of amino acids blocks endorepli-
cation of the larval tissues, but that this can be overcome by expression
of Dp110/PI(3)K16. Rheb was expressed in small clones of cells in the
salivary glands and in the fat body. Under normal food conditions,
only a very subtle increase in cell size was observed (Fig. 2e, g). In lar-
vae starved of amino acids, however, Rheb expression had a pro-
nounced effect on both DNA content (as visualised by DAPI staining)
and cell size (Fig. 2f, h). Despite the lack of amino acids, larval cells
expressing Rheb reached a normal size in the fat body, and the size and
endoreplication deficits were significantly alleviated in the salivary
glands. We conclude that Rheb is sufficient to counteract the effects of
amino-acid deprivation and thus may function in amino-acid sensing.
Given the similarities between Rheb and mutants in the InR and
TOR signalling pathways, it is conceivable that Rheb represents a novel
component of one of these growth control pathways. To test this possi-
bility, a detailed epistasis analysis was performed. First, we tested
whether the negative regulators of InR and TOR signalling — PTEN
and Tsc1–Tsc2, respectively — could counteract the effects of Rheb
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Figure 3 Epistatic relationship of Rheb with the InR/dPI(3)K and the TOR
signalling pathways. (a–l) SEMs showing ommatidial size and shape of
female flies. (a) Control (b) GMR-Gal4/+; UAS-PTEN/+ (c) GMR-Gal4/+;
UAS-Tsc1 UAS-Tsc2/+ (d) dPKB1/dPKB3 (e) S6Kl-1/S6Kl-1 (f) GMR-Gal4/+;
EP50.084/+ (g) GMR-Gal4/+; EP50.084/UAS-PTEN (h) GMR-Gal4/+;
EP50.084/UAS-Tsc1 UAS-Tsc2 (i) GMR-Gal4/+; EP50.084 dPKB1/dPKB3
(j) GMR-Gal4/+; S6Kl-1 EP50.084/S6Kl-1 (k) GMR-Gal4/TOR2L1;
EP50.084/+ (l) GMR-Gal4/TOR2L1; EP50.084/S6Kl-1. Ommatidial size
relative to the control is indicated in each panel. Expression of Rheb under
GMR-Gal4 control results in large and disorganised ommatidia (f). This
phenotype can be suppressed by co-expression of Tsc1/2 (h), but not by
PTEN (g). The enlarged ommatidial size is still evident in a dPKB mutant
background (i), but is neutralised in flies lacking S6K function (j). The
effects of Rheb overexpression are dominantly alleviated by TOR2L1 (k).
(m–r) SEMs showing heads of mosaic female flies generated by the ey-Flp
method. The heads are largely homozygous mutant for (m) Control (n)
PTEN2L117 (o) Tsc12G3 (p) Rheb2D1 (q) PTEN2L117 and Rheb2D1 (r) Rheb2D1
and Tsc12G3. Note that Rheb is epistatic over both PTEN and Tsc1, as
indicated by the Rheb-like phenotype of the respective double mutants as
shown in q and r. (s) Pupae doubly mutant for Tsc1 and Rheb (upper panel,
right) are smaller than heterozygous control pupae (left). Animals lacking
Tsc1 do survive if Rheb function is compromised (lower panel, bottom). The
surviving flies are slightly reduced in size when compared with the
heterozygous control (top). Genotypes are: Tsc12X1, Rheb2D1/TM3
(heterozygous control animals), Tsc12X1, Rheb2D1/Tsc11A2, Rheb7A1 (doubly
mutant animals).
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overexpression. All overexpression experiments were performed in the
eye using the GMR-Gal4 driver line. Expression of either PTEN or
Tsc1–Tsc2 alone resulted in a very similar size reduction of the omma-
tidia (Fig. 3b, c) when compared with control ommatidia (Fig.
3a)17–20. However, whereas expression of PTEN had no influence on
the increase in ommatidial size caused by Rheb overexpression (Fig.
3g), co-expression of Tsc1–Tsc2 resulted in ommatidia of approxi-
mately wild-type size (Fig. 3h), indicating that the activities of Rheb
and Tsc1–Tsc2 can counteract each other. Next, the enlarged omma-
tidia phenotype of GMR-Rheb was assayed in a number of mutant
backgrounds. Reducing the activity of Drosophila protein kinase B
(dPKB) had no effect on the ommatidial size (Fig. 3i). Similar results
were obtained with hypomorphic mutations in InR and Dp110,
respectively (data not shown). In contrast, ommatidial size was domi-
nantly reduced by a mutation in TOR (TOR2L1; Fig. 3k), and a suppres-
sion to wild-type size was observed in a S6K mutant background (Fig.
3j). Thus, the Rheb overexpression phenotype is dependent on TOR
and S6K function, but is independent of InR signal strength. Finally,
we analysed the behaviour of Rheb PTEN and Rheb Tsc1 double
mutants. The phenotypic consequences were assayed in mosaic ani-
mals using the ey-Flp method. As expected, the Rheb PTEN double-
mutant tissue clearly displayed a Rheb phenotype (Fig. 3q). The Rheb
Tsc1 mutant tissue also resembled Rheb single mutants (Fig. 3r), indi-
cating that Rheb is epistatic over Tsc1.
Complete loss of Tsc1 function results in larval lethality17,18,21.
Importantly, we found that a simultaneous reduction of Rheb function
was sufficient to restore viability. The emerging double-mutant flies
displayed a weak Rheb hypomorphic phenotype (a moderate size
reduction; Fig. 3s). These findings suggest that the major consequence
of a lack of Tsc1 is overactivation of Rheb.
Our genetic analysis indicated that Rheb regulates S6K through
TOR. Therefore, we tested whether S6K activity is dependent on Rheb
function. Larval extracts of various heteroallelic Rheb combinations
were subjected to S6K and PKB kinase assays. Indeed, S6K activity was
significantly reduced in all combinations without any apparent effect
on S6K protein levels (Fig. 4a). PKB activity, however, was consistently
increased (Fig. 4b). This is in agreement with the hypothesis that S6K
is an essential component of a negative feedback loop regulating InR
signalling22,23. Conversely, ubiquitous expression of Rheb resulted in
an increase in S6K activity (Fig. 4c) and a concomitant decrease in
dPKB activity (Fig. 4d). The stimulation of S6K activity by Rheb was
also observed after amino-acid deprivation (Fig. 4e). Thus, Rheb is
both necessary and sufficient for S6K activation.
Although Rheb is essential for S6K activity, and the overgrowth phe-
notype elicited by Rheb overexpression depends on S6K, regulation of
S6K is clearly not the only effect of Rheb activity. Whereas flies lacking
S6K function are semi-viable (exhibiting a severe delay in development
and a reduced body size24), loss of Rheb is lethal. Moreover, reduction
of Rheb activity results in a decrease in cell number and cell size (as
opposed to S6K mutants, which only affect cell size). Finally, the char-
acteristic shape of Rheb mutant cell clones suggests that Rheb has other
function in addition to growth control.
Two models of Rheb activity can be envisaged: first, Rheb could
function in the TOR signalling pathway directly downstream of and
negatively regulated by Tsc1–Tsc2 (Supplementary Information,
Fig. S3a). Second, Rheb might be a component of an independent
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Figure 4 Rheb affects the kinase activities of S6K and dPKB. (a) S6K
activity depends on Rheb function. Larval extracts of various Rheb
heteroallelic combinations were assayed for S6K kinase activity. All
combinations showed a significant reduction in the kinase activity. (b) In
contrast to the effect on S6K, reduction of Rheb function resulted in an
increase in dPKB activity. (c) Ubiquitous expression of Rheb resulted in a
marked increase in S6K activity, accompanied by a decrease in dPKB
activity (d). Kinase assays were performed 7 h after heat-shock-mediated
Rheb induction. (e) Amino-acid deprivation for 6 h (after 4 h recovery from
heat-shock) did not compromise the ability of Rheb to stimulate S6K
activity. Western blots of S6K and α-tubulin are shown as loading controls in
the bottom panels of a, c and e. 32P-CT: 32P-Crosstide. Western blots of
dPKB and α-tubulin are shown as loading controls in the bottom panels of b
and d.
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pathway that impinges on S6K (Supplementary Information,
Fig. S3b). In the latter model, the TOR signalling pathway and the
putative parallel pathway would both be necessary for the full activa-
tion of S6K. This could explain why impairing the activity of one path-
way interferes with the consequences of overactivating the other.
Nevertheless, we favour the former model because Rheb mutants show
striking similarities with TOR signalling defects and because of the
intimate genetic interactions of Rheb with Tsc1–Tsc2. A particularly
attractive hypothesis implicates Tsc2 as the GAP of Rheb. Indeed, in an
accompanying paper, Zhang et al. provide evidence that Tsc2 is the
GAP for Rheb in Drosophila (this issue), and the same conclusion has
been derived from studies on the mammalian homologues of
Drosophila TSC2 and Rheb (F.J.T. Zwartkruis, J.L. Bos and G.T., per-
sonal communication).
Interestingly, loss of rhb1 function in the fission yeast
Schizosaccharomyces pombe results in a growth arrest phenotype that is
very similar to that of nitrogen-starved cells25. Thus, the function of
Rheb in growth regulation in response to nutrients (amino acids) may
have been conserved during evolution. Furthermore, the fact that
impaired Rheb function is sufficient to suppress the phenotypic conse-
quences of loss of PTEN and TSC1/TSC2 suggests that Rheb might be
a suitable target for therapeutic intervention in a wide range of
tumours.
METHODS
Genetics. EMS-induced Rheb alleles were isolated in an ey-Flp mosaic screen26
that will be described elsewhere. Two alleles, Rheb2D1 and Rheb2G5, were
mapped genetically with respect to visible markers. A subsequent fine mapping
step placed the mutations between the P-element insertions EP974 (83A3) and
l(3)j1C2 (83C1-2) in a candidate region of 312.5 kb. Eight polymorphisms dis-
tributed over the candidate region were used to establish a high-resolution SNP
map. The candidate region could be narrowed down to 60 kb by mapping the
recombination sites between the Rheb alleles and the two P elements using SNP
detection by DHPLC27. Candidate open reading frames in this interval were
amplified by PCR from heterozygous Rheb flies and tested for polymorphisms
by DHPLC. Amplified fragments of CG1081 displayed various polymorphisms
and were subsequently sequenced.
The EP line 50.084 was identified among 10,000 novel insertions of a double-
headed EP element. It is inserted six nucleotides downstream of the 5′ end of
the first exon of transcript CG1081-RA (GadFly database). The EP50.084 chro-
mosome carries a closely linked lethal factor that cannot be reverted by mobili-
sation of the EP element. The UAS sites at the 5′ end of EP50.084 were excised
by Cre-loxP-mediated recombination to yield a single-headed EP element capa-
ble of driving Rheb. EP50.084 was remobilised by crossing in the transposase
source ∆2-3 to generate imprecise excision alleles. At least 83 independent
reversions of the dominant yellow+ marker were recovered; six of them failed to
complement the Rheb alleles. The two imprecise excision alleles that yielded
viable combinations with some EMS-alleles (Rheb44.1 and Rheb56) retained par-
tial sequences of the EP element (0.6 and 1.1 kb, respectively) without deleting
any flanking genomic sequences.
The following transgenes and mutations were used for interaction studies:
GMR-Gal4 (ref. 28), UAS-PTEN (ref. 20), UAS-Tsc1, UAS-Tsc2 (ref. 17),
dPKB1 (ref. 29), dPKB3 (ref. 30), TOR2L1 (ref. 13), S6Kl-1 (ref. 24), PTEN2L117
(ref. 31), Tsc12G3, Tsc12X1 and Tsc11A2 (H.S. and E.H., unpublished observa-
tions).
To generate loss-of-function clones, we used the lines y w hs-Flp; FRT82 Ubi-
GFP and y w hs-Flp; FRT82 Ubi-GFP M / TM6B for clones in the imaginal discs,
and y w hs-Flp; FRT82 w+ M / TM6B for clones in the adult eye. Clones were
induced in 48–72-h-old larvae by a 45-min heat-shock at 34 °C. To circumvent
potential side effects caused by second hits, at least three different EMS-induced
Rheb alleles were tested in each experiment. The results were always qualita-
tively similar.
Overexpression clones were generated by means of the ‘FLP-out’ technique
using the lines y w hs-Flp; Act>CD2>Gal4 UAS-GFPnls / TM6B (ref. 32) and y w
hs-Flp; GMR>w+>Gal4 (ref. 33), respectively. FLP-out clones were induced
either in 80-h-old larvae by a 13-min heat-shock at 34 °C (Act>CD2>Gal4), or
in 24–48-h-old larvae by a 1-h heat-shock at 37 °C (GMR>w+>Gal4). To
achieve overexpression in the endoreplicative larval tissues, spontaneous FLP-
out events using y w hs-Flp; Act>CD2>Gal4 UAS-GFPnls / TM6B without heat-
shock application were recovered16. All the overexpression experiments were
performed using EP50.084 and two UAS-Rheb lines (individually or in combi-
nation). The severity of the resulting phenotypes was always in accordance with
the order EP50.084 > UAS-Rheb13.1+14.2 > UAS-Rheb14.2 > UAS-Rheb13.1,
presumably reflecting different expression levels. To deprive larvae of dietary
amino acids, 60-h-old larvae were incubated in 20% sucrose solution.
Eye-specific clones were generated using the ey-Flp system, as previsouly
described26. For the double-mutant analysis of PTEN Rheb clones, the ey-Flp
systems for 2L and 3R were combined to induce clones simultaneously for
FRT40 PTEN2L117 and FRT82 Rheb. To study the effects of Rheb Tsc1 double
mutants, recombinant chromosomes were generated with various alleles.
Gal4 under control of a heat-shock promoter (hs-Gal4) was used to ubiqui-
tously overexpress Rheb. Second-instar larvae were transferred to tubes con-
taining fresh squashed fly food and placed in a waterbath at 37 °C for 45 min.
Then larvae were allowed to recover at room temperature for the indicated
times before analysis in kinase assays.
Measurements and data analysis. The body weight of male flies three days after
eclosion was measured with a precision scale (Mettler Toledo, Greifensee,
Switzerland). Wings of female flies were mounted and analysed as previously
described10. Scanning electron microscope (SEM) images of five female fly eyes
per genotype were analysed to characterise the eye phenotypes. Rosettes of
seven ommatidia were measured using the NIH image software to determine
ommatidial area.
Extraction of larvae, kinase assays and western blotting. Larvae were extracted
essentially as described13, however with a modified extraction buffer (120 mM
sodium chloride, 50 mM Tris-HCl at pH 7.0, 20 mM sodium fluoride, 1 mM
benzamidine, 1 mM EDTA, 6 mM EGTA, 15 mM Na4P2O7-10H2O and 1% NP-
40; the following reagents were added shortly before use to the indicated con-
centrations: 1/5 volume Complete Mini protease inhibitor cocktail (Roche
Diagnostics, Rotkreuz, Switzerland) prepared as a 5× stock in extraction buffer
without the reagents listed hereafter, 2 mM AEBSF (Pefabloc SC (Roche)), 30
mM para-nitrophenylphosphate, 30 mM β-glycerolphosphate, 4 µM leu-
peptin, 2 µM aprotinin, 4 µM pepstatin and 100 µM phenyl methylsulphonyl
fluoride).
Kinase activity assays of either S6K or dPKB were performed as
described13,22.
For immunoblotting, the following antibodies were used at the indicated
dilutions: S6K D-20 antibody at 1:200 (ref. 24), dPKB antibody (ref. 34) at
1:1000 and α-tubulin antibody (Sigma, St Louis, MO) at 1:1000. HRP-conju-
gated secondary antibodies (Dako A/S, Glostrup, Denmark) were diluted
1:2000. Signals were detected using ECL western blotting detection reagents
(Amersham Biosciences, Little Chalfont, Buckinghamshire, UK).
Note: Supplementary Information is available on the Nature Cell Biology website.
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Living with Lethal PIP3 Levels:
Viability of Flies Lacking PTEN
Restored by a PH Domain
Mutation in Akt/PKB
Hugo Stocker,1 Mirjana Andjelkovic,2* Sean Oldham,1
Muriel Laffargue,3 Matthias P. Wymann,3 Brian A. Hemmings,2
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The phosphoinositide phosphatase PTEN is mutated in many human cancers.
Although the role of PTEN has been studied extensively, the relative contri-
butions of its numerous potential downstream effectors to deregulated growth
and tumorigenesis remain uncertain. We provide genetic evidence in Drosophila
melanogaster for the paramount importance of the protein kinase Akt [also
called protein kinase B (PKB)] in mediating the effects of increased phospha-
tidylinositol 3,4,5-trisphosphate (PIP3) concentrations that are caused by the
loss of PTEN function. A mutation in the pleckstrin homology (PH) domain of
Akt that reduces its affinity for PIP3 sufficed to rescue the lethality of flies
devoid of PTEN activity. Thus, Akt appears to be the only critical target activated
by increased PIP3 concentrations in Drosophila.
Mutations in the tumor suppressor gene
PTEN (the phosphatase and tensin homolog
on chromosome 10) are frequent in glioblas-
tomas, endometrial carcinoma, melanomas,
and prostate cancer (1). Furthermore, two
dominant hamartoma syndromes, Cowden
disease and Bannayan-Zonana syndrome, are
linked to germ line mutations in PTEN (1).
The PTEN protein carries a phosphatase do-
main resembling those of dual-specificity
protein phosphatases (2–4). Although it can
dephosphorylate protein substrates such as
focal adhesion kinase (5) and the adapter
protein Shc (6), PTEN’s predominant enzy-
matic activity appears to be the dephospho-
rylation of phosphoinositides at the D3 posi-
tion. Because PTEN uses the second messen-
ger PIP3 as a substrate, PTEN antagonizes
the function of phosphatidylinositol-3 kinase
(PI3K) (7, 8). Immortalized mouse embryon-
ic fibroblasts or embryonic stem cells lacking
PTEN function show an approximately two-
fold increase in PIP3 concentrations (9, 10).
PIP3 interacts with a wide variety of PH
domain-containing proteins, including the
serine-threonine kinases Akt (also called
PKB) and phosphoinositide-dependent kinase
1 (PDK1), Btk family tyrosine kinases, gua-
nine nucleotide exchange factors for the Rho
and Arf families of small guanosine triphos-
phatases, and phospholipase Cg (11, 12). The
plethora of proteins that are potentially regu-
lated by PIP3 provides widespread signaling
potential for this lipid second messenger.
Genetic analyses in model organisms have
implicated PTEN as a negative regulator of
insulin receptor signaling. In the nematode
Caenorhabditis elegans, PTEN antagonizes
the activity of the PI3K AGE-1 in the regu-
lation of metabolism, development, and life
span (13–16). In the fruit fly Drosophila
melanogaster, PTEN counteracts signaling
downstream of the insulin receptor to control
cellular growth (17–19). There are, however,
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Fig. 1. Reduced kinase
activity caused by an
amino acid substitution
in the PH domain of
dAkt. (A) Effect of the
G99S substitution in
the PH domain on dAkt
kinase activity from lar-
val extracts (42). Activ-
ity from wild-type lar-
vae was considered to
be 100%. Inset, dAkt
protein was detected in 40 mg of larval extracts using the same antiserum. (B) Reduced insulin-induced
activation of the G99S mutant dAkt. The dAkt constructs were expressed in HEK 293 cells (43).
Transfected cells were starved for 24 hours before stimulation with insulin for the indicated time
periods, and dAkt kinase activity was determined (44). The activity of wild-type dAkt from unstimulated
cells was considered to be relative activity 5 1.
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additional phenotypes associated with muta-
tions in PTEN that cannot easily be recon-
ciled with an exclusive function of PTEN in
insulin receptor signaling [for example, the
burst vulva phenotype in C. elegans (13) and
defects in the actin cytoskeleton in Drosoph-
ila (17)]. To better understand the conse-
quences of loss of PTEN function, it would
be useful to know which important down-
stream effectors react to increased PIP3 con-
centrations and whether PTEN has other
physiological substrates in addition to PIP3.
The protein kinase Akt is an important
component of insulin receptor signaling (20).
Akt is recruited to the plasma membrane by
virtue of the interaction of its NH2–terminally
located PH domain with PIP3. At the mem-
brane, subsequent phosphorylation events by
PDK1 and an unidentified kinase lead to the
full activation of Akt (21–23). In PTEN-
deficient mouse embryonic fibroblasts and
embryonic stem cells, Akt is phosphorylated
and activated (9, 10). The phenotypes asso-
ciated with Akt mutations in both C. elegans
and Drosophila are consistent with its role in
signal transduction downstream of the insulin
receptor (24–27).
We monitored three properties of Dro-
sophila Akt (dAkt) separately: kinase activi-
ty, abundance of the protein, and membrane
localization. We relied entirely on mutations
in the endogenous gene encoding dAkt to
avoid potential side effects caused by over-
expression of mutant proteins. dAkt1 en-
codes a catalytically inactive protein,
dAktF327I (25). The viable dAkt4226 allele
contains a P-element insertion upstream of
the dAkt gene and therefore results in the
reduced expression of wild-type dAkt pro-
tein (19, 28). Finally, we characterized the
viable hypomorphic mutation dAkt3 (29)
that selectively impairs the membrane re-
cruitment of dAkt in response to increased
concentrations of PIP3. Sequencing of
genomic DNA extracted from dAkt3 ho-
mozygous flies revealed a single nucleotide
exchange resulting in the substitution of a
serine residue for a nonconserved glycine
at the end of the sixth b sheet of the PH
domain. To address the mechanism by
which this Gly99 3 Ser99 (G99S) mutation
in the PH domain affects dAkt, we com-
pared the amount of dAkt protein and ac-
tivity in wild-type and dAkt3 mutant larvae.
Whereas no apparent difference in expres-
sion of the protein was observed (Fig. 1A,
inset), dAkt activity from the mutant larvae
represented only 30% of that in wild-type
larval extracts (Fig. 1A). We also expressed
epitope-tagged forms of wild-type dAkt,
catalytically inactive dAktF327I, and PH
domain mutant dAktG99S in insulin-re-
sponsive human embryonic kidney (HEK)
293 cells. All three proteins were expressed
in similar amounts (30). dAktG99S activity
from insulin-stimulated cells was reduced
by about 90% as compared to that of the
wild-type kinase (Fig. 1B). All forms of
dAkt proteins were detected in the cytosol
of unstimulated cells (Fig. 2, A, D, and G).
Stimulation of the cells with insulin for 5
min resulted in association of the wild-type
and the catalytically inactive enzymes with
the plasma membrane, but failed to recruit
the dAktG99S mutant protein (Fig. 2, B, E,
and H). In contrast, treatment of HEK 293
cells with the protein-tyrosine phosphatase
inhibitor pervanadate, a potent activator of
Akt (31), led to membrane recruitment of
all dAkt proteins (Fig. 2, C, F, and J).
Fig. 2. Reduced mem-
brane localization of
the G99S mutation of
dAkt. HEK 293 cells
plated on coverslips
were transfected with
epitope-tagged wild-
type (A to C), G99S (D
to F), and F327I (G to J)
dAkt and deprived of
serum for 16 hours be-
fore stimulation with
insulin (B, E, H) or per-
vanadate (C, F, J) for 5
min. Fixed and perme-
abilized cells were incu-
bated Þrst with the
monoclonal antibody
12CA5 to the HA
epitope and then with
ßuorescein isothiocya-
nateÐconjugated sec-
ondary antibody. An
analysis by confocal mi-
croscopy revealed the
subcellular localization
of the dAkt variants.
Fig. 3. Restored viability of ßies lacking dPTEN function by the PH
domain mutation in dAkt. (A) Morphology and weight of dPTEN mutant
ßies rescued by dAkt3/dAkt1. The left panel shows female ßies, the middle
panel shows male ßies, and the right panel shows the weight of adult
male ßies. (B) PIP3 concentrations in ßies devoid of dPTEN function
rescued by the dAkt3 mutation.
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Consistently, pervanadate treatment stimu-
lated dAktG99S activity to 80% of the
wild-type level. However, pervanadate-in-
duced activation of the mutant protein oc-
curred more slowly than did that of the
wild-type kinase (30). Taken together,
these data indicate that the G99S substitu-
tion reduces the association of dAkt with
the plasma membrane, probably by affect-
ing the affinity of its PH domain for PIP3.
Thus, dAkt3 enabled us to study the conse-
quences of impaired recruitment of dAkt to
the plasma membrane.
We combined the dAkt alleles with null
mutations in dPTEN (32). Animals lacking
dPTEN function die during larval stages. A
reduction in dAkt expression using the viable
dAkt4226 allele did not rescue the lethality
associated with dPTEN. Similarly, animals
doubly mutant for dPTEN and dAkt1 did not
survive. Thus, either dAkt activation is not
the sole reason for the lethality caused by loss
of PTEN, or dAkt function is not dispensable
in the absence of dPTEN. The latter hypoth-
esis is strongly supported by results obtained
with the dAkt allele that selectively impairs
the membrane recruitment of dAkt. Flies de-
void of functional dPTEN were rescued to
viability by any dAkt allelic combination that
included dAkt3 (Fig. 3A) (33). The rescued
flies did not display morphological defects
that would be expected in light of the pheno-
types ascribed to clones of dPTEN mutant
cells (17). Tangential sections through com-
pound eyes revealed essentially normal om-
matidial and rhabdomeric structures, and the
wings of the rescued flies showed no abnor-
malities in the venation, such as missing
crossveins (34). We determined the PIP3/
PIP2 ratio by metabolic labeling of phospho-
lipids from larvae (35). PIP3 concentrations
were increased in the dPTEN dAkt doubly
mutant larvae as compared to those of wild-
type larvae (Fig. 3B), excluding the possibil-
ity that PIP3 concentrations remain within
physiological limits by a feedback regulation
mechanism involving dAkt. This suggests
that the potential activation of a number of
PH domain–containing proteins other than
dAkt does not interfere with viability.
Our results indicate that the activation of
dAkt is the only crucial outcome of the loss
of dPTEN function. Activation of dAkt
should therefore mimic the dPTEN loss-of-
function phenotype. We expressed a consti-
tutively activated membrane-anchored dAkt
during eye development (36). The resulting
eyes were increased in size due to enlarged
ommatidia (Fig. 4B), a phenotype similar to
that seen in clones of dPTEN mutant cells
(17–19). This overgrowth phenotype is inde-
pendent of upstream signals, because it was
still evident in a chico or Dp110/PI3K mutant
background (Fig. 4D) (34).
We conclude that flies devoid of the tu-
mor suppressor dPTEN can live with abnor-
mally high concentrations of PIP3 if only the
affinity of dAkt for PIP3 is decreased. Thus,
the PH domain–mediated translocation of
dAkt to the membrane and its subsequent
activation is the only lethal event triggered by
increased PIP3 concentrations. Because the
PH domain of Akt interacts with the substrate
of PTEN’s lipid phosphatase activity, we also
conclude that PTEN does not exert any es-
sential function other than the dephosphoryl-
ation of PIP3.
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Reverse Transcriptase–Mediated
Tropism Switching in Bordetella
Bacteriophage
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Host-pathogen interactions are often driven by mechanisms that promote
genetic variability. We have identified a group of temperate bacteriophages that
generate diversity in a gene, designated mtd (major tropism determinant),
which specifies tropism for receptor molecules on host Bordetella species.
Tropism switching is the result of a template-dependent, reverse transcriptase–
mediated process that introduces nucleotide substitutions at defined locations
within mtd. This cassette-based mechanism is capable of providing a vast
repertoire of potential ligand-receptor interactions.
The infectious cycles of Bordetella subspe-
cies, which cause respiratory infections in
humans and other mammals, is controlled by
the BvgAS signal transduction system (1).
Using a multistep phosphorelay, the BvgS
transmembrane sensor-kinase and the BvgA
transcriptional regulator couple environmen-
tal signals to expression of cell surface and
secreted molecules (1, 2). The Bvg1 phase,
which is necessary and sufficient for respira-
tory tract colonization, is characterized by a
high level of BvgAS activity and expression
of virulence and colonization factors that in-
clude adhesins, toxins, and a type III secre-
tion system (2). In the Bvg2 phase, BvgAS is
inactive, virulence and colonization factors
are not expressed, and numerous genes are
induced, including motility loci in Bordetella
bronchiseptica and virulence repressed genes
in Bordetella pertussis (2, 3). The Bvg2
phase appears to be adapted to ex vivo
growth and survival in B. bronchiseptica (4).
Recent evidence suggests that BvgAS is ca-
pable of controlling a spectrum of distinct
phenotypic phases in response to subtle
changes in signal intensity (5, 6).
In a search for generalized transducing
vectors, we identified several temperate bac-
teriophages present in clinical isolates of B.
bronchiseptica that displayed a marked tro-
pism for Bvg1 as opposed to Bvg2 phase
bacteria. The efficiency of plaque formation
of a representative phage, designated BPP-1
(Bvg plus tropic phage–1), was 106-fold
higher on Bvg1 phase RB50 (wild-type B.
bronchiseptica) than on an isogenic Bvg2
phase-locked strain (DbvgS) (Fig. 1A). An
adsorption assay (Fig. 1B) indicated that the
BPP-1 receptor is specifically expressed in
the Bvg1 phase. Mutagenesis of loci encod-
ing Bvg1 phase surface factors showed that
deletion of prn, which encodes the adhesin
pertactin (7), eliminated BPP-1 adsorption
and decreased phage plaquing to a level sim-
ilar to that observed on Bvg2 phase cells
(Fig. 1, A and B). Ectopic expression of prn
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Fig. 1. (A) EfÞciency of plaquing by a high-titer
BPP-1 lysate [4 3 1010 plaque forming units/ml
(pfu/ml)] on isogenic B. bronchiseptica mu-
tants. The DbvgS, DfhaB, DfimBCD, DcyaA,
Dprn, and Dtrs mutations are in-frame deletion
mutations that eliminate BvgS activity or ex-
pression of FHA (Þlamentous hemagglutinin),
Þmbriae, adenylate cyclase toxin, pertactin, or
the type III secretion apparatus. Black bars in-
dicate Bvg1 phase strains; gray bars indicate
strains genetically locked in the Bvg2 phase.
pTac-prn is a complementing plasmid that ex-
presses pertactin under control of the Tac pro-
moter. E. coli strain DH5a and Yersinia entero-
colitica strain JB580v did not support phage
growth. ND, no plaque detected. (B) BPP-1
adsorption assay (8) with the use of wild-type
B. bronchiseptica strain RB50 (4), isogenic Bvg2
(DbvgS), and Dprn derivatives, all grown under
Bvg1 phase conditions. (C) Summary of tro-
pism switching frequencies by Bordetella phag-
es. A spontaneous mutant resistant to BIP-1
but still sensitive to BPP-1 and BMP-1 were
used to obtain switching frequencies from
BIP-1 to BPP or BMP tropic variants.
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In the following sections, some studies that are relevant to the topic of insulin
signaling and growth control and to which I contributed significantly will be presented.
An evolutionarily conserved function of the Drosophila insulin receptor and of
insulin-like peptides in growth control
This study describes the identification of the seven insulin-like peptides (termed
DILPs) encoded by the Drosophila genome. Overexpression of one of these
peptides, DILP2, results in a growth promotion, and this effect is dependent on an
intact insulin signal transduction cascade.
PDK1 regulates growth through Akt and S6K in Drosophila
 A genetic characterization of phosphoinositide-dependent kinase 1 (PDK1), a
serine/threonine kinase that phosphorylates PKB and S6K.
The Drosophila Forkhead transcription factor FOXO mediates the reduction in
cell number associated with reduced insulin signaling
FOXO, a member of the forkhead family of transcription factors, is identified as a
putative target of PKB. Surprisingly, the loss of FOXO function does not result in
overgrowth. However, the growth deficit of flies with impaired insulin signaling is
ameliorated by the simultaneous loss of FOXO function.
Diet-dependent effects of the Drosophila Mnk1/Mnk2 homolog Lk6 on growth
via eIF4E
Lk6, the Drosophila homolog of Mnk1/2 kinases, phosphorylates the translation
initiation factor eIF4E. Whether eIF4E phosphorylation results in stimulation or
inhibition of translation is under debate. This study demonstrates genetically that
eIF4E phosphorylation by Lk6 promotes growth, but that Lk6 overexpression can
exert a negative effect, depending on the composition of the food source.
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Background way alone is not sufficient to promote cell growth and
Each individual organ grows by controlling cell number cell cycle progression.
and/or cell size to reach its final dimensions in relation
to the size of the organism. This process is tightly regu- The Drosophila homolog of the insulin/IGF1 receptor,
lated and modulated by environmental factors such as DInr, is essential for normal development and is required
nutrient availability and temperature [1–4]. How organ for the formation of the epidermis and the nervous system
growth is coordinated within a single individual is still during embryogenesis [15]. All described alleles of dinr
poorly understood. In mammals, hormones and growth are recessive embryonic or early larval lethal. Only weak
factors are known to play a predominant role in controlling heteroallelic combinations of dinr alleles were found to
organismal growth by orchestrating cell growth, cell prolif- be viable and yield adults with a severe developmental
eration, and cell survival [5, 6]. Reducing the levels of delay, small body size, and female sterility [15, 16]. It is
growth hormone or its mediators, IGF1 and the IGF1 not known, however, whether the effect of DInr on growth
receptor (IGF1R), strongly affects body and organ size. is cell autonomous and whether activation of DInr is suffi-
In contrast to the well-established role of the IGF1R in cient to promote growth and cell division. Furthermore,
growth control, a corresponding role of the insulin receptor the identity of a ligand(s) for DInr has remained elusive.
is less well understood.
This study examines the effects on cell, organ, and organ-
Recently, genetic studies in Drosophila have highlighted ismal size when activity levels of DInr and of a new
a conserved signaling pathway that plays an essential role putative ligand are changed during development. Fur-
in controlling body, organ, and cell size. This pathway thermore, we describe the structure and expression pat-
involves the homolog of the insulin receptor substrates tern during development of seven insulin-like genes in
(Chico), PI(3)K (Dp110), PTEN (dPTEN), Akt/PKB Drosophila.
(DAkt1/dPKB), and S6K (dS6K). Mutations in any one
of these components lead to a change in cell size and, Results and discussion
with the exception of dS6K, in cell number as well [7–14]. DInr regulates body and organ size by altering cell
number and cell size in a cell-autonomous mannerConversely, overexpression of Dp110 or DAkt1 leads to
Flies that are homozygous for a partial loss-of-functionan increased cell size without affecting cell numbers [9, 13].
Thus, it appears that stimulation of the PI(3)K/PKB path- mutation in dinr (dinrE19) [16] show a phenotype similar
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Figure 1
DInr regulates body and organ size by altering
cell number and cell size in a cell-autonomous
manner. (a) dinrE19/dinrE19 flies (right) show a
proportionate body size reduction compared
to dinrE19/1 control flies (left). (b,e) Selective
removal of DInr function in eye progenitor
cells generates flies with strongly reduced
eyes and head capsule while all other body
parts are of wild-type size. Note the relatively
smaller head size of a null allele (e) than of
a hypomorphic allele (b) compared to controls.
(c,f) Tangential sections through a mosaic
eye containing small homozygous dinr mutant
ommatidia (lacking pigment) and normal-sized
heterozygous ommatidia (containing pigment).
Homozygous dinrE19 (c) and dinr31 (f) mutant
photoreceptors are reduced in size by
approximately one third and more than half,
respectively. Arrowheads point to
rhabdomeres of small homozygous mutant
photoreceptors within genotypically mixed
ommatidial units coexisting with normal
heterozygous photoreceptors, demonstrating
a cell-autonomous requirement for DInr. (d)
Confocal microscope section of a third instar
eye imaginal disc containing mitotic clones
of dinr304 mutant cells (absence of green
staining), which are significantly smaller
than their wild-type (bright green staining)
sister clones; anterior is to the top. (g)
Quantitation of body and organ size in dinrE19
homozygous mutant male flies and in
heterozygous siblings. In homozygous flies,
the body weight and number of ommatidia is
reduced by 52% and 45%, respectively. The
wing area is decreased by 36%, due to a
significant decrease in cell size and cell
number by 23% and 17%, respectively. Values
are means 6 standard deviation; all values
of homozygous flies are significantly reduced
relative to their heterozygous siblings (t-test,
p , 0.0001). Similar results were obtained
with female flies. (h) Five dinr alleles carry
point mutations in conserved amino acid
residues of the kinase domain. An alignment
of the kinase domain of the human insulin
receptor (HInRKin) and the Drosophila
homolog of insulin receptor (DInRKin) is predicted active site residues conferring Flies were of the following genotypes: (a) y w;
shown with the localization and molecular substrate specificity [21]. The shading marks dinrE19/TM3, Sb Ser (left) and y w; dinrE19/
description of the point mutations. dinr31 and amino acid identity (black) or similarity (gray). dinrE19 (right), (b,e) y w ey-Flp; FRT82B dinrE19,
dinr304 are nonsense mutations in the same We used the amino acid numbering of 31/TM6B, y1 (left) and y w ey-Flp; FRT82B
codon at different nucleotide positions Fernandez et al. [15] for DInRKin and of Ebina dinrE19, 31/FRT82B P(w1) 3R3.7 (right), (c,f) y
(Trp1439Stop). The mutations leading to an et al. [45] for HInRKin. The sequences were w ey-Flp; FRT82B dinrE19, 31/FRT82B P(w1)
amino acid substitution are dinr353 aligned with the GCG program package. The 3R3.7, (d) y w hsFlp/y w; FRT82B dinr304/
(Arg1419Cys), dinr339 (Gly1491Glu), and abbreviations are single amino acid letter FRT82B P(arm-lacZ, w1), and (g) y w; dinrE19/
dinr211 (Gly1551Arg). Asterisks denote code, with “al” indicating an activation loop. 1 and y w; dinrE19/dinrE19.
to that previously described for weak heteroallelic combi- dinrE19 flies have an almost 2-fold increase in lipid content
(data not shown). The small body size is attributable tonations. The developmental time is extended from 10
to 20 days, and body size is severely but proportionally a reduction in cell size and cell number by 23% and 17%,
respectively (Figure 1g) as revealed by measuring cellreduced. The mutant flies are approximately half the
weight of their heterozygous siblings (Figure 1a,g), and density in the wing. Similarly, the average number of
ommatidia in the compound eye of mutant male flies isfemales are sterile. Furthermore, like chico mutant flies,
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Figure 2
Overexpression of DInr in the eye leads to a
hyperproliferative outgrowth and an increase
in cell size. (a) Scanning electron micrograph
(SEM) and (d) tangential section of control
eyes. (b) SEM of an eye displaying a dramatic
outgrowth due to an increase in ommatidia
number. This phenotype is caused by the
overexpression of UAS-dinrwt with ey-Gal4 in
proliferating eye precursor cells. A tangential
section of the corresponding eye (e) shows
that normal ommatidial arrangement and
architecture are retained. (c,f) Eyes
overexpressing UAS-dinrwt in clones under the
control of the GMR enhancer, which is mainly
activated in differentiating cells. Externally,
such clones display enlarged ommatidial
units compared with the surrounding wild-type
ommatidia (c). In tangential sections (f), these
clones (less pigment) contain enlarged
ommatidia with enlarged photoreceptors and
increased interommatidial distance. The
magnification in (d–f) is the same. The
genotypes are (a,d) y w; ey-Gal4/1 (b,e) y w;
ey-Gal4/UAS-dinrwt and (c,f) y w hsFlp;
GMR.w1; .Gal4/UAS-dinrwt.
378 6 8 compared to 683 6 8 in heterozygous control zygous mutant tissue and heterozygous tissue; within the
same ommatidial unit, small homozygous cells (arrowheadflies (Figure 1g). We did not observe any dominant size
in Figure 1c,f) coexist with normal-sized heterozygousreduction with various dinr alleles.
cells. Although cells lacking DInr function survive and
differentiate normally, they have a growth disadvantageThe reduced overall size could be due to DInr acting
in the humoral regulation of growth or to it functioning compared to heterozygous cells. When homozygous mu-
tant cell clones are induced during early larval life andautonomously in a cell- and tissue-specific manner. To
test whether DInr affects body parts autonomously, we analyzed in the imaginal discs in the third instar, clone
size is greatly reduced compared to the wild-type sisterselectively removed DInr function in the eye imaginal
disc using the ey-FLP technique [17]. The eye imaginal clone (Figure 1d). The phenotypes of dinr mutant cells
are strikingly similar to those of mutants in the PI(3)K/disc gives rise to the adult eye and the head capsule.
Mosaic flies with heads largely homozygous for various PKB pathway. Therefore, it is likely that DInr directly
regulates cell growth at least in part through the PI(3)K/dinr alleles displayed a dramatic reduction in eye tissue
and in the head capsule, whereas the other body parts PKB pathway.
were of wild-type size (Figure 1b,e). Notably, the head
size was dependent on the allele. This allowed us to Identification of mutations affecting conserved amino
arrange the alleles according to their phenotypic strength acid residues of the kinase domain of DInr
(compare Figure 1b with 1e). The strongest reduction in The structure of DInr is similar to the mammalian insulin
head size was observed with dinr339, a putative null allele receptor (Inr) and the IGF1 receptor (IGF1R) [15]. It is
(see below), followed by dinr31, dinr211, dinrE19, and dinr353. a tetramer composed of two a subunits containing the
Thus, DInr regulates head size autonomously. putative ligand binding domains and two transmembrane
b subunits containing the cytoplasmic tyrosine kinase do-
Comparison of homozygous mutant tissue with heterozy- mains. In contrast to human receptors, DInr possesses
gous tissue in tangential sections of mosaic eyes (Figure extensions at the amino and carboxy termini. The C-ter-
1c,f) revealed an estimated reduction in ommatidial size minal extension contains binding sites for downstream
of one third for dinrE19 homozygous mutant tissue (Figure components similar to those found in insulin receptor
1c) and of more than half for a candidate null allele (Figure substrates (IRS), and has been shown to be able to signal
1f). Importantly, this growth defect does not impede in the absence of IRS proteins [18]. Furthermore, genetic
proper cell fate determination, given that the normal ar- evidence in Drosophila suggests that DInr can signal in
rangement of the photoreceptor rhabdomeres is retained the absence of Chico, the IRS1-4 homolog [7]. In order
(Figure 1c,f). Furthermore, the cell size reduction is cell to understand the molecular basis for differences in
strength of DInr phenotypes, we sequenced the cyto-autonomous, as can be seen at the border between homo-
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Figure 3
A new family of genes encoding putative
insulin-related peptides. (a) Genomic
organization of the dilp gene cluster containing
dilp1–5 mapping to 67C1-2 on the third
chromosome. Genomic DNA (GenBank
accession number AE003550.1) is
represented by a line (top) with distances in
kb and an arrow pointing to the centromere.
Black boxes indicate exons of dilps for which
mRNA expression has been detected (Table 1).
A gray box indicates the predicted exon of
dilp1, which did not show mRNA expression
and therefore may be a pseudogene.
Exon–intron boundaries were determined by
comparing genomic DNA and expressed
sequence tags (EST; bottom lines), or were
predicted by the Genscan program [38]. dilp5
is separated by one intervening gene from
dilp4. Interestingly, each intron splits the
reading frame between position 1 and 2 of
a codon; this is typical for insulin-related genes
[46]. (b) Schematic representation of the
predicted structure of Drosophila insulin-like
peptides (DILP1–7) and comparison with
human IGF and insulin. Domains are denoted
by letters. The spaces between domains
represent predicted proteolytic cleavage [26]
during maturation of the propeptide (see also
supplementary figure). The active peptides
(dark boxes) consist of one polypeptide chain
(IGF) or two chains (DILP1–7 and human
insulin). Disulfide bonds between conserved
cysteines are indicated. (c) Proportionate
increase in body size of male flies
overexpressing DILP2 (top). To achieve
ubiquitous expression of DILP2, we used an
hs-Gal4 driver line (Bloomington stock
center). Heat shocks at 378C were applied
for 1 hr every 12 hr during development,
starting at 24 hr AED. Genotypes are y w;
hs-Gal4/UAS-dilp2 (top) and y w; hs-Gal4/1
(bottom). (d) DILP2 overexpression
increases organismal size by increasing the
cell size and cell number of individual organs. increase in cell size and cell number by 9% 0.001). Male flies that were 2–3 days old were
Compared to control flies, body weight and and 11%, respectively. Values are means 6 weighed and analyzed. Similar results were
number of ommatidia are increased by 39% standard deviation; all values of hs-Gal4/UAS- obtained with female flies. Five independent
and 5%, respectively. The wing area is dilp2 males are significantly increased UAS-dilp2 transgenic lines yielded similar
increased by 21% due to a significant relative to hs-Gal4/1 control flies (t-test, p , results (n 5 16–78).
plasmic region of several dinr alleles [15, 16, 19]. In the [22]. It is the only reported homozygous viable mutation
in the kinase domain of the human Inr. The patient’scytoplasmic portion, 5 out of 22 alleles carry a point muta-
tion. All of them map to conserved amino acid residues parents were heterozygous for this substitution and had
severe insulin resistance, but no growth anomalies. Simi-within the kinase domain. Two of these point mutations
lead to premature stop codons and three are missense larly, heterozygosity for dinr alleles does not lead to growth
phenotypes. These results suggest a role for the insulinmutations (Figure 1h). In humans, most of the mutations
that occur within the tyrosine kinase domain of the Inr receptor in growth control that has been conserved from
insects to humans.have been shown to impair insulin-stimulated tyrosine
kinase activity [20]. dinr353 (Arg1419Cys) affects an active
site residue, which mediates insulin receptor kinase sub- Overexpression of DInr in the eye leads
strate specificity [21]. Remarkably, a human patient with to hyperproliferation and an increase
in cell sizesevere growth retardation associated with insulin resis-
It has been proposed that a bona fide growth controltance, a syndrome called leprechaunism, carries an amino
acid exchange at the corresponding position (Arg1092Glu) gene should meet two criteria [6], namely that elimination
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Table 1
Summary of dilp expression in embryos and larvae.
Gene Embryo Larva
dilp1 no signal N.D.
dilp2 high signal in midgut, low signal in mesoderm stage 12–16 ubiquitous low signal in imaginal discs, high signal in seven
cells of each brain hemisphere and in salivary glands
dilp3 no signal high signal in seven cells of each brain hemisphere
dilp4 high signal in mesoderm stage 2–6, anterior midgut high expression in midgut
rudiment
dilp5 no signal high signal in seven cells of each brain hemisphere,
moderate signal in gut
dilp6 no signal low signal in gut
dilp7 ubiquitous (except yolk) low signal, moderate signal in high signal in ten cells of ventral nerve cord
midgut
N.D., not determined
should result in growth retardation, whereas overexpres- dilp1–5 are on the third chromosome at cytological posi-
tion 67C1-2, and constitute a cluster of four contiguoussion of the gene should promote excessive growth. To
determine whether DInr has a direct growth- and prolifer- insulin-related genes with dilp5 separated by one in-
tervening gene from dilp4 (Figure 3a). The other genes,ation-promoting effect, we overexpressed a wild-type dinr
cDNA using the UAS/Gal4 system [23]. Expressing UAS- dilp6 and dilp7, are on the X chromosome at two different
loci at cytological positions 2F4 and 3F2, respectively.dinr wt specifically in proliferating eye precursor cells using
an eyeless-Gal4 driver resulted in a dramatic outgrowth in dilp1–7 encode putative precursor proteins of 107 to 156
amino acid residues in length that are structurally similarthe adult eye because of an increase in the number of
ommatidia (Figure 2b). Histological sections through the to preproinsulin, with a signal peptide, a B chain, a C
peptide, and an A chain (Figure 3b; supplementary figureovergrown eyes revealed essentially normal cell differenti-
ation but a slight increase in the size of photoreceptor published with this paper on the internet). Consensus
cleavage sites [26] between the B and A chains of allcell bodies (Figure 2e). To further explore the effect on
cell size, we overexpressed DInr in clones of cells dur- seven DILPs suggest that the active peptides consist of
two separate polypeptide chains. Thus, these peptidesing cell differentiation. External observation of such clones
showed strongly enlarged ommatidia (Figure 2c). Histo- resemble insulin rather than IGF1 or IGF2, which are
single polypeptides (Figure 3b). Comparison of the aminological sections revealed a cell-autonomous increase in
photoreceptor cell size but only a moderate disruption of acid sequence of the A and B chains of DILP1–7 with
insulin, IGF1, and IGF2 again reveals a higher degree ofthe ommatidial pattern (Figure 2f). Taken together, these
results indicate that DInr activity controls growth in two identical amino acids between these peptides and insulin.
DILP2 is the most closely related, with 35% identity toways: by regulating cell proliferation and cell size. Inter-
estingly, although overexpression of Dp110 has been mature insulin (supplementary table). These structural
similarities suggest that DILP1–7 are candidate ligandsshown to increase cell size, it does not increase cell divi-
sion rates (data not shown) [9]. The IRS homolog Chico for DInr.
contains consensus binding sites for the Drk/Grb2 adaptor
Highly regulated expression of the Drosophila insulinand thus may provide a link to the Ras/MAPK pathway.
genes during developmentActivation of DInr may promote cell growth and cell divi-
To determine the expression pattern of the insulin-likesion by activation of two signaling pathways. Indeed,
genes, we performed in situ hybridization on embryosMAPK activation is observed in extracts of heads overex-
and larval tissues. The results are summarized in Tablepressing an activated form of DInr (Sean Oldham and
1 and Figure 4. In the embryo, only dilp2, 4 (Figure 4a,c),E.H., unpublished observation).
and 7 are expressed at different levels in the mesoderm
and midgut. It is interesting to note that the main insulin-Identification of a new family of genes encoding
putative insulin-related peptides producing organs in mammals, the Langerhans islets in
the pancreas, are of endodermal origin [27]. Four of theTo identify extracellular ligands that regulate DInr activ-
ity during development, we searched the Drosophila ge- seven genes show a remarkably specific and unique pat-
tern of expression in larvae. dilp2, 3, and 5 display highnome [24] for genes encoding insulin-like peptides. Using
the conserved spacing of four cysteines within the A chain expression levels in seven cells of anteromedial localiza-
tion in the brain hemispheres that may correspond toas a signature for insulin-like peptides [25], we identified
seven predicted genes matching these criteria, which neurosecretory cells (Figure 4f). dilp3 is exclusively tran-
scribed in these seven cells during larval development,we termed dilp1–7 for Drosophila insulin-like peptides.
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Figure 4 whereas dilp2 (Figure 4c,d,e) and dilp5 show additional
expression domains. dilp7 mRNA detection is restricted
to the ventral nerve cord in a segmental fashion, in four
pairs of ventrally located cells in the most posterior ab-
dominal segments and in one pair of dorsally located cells
in A1 or A2 (Figure 4g,h). Interestingly, neither of the
dilps shows detectable levels of expression in the larval
fat body.
Expression of insulin-related genes in neurosecretory cells
has been identified in other invertebrates, such as the in-
sects Bombyx mori and Locusta migratoria and in the mollusc
Lymnaea stagnalis [28–30]. In Bombyx mori, the neurosecre-
tory cells in the brain are connected to the corpora cardi-
aca, a secretory gland from which release of insulin-like
hormones is triggered by nutrient levels (possibly carbo-
hydrate levels) [31]. We speculate that DILP-expressing
neurosecretory cells are connected to the ring gland (the
compound endocrine gland of Drosophila), which includes
the cells of the corpora cardiaca. Release of DILPs from
the ring gland may also be under nutritional control. The
complex expression pattern of the DILPs, however, sug-
gests a combination of neurosecretory and autocrine/para-
crine control mechanisms of cell growth and division dur-
ing larval development. Mutations in individual dilp genes
or targeted ablation of specific DILP-expressing cells may
help resolve the functions of the Drosophila insulins.
DILP2 overexpression increases organismal
size by increasing cell size and cell number
of individual organs
To gain insight into the function of the DILPs, we over-
expressed one insulin-like peptide. For this purpose, we
chose DILP2 because it is the closest homolog of human
insulin (see supplementary table) and because it is the
only DILP with broad expression in imaginal discs (Figure
Spatial and temporal regulation of the expression of Drosophila insulin- 4d). If DILP2 is a limiting ligand of DInr, we expect that
like peptides. Wild-type embryos (a,c) and third instar larval tissues overexpression of DILP2 should promote growth. Indeed,
(b,d–h) after in situ hybridization with dilp antisense probes. (a) dilp4
repeated induction of ubiquitous expression of DILP2mRNA is detected at the blastoderm stage in the presumptive
during development by means of the UAS/Gal4 systemmesoderm and in the anterior midgut rudiment. Shown is a ventral
view. Expression in the mesoderm is still detected after gastrulation, gives rise to bigger flies (39% increase in body weight;
but is reduced from stage 12 onward. (b) dilp4 is reexpressed in the Figure 3c,d). Analysis of the eyes of such flies revealed
larval midgut. (c) dilp2 shows a broad expression in the embryonic an increase in the number of ommatidia (from 733 6 10mesoderm starting at stage 12 and an especially intense expression
to 767 6 25 in male flies). Furthermore, quantitative analy-in the midgut, which diminishes at late stage 16. A lateral view is
shown. (d) dilp2 is ubiquitously expressed in third larval imaginal discs sis of the wing blade showed an increase in both cell size
and in the salivary glands (e). In addition, dilp2 mRNA is specifically (by 9%) and cell number (by 11%). These results suggest
transcribed in seven cells of each brain hemisphere (f). The right panel a role for DILP2 in controlling organismal size by aug-is a high magnification image. Expression in these seven cells is
menting both cell number and cell size of different organs.also detected for dilp3 and 5. (g) dilp7 is expressed in a segmental
fashion in the ventral nerve cord in four pairs of ventrally located
cells in the posterior-most segments and (h) in one pair of dorsally In humans, the in vivo role of insulin as a growth factor
located cells in the abdominal segment A1 or A2. Anterior is to the is inferred from clinical syndromes, in which excessiveleft in (a,c,f,g,h). Note that sense probes of dilps did not detect any
specific signals in all experiments except for the dilp2 sense probe,
which was uniquely detected in the same seven cells of each brain
hemisphere as for the dilp2, 3, and 5 antisense probes. This may
to the dilp2 region of the dilp3 transcript. Consistently, dilp3 mRNAbe explained by the fact that dilp3 is located adjacent to and in the
is also uniquely detected in those seven cells of the brain duringopposite orientation of dilp2 in the genome. Therefore, it is possible
development.that during dilp3 transcription, the polymerase reads through into
the dilp2 region and, thus, the dilp2 sense probe could hybridize
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Figure 5
Dominant suppression of a DInr-mediated big
eye phenotype by a deficiency uncovering
dilp1–5. (a) Overexpression of UAS-dinrwt
with the GMR-Gal4 driver line in differentiating
eye cells leads to bulging and rougher eyes.
(b) Df(3L)AC1 dominantly suppresses the
big eye phenotype caused by the
overexpression of DInr. (c) Introducing one
copy of UAS-dilp2 efficiently counteracts the
suppressive effect of Df(3L)AC1. The crosses
were performed at 188C. Flies are of the
following genotypes: (a) y w; GMR-Gal4, UAS-
dinrwt/1, (b) y w; GMR-Gal4, UAS-dinrwt/1;
Df(3L)AC1/1, and (c) y w; GMR-Gal4,
UAS-dinrwt/UAS-dilp2; Df(3L)AC1/1.
insulin secretion results in excessive growth and where a expression phenotype, we lowered DInr activity in a
severe deficiency of insulin secretion is associated with DILP2-overexpressing background. Indeed, introducing
poor intrauterine and postnatal growth [32]. For instance, one mutant copy of dinr (dinr304) dominantly reduces the
neonates born to women with diabetes in pregnancy or increased body weight, cell size, and cell number caused
born with Beckwith-Wiedemann syndrome or Nesidio- by ubiquitous DILP2 overexpression, indicating a strong
blastosis are macrosomic. In all cases, the growth anomaly genetic interaction between dinr and dilp2 (data not
is associated with hyperinsulinemia during embryonic de- shown). Persistent expression of DILP2 under the control
velopment [32–35]. Our demonstration in transgenic flies of an actin promoter (Act5C-Gal4) caused embryonic lethal-
that overexpression of an insulin-like peptide during de- ity. This lethality is dependent on normal levels of DInr,
velopment can increase animal size provides further evi- as expression of DILP2 in the presence of strongly re-
dence for an evolutionarily conserved role of the insulin duced levels of DInr (see Materials and methods for geno-
pathway in growth control. types) generated viable adults that were small and devel-
opmentally delayed. These results are consistent with
DInr mediating the effects of DILP2. Furthermore, givenDILP2 genetically interacts with DInr
that a viable heteroallelic combination of dPKB alleles isThe complementarity between the loss-of-function phe-
also able to suppress the embryonic lethal phenotype ofnotype of dinr and the DILP2 overexpression phenotype
DILP2 overexpression, we postulate that the action of(increase in size) suggests that DILP2 may be one of the
DILP2 by DInr is transduced at least in part through theligands for DInr. We found that a deficiency (Df(3L)AC1)
Chico/PI(3)K/dPKB pathway.uncovering dilp1–5 dominantly suppressed the big and
rough eye phenotype caused by targeted overexpression
of DInr in differentiating eye cells (Figure 5a,b). To test Conclusions
whether the observed dominant suppression was caused In humans, syndromes with mutations in the insulin re-
by hemizygosity for dilp2, we selectively increased the ceptor or with excessive insulin secretion lead to growth
dilp2 gene dosage by crossing in the UAS-dilp2 transgene. abnormalities. This study shows in vivo that altering ex-
A single copy of UAS-dilp2 was sufficient to revert the pression levels of a Drosophila insulin-like gene and vary-
suppression by Df(3L)AC1 (Figure 5c), strongly suggesting ing the activity of the Drosophila insulin receptor changes
that dilp2 is rate limiting for the DInr overexpression the size and number of cells in organs, thereby regulating
phenotype. An analysis of individually mutated dilp genes organismal size. It seems, therefore, that the insulin recep-
will be required to determine the contribution of the other tor pathway has been conserved during evolution for a
dilps of the cluster (dilp1 and 3–5) to the suppressive role in growth control from insects to humans. Given the
effect of Df(3L)AC1. highly tissue-specific expression of the dilps in the central
nervous system and a broad expression in precursor tissues
of adult organs, we propose a nutritionally regulatedTo examine whether DInr is limiting for the DILP2 over-
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mechanism whereby Drosophila insulin-like peptides co- Genome search for insulin-like genes, gene structure,
and protein structure analysisordinate growth in a neurosecretory and local fashion.
We searched for insulin-like genes in the Drosophila nucleotide database
with the human A chain, which yielded a full-length dilp2 cDNA clone,
GH11579. We then used the predicted Drosophila A chains to identifyMaterials and methods
a total of seven insulin-like genes. Searches with A chains were performed
Generation of mosaic flies by mitotic recombination with the TBLASTN program (National Center for Biotechnology Informa-
The dinr alleles (E19, 31, 304, 211, 339, and 353) were individually tion). Gene prediction and conceptual translation was performed with
recombined onto the FRT 82B chromosome [36]. Mosaic heads were Genscan [38], and signal peptides were predicted using the SignalP
generated with the ey-FLP/FRT recombination system [17], which drives program [39]. Cleavage sites were predicted at either specific single or
the FLP recombinase under the control of the eyeless enhancer, thereby pairs of basic residues of the general formula (R/K)-Xn-(R/K), where
inducing mitotic recombination in eye progenitor cells of embryos that cleavage preference decreases with n 5 0, 2, 4, or 6 [26].
are heterozygous for different dinr alleles. A recessive cell lethal mutation
on the homologous chromosome prevents the growth of the sister clone. The Berkeley Drosophila Genome Project (BDGP) [24] has identified
Thus, the dinr homozygous mutant clone contributes the majority of cells four genes as being insulin-like (corresponding to dilp1–4). dilp5 has
in the eye and the head capsule. Such flies have heads that are largely not been predicted by BDGP. dilp5 has its predicted translational start
homozygous mutant while the rest of the body is heterozygous. To site at nucleotide position 237,598 and stop codon at 237,990 within
establish an allelic series, we determined the growth defect of each the contig (nucleotide positions refer to GenBank accession number
mosaic head (n 5 10) by measuring the ratio between head and thorax AE003550.1). We found that the dilp3 gene consists of two exons and
widths and by analyzing the cell size defect in histological sections. The has its translational start at 259,432 and stop at 259,854. Corresponding
head to thorax ratio of mosaic heads (and control flies) are, in the order gene numbers in the genome annotation database of Drosophila (Gad-
of severity, dinr339: 0.68 (1.23), dinr31: 0.74 (1.20), dinr211: 0.79 (1.22), Fly) for dilp1–4 and dilp6 and 7 are: CG14173, CG8167, CG14167,
dinrE19: 0.81 (1.16), and dinr353: 0.82 (1.19). The differences in head CG6736, CG14049, and CG13317.
size compared to controls and between the alleles analyzed were signifi-
cant (p , 0.0001 and p , 0.005).
In situ hybridization
In situ hybridization to larval tissues and embryos was performed essen-
tially as described [40, 41]. The genomic region including dilp genesTo generate clones of homozygous dinr mutant cells in imaginal discs,
was PCR amplified and cloned into the pCRII-Topo vector (Invitrogen)y w hsFLP/y w; FRT82B dinr304/FRT82B P(arm-lacZ, w1) larvae were
except for dilp2 and dilp4, which we obtained as an EST clone (LD06542heat shocked 24–48 hr AED for 0.5 hr at 348C to induce expression
and GH11579) from Research Genetics. In vitro transcription was doneof the FLP recombinase. Larvae were dissected at the late third instar
using the DIG RNA labeling kit (Roche). Digoxigenin (DIG)–labeledstage. Discs were fixed, permeabilized, and stained with mouse anti-
RNA sense probes were transcribed by SP6 polymerase, and antisenseb-gal (1/1000) and FITC-conjugated secondary antibodies (1/200).
probes by T7 polymerase. Hydrolysis time was shortened to 5 min to
prevent cross-hybridization.
Measurements of cell number, cell size, and weight
Each cell in the wing blade gives rise to a single wing hair. Thus, the Genetic interaction analysis
cell density was assessed by counting the number of wing hairs on the Df(3L)AC1 (breakpoints 67A2; 67D13, Flybase) removes dilp1–5, as
dorsal wing surface in a 10,000 mm2 area just posterior to the posterior dshc (67B3) [42], which lies distal to the dilp cluster (67C1-2), and
cross vein. The reciprocal value of the cell density is the cell area. Gap1 (67C2-3) [43], which lies proximal to the dilp cluster, are both
The approximate number of cells in the whole wing was calculated by uncovered by this deficiency. Targeted overexpression of UAS-dinrwt in
multiplying the cell density by the wing area excluding the alula and the differentiating eye cells by means of GMR-Gal4 [44] leads to bulging
costal cell. NIH Image 1.60 was used to measure the wing area. Individual rough eyes (Figure 5a), a phenotype that is dominantly suppressed by
male and female flies were weighed with a precision scale (Mettler ME30, Df(3L)AC1 (Figure 5b). Introducing one copy of UAS-dilp2 restores the
range 0.001–10 mg). Flies homozygous for dinrE19 were obtained after big eye phenotype (Figure 5c). This cannot simply be an additive effect
removing linked lethal mutations by recombination. because in a wild-type background, overexpression of USA-dilp2 under
the control of GMR-Gal4 is phenotypically neutral.
Molecular analysis of dinr alleles The lethality resulting from overexpression of UAS-dilp2 with Act5C-
The following dinr alleles were sequenced: E16, E19, E21, 31, EC34, Gal4 (Bloomington stock center) was rescued in the following genotypic
35, 76, 87, 117, 211, 242, 262, 273, 277, 304, 306, 310, 313, 322, backgrounds, in order of decreasing viability: (1) y w; Act5C-Gal4/UAS-
327, 339, and 353 [15, 16, 19]. Genomic DNA was extracted from dilp2; dinr05545/dinr211, (2) y w; Act5C-Gal4/UAS-dilp2; dinr05545/dinrE19,
heterozygous flies balanced over TM3 Sb. The region coding for the (3) y w; Act5C-Gal4/UAS-dilp2; dPKB1/ dPKB3, (4) y w; Act5C-Gal4/
cytoplasmic portion was amplified by PCR (primer sequences are avail- UAS-dilp2; dinrE19/dinr211, (5) y w; Act5C-Gal4/UAS-dilp2; dinrE19/
able on request), sequenced, and analyzed with SequencherTM software dinrE19, and (6) y w; Act5C-Gal4/UAS-dilp2; dinr304/1.
and compared to the published sequence [15].
Supplementary material
Supplementary material including a figure showing an alignment of theGeneration of transgenic flies
predicted amino acid sequences of Drosophila insulin-like peptides with
The dinr cDNA was subcloned as an EcoRI fragment into the pUAST
human preproinsulin, and a table comparing the predicted mature
vector to generate transgenic flies by means of P element–mediated
DILP1–7 with human insulin and IGFs are available at http://www.
germline transformation. To achieve expression of UAS-dinrwt in proliferat-
current-biology.com/supmat/supmatin.htm.
ing eye precursor cells, the ey-Gal4 driver line was used [37]. To achieve
expression of UAS-dinrwt in clones of eye precursor cells undergoing a
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The insulininsulin-like growth factor-1 signaling pathway pro-
motes growth in invertebrates and vertebrates by increasing the
levels of phosphatidylinositol 3,4,5-triphosphate through the ac-
tivation of p110 phosphatidylinositol 3-kinase. Two key effectors
of this pathway are the phosphoinositide-dependent protein ki-
nase 1 (PDK1) and AktPKB. Although genetic analysis in Caeno-
rhabditis elegans has implicated Akt as the only relevant PDK1
substrate, cell culture studies have suggested that PDK1 has
additional targets. Here we show that, in Drosophila, dPDK1
controls cellular and organism growth by activating dAkt and S6
kinase, dS6K. Furthermore, dPDK1 genetically interacts with dRSK
but not with dPKN, encoding two substrates of PDK1 in vitro. Thus,
the results suggest that dPDK1 is required for dRSK but not dPKN
activation and that it regulates insulin-mediated growth through
two main effector branches, dAkt and dS6K.
Genetic studies in Caenorhabditis elegans and Drosophila, andbiochemical analyses in vertebrate cell culture systems have
led to the identification of key components of the insulin signal
transduction pathway, including members of the phosphatidyl-
inositol 3-kinase [PI(3)K] signaling pathway; the protein kinases
PDK1, Akt, GSK3, and S6K and the 3-phosphatidylinositide
phosphatase PTEN, which antagonizes the effects of PI(3)K by
converting phosphatidylinositol 3,4,5-triphosphate (PIP3) to
phosphatidylinositol 4,5-biphosphate. In addition, studies in vitro
and in vertebrate cell culture systems have implicated phospho-
inositide-dependent protein kinase 1 (PDK1) as the critical
regulator of T-loop phosphorylation in many members of the
AGC family of kinases, which include Akt (1–6), S6K (7, 8), RSK
(9, 10), PKN (11), and all isoforms of protein kinase C (12–15).
PDK1 possesses two functional domains, a serinethreonine
kinase domain located amino-terminally and a Pleckstrin-
homology domain with a high affinity to PIP3. Owing to this high
affinity to PIP3, PDK1 is located at the membrane even in resting
cells and controls activity of its target kinases at the plasma
membrane (4, 16). Consistent with PDK1 being a direct effector
of Akt, S6K, and RSK, activation of all three kinases is blocked
in PDK1/-deficient embryonic stem cells (17). These findings
imply that in vivo PDK1 has multiple targets and acts as a
downstream branch point for PI(3)K signaling. However, despite
these observations, genetic analyses in C. elegans and a recent
study in Drosophila have implicated Akt as the only relevant
target for PDK1 function (18, 19). In contrast, the detailed
genetic analysis of dPDK1 function in Drosophila presented here
indicates that PDK1 functions as a central regulator of cell
growth by regulating two effector pathways controlled by the
AGC kinases Akt and S6K, respectively.
Methods
Ethyl Methanesulfonate (EMS) Mutagenesis and Analysis of Mutants.
To generate mutations in dPDK1, y w; EP(3)0837TM2 y males
were treated with EMS according to Lewis and Bacher (20) and
mated to y w; GMR-Gal4 UAS-dAktCyO; MKRSTM2 females.
A total number of 2,300 F1 progeny of the genotype y w;
GMR-Gal4 UAS-dAkt; EP(3)0837MKRS or TM2 was
screened for a suppression of the big eye phenotype shown in Fig.
2d. Primary positives were retested, and stocks were established
by balancing the potential dPDK1 alleles with the TM6B y
balancer.
Genomic DNA was extracted from heterozygous flies, and
coding exons of dPDK1 were amplified by PCR. The PCR
products were sequenced and analyzed with SEQUENCHER soft-
ware for the appearance of double peaks in the sequence
chromatogram, and compared with the published sequence (21).
The nucleotide changes are: dPDK13 (GGT3AGT), dPDK14
(CCG3CTG), dPDK15 (CAG3TAG).
Clonal Analysis. Clonal analysis of dPDK1 loss-of-function alleles
was performed by using the FlpFRT and the ey-Flp systems as
described (22, 23). To generate marked clones that express either
EP(3)0837 controlled dPDK1 andor UAS-dAkt in eye disk cells
during the last cell cycle and subsequent differentiation, 24- to
48-h-old larvae containing a heat-shock-inducible Flp recombi-
nase, a Flp-out transgene (GMRFRT w STOP FRTGal4),
the EP(3)0837 element, andor a UAS-dAkt construct were
subjected to a heat shock for 1 h at 37°C. This procedure induces
recombination between the FRT sites of GMRFRT w STOP
FRTGal4 and removes the w STOP cassette in clones, thus
allowing expression of dPDK1 and dAkt under the control of
GMR-Gal4. Histological sections of the eyes were performed as
described (24).
Plasmids and Germ-Line Transformation. To generate UAS-dPDK1,
the ORF coding for dPDK1 was amplified from the full-length
cDNA clone LD16509 (obtained from Research Genetics,
Huntsville, AL) by PCR by using the primers 5-GGAATTCAT-
GGCCAAGGAGAAAGCATC-3 (ofr77) and 5-GCTCTA-
GACGTTTACTTAGACGCCGTC-3 (ofr80), which intro-
duced EcoRI and XbaI sites at the 5 and 3 ends, respectively.
The PCR product was ligated into the pUAST Drosophila
transformation vector (25), and the resulting plasmid UAS-
dPDK1 was used for transformation.
To generate UAS-PDK1A467V the point mutation C3T at
dPDK1 nucleotide position 2,032 was introduced with a Quick-
Change Site-Directed Mutagenesis Kit from Stratagene. For
PCR we used the primers 5-GTTTATCAGATGATCGTCG-
GCCTACCGCCATTC-3 and 5-GAATGGCGGTAGGC-
CGACGATCATCTGATAAAC-3 and the pBluescript SK()
plasmid containing the cDNA clone LD16509 as a template. The
resulting plasmid was used as a template for PCR with primers
ofr77 and ofr80. The PCR product was digested with EcoRI and
XbaI and cloned into the pUAST vector. The resulting plasmid
UAS-PDK1A467V was used for transformation.
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To generate UAS-dPKN and UAS-dRSK we performed PCR by
using as a template double-stranded cDNA derived from 0- to
24-h-old Drosophila embryos (kindly provided by K. Nairz, Uni-
versita¨t Zu¨rich, Zu¨rich, Switzerland) with the following primer
pairs: 5-CGGCGAATTAACGAGAAACC-3 and 5-GGC-
CCGTTAGTAAATCCTTG-3 for dPKN and 5-AACAAAG-
GAACCGCTAGGAG-3 and 5-AAGTAGTCGGACTATCT-
GCC-3 for dRSK. The PCR products were cloned by using the
pCRII-TOPOTA vector system (Invitrogen). Subsequently, the
dPKN and dRSK cDNAs were cut out with Asp-718 and NotI and
ligated into the pUAST vector. The resulting plasmids UAS-dPKN
and UAS-dRSK were used for transformation.
P element-mediated germ-line transformation was performed
as described (26). The constructs were injected into y w embryos.
Several independent transformant lines were established for all
constructs.
Phenotypic Analysis. Unless indicated otherwise, all phenotypic
analyses were done in females. Measurements of cell number,
cell size, and body weight were performed as described (27).
National Institutes of Health IMAGE 1.61 was used to quantify the
size of ommatidia and rhabdomeres by measuring the corre-
sponding area.
Drosophila Strains. EP(3)0837, EP(3)3091, and EP(3)3644 f lies
were obtained from the Bloomington Drosophila Stock Center
(Bloomington, IN). Genomic sequences flanking the 3 end of
the enhancer–promoter (EP) elements was isolated by plasmid
rescue (28), sequenced, and analyzed with use of the Berkeley
Drosophila Genome Project database (Berkeley, CA). The Gal4
driver GMR-Gal4 was a gift of M. Freeman (MRC Laboratory
of Molecular Biology, Cambridge, U.K.), ap-Gal4 was described
in ref. 29, and arm-Gal4 was obtained from the Bloomington
Drosophila Stock Center. The following alleles were used for
genetic interaction studies: DPTENdj189 [a putative null mutation
caused by the insertion of an F element in a coding exon which
disrupts the dPTEN ORF after amino acid 89 (30)], dPTENc494
[encoding a strong hypomorph of dPTEN caused by an EMS-
induced amino acid exchange (G135E) in the active-site motif of
the catalytic domain required for phosphatase activity (31)],
dS6Kl-1 [a putative null mutation generated by imprecise excision
of a P element insertion in the dS6K gene, which removed part
of the first exon, including a portion of the catalytic domain (32)],
and dAkt1 [encoding a kinase dead version of dAkt carrying a
single amino acid substitution (F327I) in the DFG motif in
kinase domain VII (33)]. ap-Gal4 UAS-dS6K f lies are described
in ref. 32. The construction of UAS-dAkt f lies will be described
elsewhere. For overexpression studies in which the EMS-induced
dPDK1 alleles dPDK14 and dPDK15 were used, we induced the
jump-out of the EP element EP(3)0837 from fly stocks dPDK14
and dPDK15 to avoid overexpression of mutant dPDK1 proteins
in a background where Gal4 is expressed. P element mobilization
was achieved by standard genetic techniques.
Results and Discussion
To analyze the function of dPDK1 in Drosophila, we aimed to
generate both gain- and loss-of-function alleles of the kinase.
Drosophila contains a single gene that encodes a kinase that is
highly homologous to PDK1 in its primary sequence and its
domain structure (2). Initially, we identified two EP transposable
elements in the 5 region of the endogenous Drosophila PDK1
gene dPDK1 (Fig. 1a). These EP elements drive expression of
dPDK1 under the control of the Gal4 system (25, 34), allowing
us to test whether dPDK1 and dAkt cooperate in promoting
Fig. 1. Gain- and loss-of-function mutations in the dPDK1 locus. (a) Genomic structure of the dPDK1 locus. One of several reported transcripts (42) represented
by the expressed sequence tag (EST) cDNA LD16509 is shown. Boxes represent exons. Dark boxes indicate the ORF; hatched and gray boxes represent the kinase
and Pleckstrin-homology domains, respectively. EP insertions EP(3)0837, EP(3)3091, and EP(3)3644 are shown as triangles, and the direction of transcription from
the UAS-controlled promoter is marked by arrows. EP(3)3644 inserted 7,081 and EP(3)0837 3,875 nt upstream of the putative start codon (Met). EP(3)3091 inserted
710 bp upstream of the 5 end of exon 3. The three EMS-induced loss-of-function mutations and the activating mutation A467V are shown above exon 4. (b)
Kinase domain alignment of Drosophila, C. elegans, and human PDK1. Dark and gray boxes indicate amino acid identity and similarity, respectively. Amino acid
changes in the dPDK13–5 and dPDK1A467V mutants are shown above the dPDK1 sequence. Note that the amino acid substitutions in dPDK13 (G352S) and dPDK14
(P441L) are in highly conserved amino acid residues.
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growth in Drosophila. Overexpression of either kinase in the eye
imaginal disk during the last cell division cycle and subsequent
differentiation showed little effect on the size or the structure of
the eye (Fig. 2 b and c). Co-overexpression of dAkt and dPDK1,
however, led to a significant increase in eye size (Fig. 2d).
Furthermore, analysis of clones of cells in the eye overexpressing
dPDK1 andor dAkt revealed that the observed effect on cell
size is strictly autonomous (Fig. 2 e–g). These results indicate that
overexpression of dPDK1 does not interfere with the normal
differentiation of eye disk cells and that it promotes local growth
through dAkt activation.
To generate loss-of-function alleles of dPDK1, the dominant
eye size phenotype caused by co-overexpression of dPDK1 and
dAkt was reverted by using EMS mutagenesis, leading to three
partial or complete loss-of-function mutations. dPDK13 causes a
G(352) to S substitution in the conserved DFG motif in the
kinase subdomain VII (Fig. 1 a and b). The D residue in this
motif is essential for kinase activity by orienting the ATP-Mg2
complex for phosphotransfer (35–37). dPDK14 causes a P(441) to
L substitution in a conserved residue in kinase subdomain VIII.
In the dPDK15 allele, a Q codon at position 437 in kinase
subdomain VIII is mutated to a STOP codon. Because this latter
mutation results in the formation of a truncated dPDK1 protein
lacking part of the kinase domain and the Pleckstrin-homology
domain, dPDK15 is likely to be a null mutation. A fourth allele
EP(3)3091 (dPDK11), from the Berkeley Drosophila Genome
Project, has an EP element located in the third intron of dPDK1
(Fig. 1a) and is homozygous lethal. It failed to complement
dPDK15 (data not shown), and the lethality was reversed by EP
element excision.
Combinations of loss-of-function alleles provided mutants of
varying strengths. Larvae homozygous for the dPDK15 null allele
or larvae of the dPDK11/5 heteroallelic combination die during
the second instar stage. A less severe reduction in dPDK1
function (dPDK14/5) permits development of viable dPDK1
mutant flies that are delayed 1 day in development and smaller
than their heterozygous siblings, having an 18% reduction in
body weight (Fig. 3 a and d). By measuring the cell density in the
wing, the reduction in size and weight apparently is primarily
caused by a decrease in cell size, because cell number is only
slightly affected (Fig. 3d). The lethality associated with the
dPDK1 null allele and the size defect of dPDK1 hypomorphs was
rescued by ubiquitous expression of a wild-type dPDK1 trans-
gene with armadillo (arm)-Gal4 as a driver. dPDK14/5 male flies
are almost completely sterile, although they show no obvious
defect in sperm morphology and motility and in mating behavior
(data not shown). That loss of zygotic dPDK1 function results in
larval lethality is in contrast to a recent analysis of two dPDK1
mutations caused by the EP insertion EP(3)3091 (dPDK11) or a
10-kb deletion (dPDK12), which were homozygous embryonic
lethal (19). It is possible that the embryonic lethality observed
by Cho et al. (19) is not caused by loss of dPDK1 function but by
a linked lethal mutation on the same chromosome, because no
rescue was attempted, and the phenotype was only analyzed in
Fig. 2. Simultaneous overexpression of dPDK1 and dAkt with GMR-Gal4 increases eye and cell size. (a–d ) Simultaneous overexpression of dPDK1 and dAkt in
the developing third instar eye imaginal disk results in the formation of larger eyes. Scanning electron micrographs of adult eyes of the following genotypes:
(a) OregonR, wild type; (b) y w; GMR-Gal4; EP(3)0837; (c) y w; GMR-Gal4 UAS-dAkt; TM2; (d) y w; GMR-Gal4 UAS-dAkt; TM2EP(3)0837. Although
the overexpression of dPDK1 or dAkt alone results only in a slight, but in the case of dPDK1, significant increase in eye size (b and c), simultaneous expression
of dPDK1 and dAkt causes a substantial increase in eye size (d). The area of at least 29 ommatidia in 3–6 eyes was measured for each genotype. Because the size
of ommatidia of the genotypes y w; GMR-Gal4 UAS-dAkt; TM2 and y w; GMR-Gal4 UAS-dAkt; TM2EP(3)0837 is variable, only the values of the 30%
largest ommatidia were included in the calculation. We used flies of the following genotype, y w; GMR-Gal4UAS-lacZ, as a control. The means of these values
are (normalized to a value of 100  SD): 100  3 (control); 113  3 (b); 108  6 (c); 131  10 (d). (e–g) dPDK1 and dAkt act synergistically to increase cell size
in a cell-autonomous manner. Tangential sections through adult eyes containing clones in which dPDK1 andor dAkt were overexpressed: (e) y w hs-Flpy w;
GMRFRT w STOP FRTGal4; EP(3)0837; ( f) y w hs-Flpy w; GMRFRT w STOP FRTGal4UAS-dAkt; (g) y w hs-Flpy w; GMRFRT w STOP
FRTGal4UAS-dAkt; EP(3)0837. Clones are marked by the lack of red pigment. No increase in cell size is observed by overexpressing dPDK1 or dAkt alone
(e and f ), but simultaneous overexpression of dPDK1 and dAkt slightly increases cell size (g). For quantification, the area of the R6 rhabdomere for 15
photoreceptors in clones overexpressing dPDK1 andor dAkt (white arrowhead) were compared with the corresponding value for the sister control clone in the
same section (yellow arrowhead): The values were normalized to 100 SD for the sister control clone and compared with the value in the overexpression clone:
100 6 vs. 110 7 (e); 100 7 vs. 113 7 ( f); 100 6 vs. 155 10 (g). At the border of the clones, ommatidia composed of wild-type cells and cells overexpressing
dPDK1 andor dAkt are visible, indicating that the increase in cell size in g is cell-autonomous. (Bar  100 m.)
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homozygotes. Consistent with this observation, larvae homozy-
gous for a dPDK11 mutant chromosome, which has been cleaned
from second hits by recombination, die during the second instar
stage. Although it is very likely that dPDK1 functions during
embryogenesis, like dAkt (33), maternal transcripts may be
sufficient to support embryonic development.
To determine whether the effects of loss of dPDK1 function on
cell growth and organ development are autonomous events, we
analyzed loss of dPDK1 in clones of cells by using the FRT mitotic
recombination system (22). In contrast to organism lethality, clones
of cells homozygous for the dPDK1 null allele dPDK15 survive to
adulthood. These cells show no defect in their ability to differentiate
into photoreceptor cells or accessory cells, but mutant photorecep-
tor cells are 30% smaller than the heterozygous cells outside the
clone (Fig. 3b), a strictly cell autonomous effect. To test whether an
entire body part could develop in the absence of dPDK1 function,
dPDK1 was selectively removed in much of the head primordium
by using the ey-Flp system (23). Heads homozygous mutant for
anyone of the three alleles, dPDK13, dPDK14, and dPDK15, are
reduced in size (Fig. 3c; data not shown), which indicates that entire
organs differentiate and develop in the absence of dPDK1 function,
but that the final size of these organs autonomously depends on the
amount of dPDK1 activity. The reduction in head size was most
severe with dPDK15 followed by dPDK14 and dPDK13, with the
complete removal of dPDK1 function similar to that observed for
loss-of-function mutations in the Drosophila insulin receptor (dInr),
Dp110PI(3)K, and dAkt (ref. 27; H.S. and E.H., unpublished
work).
The pronounced effect of loss of dPDK1 function on head size
suggested that it is a dominant constituent in the dInr pathway.
To test this possibility, we examined the ability of complete and
partial loss-of-function alleles of dPDK1 to reverse phenotypes
caused by either overexpression of dInr or by mutations in
dPTEN, the 3-phosphatidylinositide phosphatase. Overexpres-
sion of a wild-type dInr cDNA under the control of GMR-Gal4
led to a marked increase in eye size and a slightly rough eye
surface (27), an effect dominantly suppressed by removing one
copy of dPDK1 (Fig. 4a). Further reduction of dPDK1 function
by the dPDK11/4 heteroallelic combination reduced the eye to
almost wild-type size (Fig. 4b), suggesting that the amount of
dPDK1 protein is rate-limiting for the dInr overgrowth pheno-
type. Null mutations in dPTEN cause lethality, and removal of
dPTEN function in clones stimulates cell autonomous growth
(30, 31, 38), suggesting that increased levels of PIP3 promote
growth and are the likely cause of lethality. Thus, if dPDK1 is an
essential target of PIP3, mutations in dPDK1 may suppress the
dPTEN phenotype. Surprisingly, some dPTENdPDK1 double
mutant flies survive to adulthood (Fig. 4c), indicating that the
presumed PIP3-induced lethality is primarily caused by the
hyperactivation of dPDK1 or of one of its targets.
The fact that the growth phenotypes of dPDK1 mutations are
similar to those caused by mutations in genes coding for dS6K (32),
and dAkt (refs. 39 and 40; H.S. and E.H., unpublished work), and
that S6K1 is a mammalian PDK1 substrate, raised the possibility
that dPDK1 may independently control growth through dS6K. This
possibility was tested in the wing, which is composed of a dorsal and
a ventral epithelial sheet that are tightly attached to each other
through extracellular matrix. We have shown that selective over-
expression of a wild-type dS6K cDNA in the dorsal wing epithelium
with the apterous (ap)-Gal4 driver leads to a bending down of the
wing blade, probably because of a cell-size increase in the dorsal
surface (32). This phenotype was suppressed by a reduction of
dPDK1 function (Fig. 5 a–c). Although ap-Gal4 induced overex-
pression of wild-type dPDK1 alone had little effect on wing
morphology (data not shown), overexpression of a dPDK1A467V
variant was sufficient to cause a bent-wing phenotype (Fig. 5d). The
corresponding amino acid substitution in the C. elegans PDK1 is
thought to cause a hyperactivation of the kinase (18). The
dPDK1A467V-induced bent wing phenotype depends on normal
levels of dS6K and dAkt, because null mutations in either of the
corresponding genes dominantly suppress the phenotype (Fig. 5 e
and f). Together with the biochemical evidence in cultured cells and
in vivo that dPDK1 controls the activity of dAkt and dS6K (ref. 19;
T. Radimerski, J. Montagne, F. R. J. van der Kaay, C. P. Downes,
E.H., and G.T., unpublished work) these results provide functional
evidence that dPDK1 is a key regulator in the control of growth
and cell size by regulating the activity of two AGC kinases, dAkt and
dS6K.
The effects of dPDK1 on dS6K raised the possibility that
dPDK1 controls the activity of other AGC kinases in vivo, such
as dRSK and dPKN, which have been implicated as mammalian
PDK1 substrates. Because the developing eye depends on en-
dogenous levels of dPDK1, we examined whether lowering the
dose of dPDK1 was sufficient to suppress dominantly the rough
eye phenotype caused by overexpression of dRSK and dPKN
under GMR-Gal4 control (Fig. 5g; data not shown). Reduction
of dPDK1 activity in a viable dPDK1 mutant combination was
sufficient to suppress the rough eye phenotype of dRSK but not
Fig. 3. dPDK1 loss-of-function phenotypes. (a) Body size reduction of hetero-
allelic mutant flies. Males (Right) and females (Left) of the following geno-
types are shown: y w; dPDK15 (Top); y w; dPDK14dPDK15 (Bottom). (b)
Tangential section through an eye containing a dPDK15/5 clone. Within the
clone, all photoreceptor cells are reduced in size compared with wild-type
photoreceptor cells. At the border of the clone, ommatidia composed of
phenotypically wild-type and mutant cells (arrowhead) are visible, indicating
that dPDK1 controls cell size autonomously. The genotype is as follows: y w
ey-Flpy w; dPDK15 FRT80BFRT80B. (c) Selective removal of dPDK1 function
from the eye imaginal disk results in a reduction of head and eye size. y w
ey-Flpy w; dPDK15 FRT80BM(3)67c4 FRT80B (Left); OregonR, wild type
(Right). (d) Quantification of body and organ size in dPDK1 heteroallelic
mutant male flies compared with heterozygous and rescued flies, which
overexpress a wild-type dPDK1 cDNA under the control of the ubiquitous
arm-Gal4 driver. Values of y w; dPDK15 (), y w; dPDK14dPDK15 (),
and y w; arm-Gal4UAS-dPDK1; dPDK14dPDK15 flies (resc.) are shown. Values
are the mean  SD.
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of dPKN overexpression (Fig. 5g; data not shown). These results
suggest that at least in this in vivo assay, dRSK activity critically
depends on dPDK1 function, whereas dPKN activity is not
changed by a reduction in dPDK1 levels. This idea is in line with
the recent finding that in PDK1/ embryonic stem cells the
protein kinase C-related protein kinase PRK2, which shares
extensive homology with PKN, is still partially phosphorylated at
its T loop residue (41), indicating that PDK1-independent
mechanisms for the phosphorylation of the T loop of certain
AGC kinases including dPKN may exist.
Our results show that dPDK1 is an essential component in the
insulin signaling pathway in the control of cell growth and body size
through its two substrates, dAkt and dS6K. These results are distinct
from the genetic evidence in C. elegans where Akt is the primary
target of PDK1 in dauer formation. Because mutations in the
insulin signaling pathway do not show an autonomous alteration of
cell size in C. elegans, the regulation of the rate of protein synthesis
through S6K does not seem to be a primary target of this pathway.
However, that dPDK1 may yet have additional substrates is sug-
gested by the genetic interaction with dRSK gain-of-function mu-
tations and because viable dPDK1 males are almost completely
sterile. Although mutations in components of the insulin signaling
pathway such as dInr, chico, Dp110PI(3)K, and dAkt cause female
sterility, male sterility is not observed. Further genetic dissection of
dPDK1 function is required to determine the role of dPDK1 in male
fertility. Our findings in Drosophila are consistent with the absence
of insulin growth factor-1-induced activation of S6K, Akt, and RSK
in mammalian PDK1/ embryonic stem cells (17), and therefore
provide evidence for the functional conservation of branch points
in kinase networks during evolution.
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Fig. 4. dPDK1 loss-of-function mutations suppress dInr and dPTEN mutant phenotypes. (a and b) The eye phenotype caused by overexpression of UAS-dInr with
the GMR-Gal4 driver is dominantly suppressed by removing one copy of dPDK1, and the eye size is almost completely restored to wild-type size in a dPDK11/4
heteroallelic mutant background, although eye roughness is increased. The reason for this latter observation is unclear. (a) y w; GMR-Gal4 UAS-dInr; dPDK15
(Left); y w; GMR-Gal4 UAS-dInr; MKRS (Right); (b) y w; GMR-Gal4 UAS-dInr; dPDK11dPDK14 (Left); y w; GMR-Gal4 UAS-dInr; dPDK14 (Right). (c)
The lethality caused by mutations in dPTEN is rescued in a dPDK1 heteroallelic mutant background: Some dPTEN, dPDK1 double-mutant flies survive to
adulthood, although they display mutant phenotypes like an unproportionally reduced size of the abdomen and deformed leg structures. Similar phenotypes
have been observed in partial loss-of-function mutations for dTOR (S. Oldham and E.H., unpublished work). Flies of the following genotypes are shown: y w
dPTENdj189dPTEN494; dPDK14dPDK15 (Upper), OregonR, wild-type (Lower).
Fig. 5. Genetic interaction of dPDK1 with the AGC kinases dAkt, dS6K, and
dRSK. (a–c) Mutations in dPDK1 suppress the ap-Gal4 UAS-dS6K bent-wing
phenotype. (a) y w; ap-Gal4 UAS-dS6K; MKRS; (b) y w; ap-Gal4 UAS-
dS6K; dPDK15; (c) y w; ap-Gal4 UAS-dS6K; dPDK14dPDK15. (d–f ) Null
mutations in dS6K and dAkt dominantly suppress the ap-Gal4 UAS-
dPDK1A467V bent-wing phenotype. (d) y w; ap-Gal4 UAS-dPDK1A467V; (e) y
w; ap-Gal4 UAS-dPDK1A467V; dS6Kl-1; ( f) y w; ap-Gal4 UAS-
dPDK1A467V; dAkt1. (g) Mutations in dPDK1 suppress the rough eye
phenotype caused by overexpression of UAS-dRSK under GMR-Gal4 control. y
w; GMR-Gal4 UAS-dRSK; dPDK15 (Left); y w; GMR-Gal4 UAS-dRSK;
dPDK14dPDK15 (Right).
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Abstract
Background: Forkhead transcription factors belonging to the FOXO subfamily are
negatively regulated by protein kinase B (PKB) in response to signaling by insulin and insulin-
like growth factor in Caenorhabditis elegans and mammals. In Drosophila, the insulin-signaling
pathway regulates the size of cells, organs, and the entire body in response to nutrient
availability, by controlling both cell size and cell number. In this study, we present a genetic
characterization of dFOXO, the only Drosophila FOXO ortholog.
Results: Ectopic expression of dFOXO and human FOXO3a induced organ-size reduction and
cell death in a manner dependent on phosphoinositide (PI) 3-kinase and nutrient levels.
Surprisingly, flies homozygous for dFOXO null alleles are viable and of normal size. They are,
however, more sensitive to oxidative stress. Furthermore, dFOXO function is required for
growth inhibition associated with reduced insulin signaling. Loss of dFOXO suppresses the
reduction in cell number but not the cell-size reduction elicited by mutations in the insulin-
signaling pathway. By microarray analysis and subsequent genetic validation, we have identified
d4E-BP, which encodes a translation inhibitor, as a relevant dFOXO target gene. 
Conclusion: Our results show that dFOXO is a crucial mediator of insulin signaling in
Drosophila, mediating the reduction in cell number in insulin-signaling mutants. We propose
that in response to cellular stresses, such as nutrient deprivation or increased levels of
reactive oxygen species, dFOXO is activated and inhibits growth through the action of target
genes such as d4E-BP.
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Background
Receptors for insulin and insulin-like growth factors (IGFs)
are central regulators of energy metabolism and organismal
growth in vertebrates and invertebrates. In mammals, the
insulin receptor regulates glucose homeostasis and embry-
onic growth [1], whereas the insulin-like growth factor 1
receptor (IGF1-R) regulates embryonic and postembryonic
growth [2] and longevity [3]. In Caenorhabditis elegans,
DAF-2 - the homolog of the mammalian insulin/IGF receptor
- controls organismal growth in response to poor nutrient
conditions indirectly by controlling formation of the long-
lived, stress-resistant dauer stage during larval develop-
ment, and lifespan in the adult [4]. In Drosophila, the
insulin/IGF receptor homolog DInr controls organismal
growth directly by regulating cell size and cell number [5].
Furthermore, reduced insulin signaling causes female steril-
ity and independently increases lifespan [6,7]. The striking
conservation of insulin receptor function is also reflected in
the conservation of the intracellular signaling cascade.
Binding of insulin-like peptides to their receptor tyrosine
kinases leads to the activation of class IA phosphatidylinos-
itol (PI) 3-kinases and increased intracellular concentra-
tions of the lipid second messenger phosphatidylinositol
(3,4,5)-trisphosphate (PIP3). This results in recruitment to
the membrane, and activation, of the protein kinases phos-
phoinositide-dependent protein kinase 1 (PDK1) and
protein kinase B (PKB/AKT), both of which contain pleck-
strin homology (PH) domains and which in turn modulate
the activity of downstream effector proteins [8]. The lipid
phosphatase PTEN (phosphatase and tensin homolog on
chromosome 10) catalyzes the 3-dephosphorylation of
PIP3, thereby acting as a negative regulator of insulin sig-
naling [9]. The demonstration that the lethality associated
with loss of dPTEN in Drosophila is rescued by a mutant
form of dPKB with impaired affinity for PIP3 indicates that
PKB is a key effector of this pathway [10]. Genetic and bio-
chemical studies have identified two critical targets of PKB,
namely forkhead transcription factors of the FOXO sub-
family and the Tuberous Sclerosis Complex 2 (TSC2)
tumor suppressor protein.
In C. elegans, the only FOXO transcription factor is encoded
by daf-16. Loss-of-function mutations in daf-16 completely
suppress the dauer-constitutive and longevity phenotypes
associated with reduced function of insulin-signaling compo-
nents. On the basis of knowledge about DAF signaling in C.
elegans, forkhead transcription factors belonging to the FOXO
subfamily have been identified as direct targets of insulin/IGF
signaling in mammals [11-13]. The mammalian DAF-16
homologs comprise the proteins FOXO1 (FKHR), FOXO3a
(FKHRL1) and FOXO4 (AFX). Their phosphorylation by the
insulin-activated kinases PKB and serum- and glucocorticoid-
regulated protein kinase (SGK) creates binding sites for
14-3-3 proteins, and this leads to inactivation of FOXO pro-
teins via cytoplasmic sequestration [12,14]. The result of
this process is an insulin-induced transcriptional repression
of FOXO target genes, which are involved in the response to
DNA damage [15] and oxidative stress [16,17], apoptosis
[12,18], cell-cycle control [19-21] and metabolism [22]. In
addition to their transcriptional activation capabilities,
FOXO proteins have recently been shown to induce cell-
cycle arrest by repressing transcription of genes encoding D-
type cyclins [23,24]. FOXO transcription factors mediate
insulin resistance in diabetic mice [25], and have been pro-
posed to be tumor suppressors, as several chromosomal
translocations disrupting FOXO genes are found in cancers
[26,27], and overexpressed FOXO proteins can inhibit
tumor growth [23].
TSC2, the second target of PKB, forms a complex with TSC1
and acts as a negative regulator of growth in Drosophila, and
as a tumor suppressor in mammals. Overexpressed activated
PKB phosphorylates TSC2 and thereby disrupts the TSC1/2
complex in Drosophila and in mammalian cells [28,29]. In
Drosophila, the TSC1/2 complex functions by negatively reg-
ulating two kinases, dTOR (homolog of the mammalian
target of rapamycin) [30] and dS6K (homolog of the mam-
malian ribosomal protein S6 kinase) [31]. Recent genetic
and biochemical evidence indicates that TSC1/2 regulates
S6K activity by acting as a GTPase-activating protein (GAP)
for the small GTPase Rheb [32-35]. Interestingly, flies
lacking dS6K function are reduced in size because of a
reduction in cell size but not in cell number [36]. The
growth control pathways regulating cell size and cell
number therefore bifurcate either at dPKB or between dPKB
and dS6K.
In this study, we describe the identification of dFOXO, the
single FOXO ortholog in Drosophila. Although dFOXO func-
tion is not essential for development and organismal
growth control under normal culture conditions, it medi-
ates the reduction in cell number associated with reduced
insulin signaling. Our results show that dFOXO regulates
expression of d4E-BP, which mediates part of the cell-
number reduction in dPKB mutants. We propose that
dFOXO upregulates d4E-BP transcription under conditions
of low insulin signaling. Furthermore, our observations
suggest that dFOXO is required for resistance against oxida-
tive stress in adult flies.
Results 
dFOXO is the only Drosophila homolog of FOXO
and DAF-16 
The Drosophila genome contains a single homolog of the
DAF-16/FOXO family of transcription factors. This notion is
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supported by the phylogenetic tree diagram calculated from
the multiple sequence alignment (Figure 1a). The dFOXO
gene is more closely related to the mammalian FOXO sub-
family and daf-16 than any other Drosophila forkhead gene.
The amino-acid sequences of the predicted 613 amino-acid
dFOXO protein and hFOXO3a are 27% identical over the full
protein length, and 82% identical within the forkhead DNA-
binding domain. Furthermore, dFOXO is the only Drosophila
forkhead gene encoding a putative protein containing con-
served PKB phosphorylation sites [37]. The orientation of the
three PKB consensus sites relative to the forkhead domain
(Figure 1b) is conserved among the mammalian FOXO
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Figure 1
dFOXO is the only Drosophila FOXO/DAF-16 homolog. A TBLASTN search of the Drosophila genome for known and predicted genes encoding
forkhead transcription factors retrieved 16 genes. (a) A phylogenetic tree calculated from a multiple sequence alignment of the forkhead domains of
these 16 proteins and of the human FOXO proteins FOXO1 (FKHR), FOXO3a (FKHRL1) and FOXO4 (AFX), the C. elegans DAF-16 and mouse
Foxa3 (HNF-3; protein names on the figure are from GenBank). The similarity of dFOXO to FOXO proteins is highlighted in blue. (b) dFOXO has
three PKB phosphorylation sites in the same orientation as those of mammalian FOXO proteins. The sites are indicated above the protein; PEST
(destruction), nuclear localization (NLS), nuclear export (NES) and DNA-binding sequences are also shown. (c) A multiple amino-acid sequence
alignment of the dFOXO, human FOXO and DAF-16 forkhead domains illustrates the high degree of sequence conservation especially within the
DNA-binding domain. The secondary structure is indicated above the alignment. Similar and identical amino-acid residues are shaded in gray and black,
respectively. The region encoding helix 3 of the forkhead domain, which is the DNA-recognition helix contacting the major groove of the DNA
double helix, is identical in the five proteins. Given the high structural similarity between the DNA-binding domains of FOXO4 (AFX) and HNF-3
[86], it is likely that FOXO proteins contact insulin response elements through helix 3. Two EMS-induced point mutations described in this study are
shown in red. (d) The dFOXO gene spans a genomic region of 31 kilobases (kb) and contains 11 exons (blue bars). The EP35-147 transposable element
is inserted in the second intron upstream of the open reading frame, allowing GAL4-induced expression of endogenous dFOXO.
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proteins, DAF-l6 and dFOXO. Figure 1c shows the high
degree of sequence conservation between dFOXO and
FOXO/DAF-16 proteins within the DNA-binding domain.
Taken together, these observations strongly suggest that
dFOXO is the only Drosophila homolog of the mammalian
FOXO transcription factors and C. elegans DAF-l6.
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Figure 2
Targeted hFOXO3a and dFOXO expression in the developing Drosophila eye induces organ-size reduction and cell death, and the phenotypes are
sensitive to insulin signaling and nutrient levels. (a) GMR-Gal4-expressing control fly. (b) No discernible phenotype results from hFOXO3a
expression. (c) Expression of hFOXO3a-TM in the eye disc leads to pupal lethality; escapers at 18°C show a necrotic phenotype and severely
disrupted cell specification. (d) Expression in w--marked clones of cells induces a similar phenotype at 25°C. (e) Dp110DN expression slightly
reduces eye size, and (f) co-expression of wild-type hFOXO3a partially mimicks the hFOXO3a-TM escaper phenotype. (g) The same enhancement of
hFOXO3a activity was observed in a dPKB-/- background. (h,i) Expression of transgenic or endogenous dFOXO results in a small-eye phenotype,
which is also dramatically enhanced by (j) Dp110DN. (k-o) hFOXO3a and dFOXO phenotypes are progressively exacerbated by protein deprivation
(‘sugar’) and complete starvation (‘PBS’). Flies like the one shown in (m) die within one day, and complete starvation of dFOXO-expressing flies
resulted in pupal lethality (not shown). Genotypes are: (a) y w; GMR-Gal4/+; (b) y w; GMR-Gal4/+; UAS-hFOXO3a/+; (c) y w; GMR-Gal4/+; UAS-
hFOXO3a-TM/+; (d) y w hs-flp/y w; GMR > FRT- w+ STOP - FRT > Gal-4/+; UAS-hFOXO3a-TM/+; (e) y w; GMR-Gal4 UAS-Dp110DN/+; (f) y w; GMR-Gal4
UAS-Dp110DN/+; UAS-hFOXO3a/+; (g) y w; UAS-hFOXO3a/GMR-Gal4; dPKB3/dPKB1; (h) y w; UAS-dFOXO/GMR-Gal4; (i) y w; GMR-Gal4/+; EP-dFOXO/+;
(j) y w; GMR-Gal4 UAS-Dp110DN/+; EP-dFOXO/+; (k-m) y w; GMR-Gal4/+; UAS-hFOXO3a/+; (n,o) y w; GMR-Gal4/+; EP-dFOXO/+.
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Overexpressed dFOXO is responsive to insulin
signaling and nutrient levels, inducing organ-size
reduction and cell death
To assess whether dFOXO has a key function in insulin sig-
naling like that of DAF-16 in C. elegans, we tested whether
overexpression of wild-type or mutant forms of hFOXO3a
and dFOXO could antagonize insulin signaling. Elimination
of the three PKB consensus phosphorylation sites in mam-
malian FOXO3a prevents its phosphorylation, subsequent
binding to 14-3-3 proteins, and sequestration in the cyto-
plasm [12]. This leads to constitutive nuclear localization of
the mutant FOXO3a and transcriptional activation of its
target genes. Assuming that blocking the PKB signal would
have the same activating effect on dFOXO, we overexpressed
wild-type and triple PKB-phosphorylation-mutant variants
of both dFOXO and human FOXO3a. Furthermore, we iden-
tified an EP transposable element insertion in the second
dFOXO intron, which permits the GAL4-induced over-
expression of endogenous dFOXO (Figure 1d). We used the
GMR-Gal4 construct to drive UAS-dependent expression in
postmitotic cells in the eye imaginal disc [38]. While expres-
sion of wild-type hF0X03a in the developing eye did not
result in a visible phenotype (Figure 2b), hFOXO3a-TM
expression caused pupal lethality. Few escaper flies eclosed
and displayed a strong necrotic eye phenotype (Figure 2c).
A block of cell differentiation and necrosis was also
observed when hFOXO3a-TM was expressed in cell clones in
the developing eye (Figure 2d). 
Assuming that the lack of a phenotype observed upon UAS-
hFOXO3a expression is due to hFOXO3a inactivation by
endogenous DInr signaling in the eye disc, we performed the
same experiment in a background of reduced insulin signal-
ing. Indeed, in the presence of a dominant-negative (DN)
form of Dp110 (encoding the PI 3-kinase catalytic subunit)
[39], hFOXO3a expression induced a necrotic phenotype
similar to the one observed with the hyperactive phosphory-
lation mutant (Figure 2f). To confirm that hFOXO3a is
responsive to Drosophila insulin signaling and rule out artifi-
cial coexpression effects, we expressed hFOXO3a in flies
mutant for either dPKB (Figure 2g) or Dp110 (not shown),
and observed similar phenotypes to those seen upon coex-
pression of Dp110DN. Drosophila FOXO has qualitatively
similar, but stronger effects. Expressing the wild-type form of
dFOXO causes a weak eye-size reduction and disruption of
the ommatidial pattern even in a wild-type background
(Figure 2h,i), and the phenotype is strongly affected by
Dp110DN as well (Figure 2j). The UAS-dFOXO-TM transgene
appears to cause lethality even in the absence of a Gal4 driver,
as we did not obtain viable transgenic lines with this con-
struct. Furthermore, we examined the effects of nutrient
deprivation on FOXO-expressing tissues. If nutrient availabil-
ity is limited, FOXO should be more active in response to
lowered insulin signaling. Indeed, we observed that the over-
expression phenotypes of both hFOXO3a and dFOXO are
enhanced under conditions of starvation. Drosophila larvae
that are starved until 70 h after egg laying (AEL) die within a
few days. But if the onset of nutrient deprivation occurs after
they have surpassed the metabolic ‘70 h change’ [40,41], they
survive and develop into small adult flies. We therefore sub-
jected larvae expressing hFOXO3a or dFOXO (under GMR
control) to either protein starvation (sugar as the only energy
source) or complete starvation, starting 80-90 h AEL, and
analyzed the effect on the adult’s eyes. Both phenotypes
(Figure 2k,n) were progressively exacerbated by protein star-
vation (Figure 2l,o) and complete starvation (Figure 2m), the
latter condition being accompanied by early adult or larval
lethality, in the case of hFOXO3a or dFOXO, respectively. The
resulting phenotypes are due to the FOXO transgenes, as
wild-type control flies that have been starved during develop-
ment display only a body-size reduction while maintaining
normal proportions and normal eye structure.
The dFOXO overexpression phenotype (Figure 2i,j) does not
appear to be caused by the activation of any of the known
cell-death pathways. Expression of the caspase inhibitors
p35 or DIAP1, or of p21, an inhibitor of p53-induced apop-
tosis [42], and loss of eiger, which encodes the Drosophila
homolog of tumor necrosis factor (TNF) [43], did not sup-
press the eye phenotype (data not shown). In agreement
with our results, it was observed in a parallel study that the
GMR-dFOXO overexpression phenotype is insensitive to
caspase inhibitors, and is not accompanied by increased
acridine-orange-detectable apoptosis in the imaginal disc
[44]. It therefore remains unclear whether high levels of
nuclear dFOXO induce a specific caspase-independent cell-
death program or whether nuclear accumulation of overex-
pressed dFOXO leads to secondary necrosis in a rather
nonspecific fashion. Furthermore, the necrotic eye pheno-
type does not reflect the phenotype observed following a
complete block in insulin signaling. Loss-of-function muta-
tions in insulin-signaling components reduce cell size and
cell number but do not increase cell death in larval tissues
[45,46]. In summary, our overexpression experiments are
consistent with a model in which, under normal conditions,
excess FOXO transcription factor is phosphorylated by
dPKB and kept inactive in the cytoplasm. Under conditions
of reduced insulin-signaling activity or nutrient deprivation,
dFOXO or hFOXO3a protein translocates to the nucleus
and induces growth arrest and necrosis. 
dFOXO loss-of-function mutants are viable, have no
overgrowth phenotype and are hypersensitive to
oxidative stress
Although the overexpression experiments described above
did not reveal the physiological function of dFOXO, they
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provided the entry point for isolation of loss-of-function
mutations. We made use of the EP35-147 element, which
permits the generation of the necrotic eye phenotype
(Figure 2j) by driving expression of endogenous dFOXO in
the presence of Dp110DN. We mutagenized homozygous EP
males, mated them to homozygous GMR-Gal4 UAS-
Dp110DN females and then screened the F1 generation for
reversion of the strong gain-of-function phenotype and its
associated semilethality. Several loss-of-function alleles of
dFOXO were isolated and molecularly characterized. Two
such revertants are shown in Figure 3c (dFOXO21) and
Figure 3d (dFOXO25). In dFOXO21 and dFOXO25, the codons
for W95 and W124 within the forkhead domain are mutated
to stop codons, respectively (Figure 1c), so they are assumed
to be null alleles of dFOXO. We performed the subsequent
phenotypic and epistasis analyses with these two lines. 
Because FOXO transcription factors have been proposed to
be the primary effectors of insulin signaling, on the basis of
epistasis of daf-16 over daf-2 in C. elegans, it seemed reason-
able to expect an overgrowth phenotype in dFOXO-/- flies as
is observed in dPTEN loss-of-function mutants. To our sur-
prise, dFOXO loss-of-function mutants are homozygous-
viable and display no obvious phenotype under normal
culturing conditions (Figure 3h). Thus, dFOXO is not essen-
tial for development. Only close inspection of the dFOXO
mutants revealed that their wing size is significantly reduced
(Figure 4i). But cellular and organismal growth are unaffected
by dFOXO mutations. To assess whether dFOXO-mutant tissue
grows to a different size than wild-type tissue, we recombined
the dFOXO21 and dFOXO25 alleles onto the FRT82 chromo-
some and induced genetic mosaic flies with the ey-Flp/FRT
system [47]. When the eye and head capsule were composed
almost exclusively of dFOXO-/- tissue (w--marked in
Figure 3e,f, on the right), no head-size difference was observed
compared to the control fly with a head homozygous for the
FRT82 chromosome without the dFOXO mutation
(Figure 3e,f, left). This is consistent with experience from
extensive genetic screens for recessive growth mutations
carried out in our lab. An ey-Flp-screen on the right arm of
chromosome 3 did not reveal any mutations in dFOXO
based on an altered head-size phenotype (H.S. and E.H.,
unpublished observations). 
We next asked whether cell size, like organ size, was not
affected by the loss of dFOXO. For this purpose, we used a
heat shock-inducible Flp construct to generate clones of
homozygous dFOXO-/- photoreceptor cells and wild-type
cells within one adult eye (Figure 3g). The cells lacking
dFOXO are marked by the absence of pigment granules.
Consistent with the absence of a ‘bighead’ phenotype,
dFOXO-/- cells and wild-type cells have the same size. Simi-
larly, no significant difference in the body weight of mutant
and control flies was observed (Figure 3h). In contrast, flies
with a viable heteroallelic combination of dPTEN loss-of-
function alleles are significantly bigger than wild-type flies
[48]. Taken together, these results argue that with the excep-
tion of the slight wing-size reduction, dFOXO is not
required to control cellular, tissue, or organismal growth in
a wild-type background.
A critical role has been reported for mammalian and
C. elegans FOXO proteins in resistance against various cellu-
lar stresses, in particular oxidative stress [16,17,49], DNA
damage [15] and cytokine withdrawal [50]. We tested the
stress resistance of adult dFOXO mutant flies by measuring
survival time following different challenges. Among starva-
tion on water, oxidative-stress challenge, bacterial infection,
heat shock, and heavy-metal stress, the only condition for
which hypersensitivity was observed is oxidative stress.
When placed on hydrogen-peroxide-containing food,
dFOXO mutant flies display a significantly reduced survival
time compared to control flies (Figure 3i). A very similar
effect is elicited by paraquat feeding. These observations are
consistent with the paraquat hypersensitivity of daf-16
mutants in C. elegans [51], suggesting that a role for FOXO
proteins in protecting against oxidative stress is conserved
across species.
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Figure 3 (see figure on the next page)
Null dFOXO mutants are viable, have no overgrowth phenotype and are hypersensitive to oxidative stress. (a) Dp110DN expressing control fly.
(b) EP-driven coexpression of dFOXO elicits a necrotic eye phenotype. (c,d) EMS-induced mutations in dFOXO lead to a reversion of the
overexpression phenotype. (e,f) Selective removal of dFOXO from the head (right) does not lead to an organ-size alteration compared to a control
fly (left). (g) w --marked dFOXO-deficient photoreceptor cells are the same size as wild-type cells. (h) In contrast to dPTEN, dFOXO null mutants
have no organismal growth phenotype. For each genotype, the left bar indicates the body weight of females and the right bar the weight of males.
Values are shown ± standard deviation (SD). (i) dFOXO mutants are hypersensitive to oxidative stress. The graph shows a survival curve of male
adult flies on PBS/sucrose gel containing 5% hydrogen peroxide. The observed hypersensitivity is more pronounced in males, but is also observed in
females (not shown). The increased resistance of homozygous EP-dFOXO flies might be caused by low basal dFOXO overexpression from the EP
element, which occurs due to leakiness of UAS enhancers in the absence of Gal4. Control flies placed on PBS/sucrose without oxidant survived
during the time window shown. Genotypes are: (a) y w; GMR-Gal4 UAS-Dp110DN/+; (b) y w; GMR-Gal4 UAS-Dp110DN/+; EP-dFOXO/+; (c) y w; GMR-
Gal4 UAS-Dp110DN/+; EP-dFOXO21/+; (d) y w; GMR-Gal4 UAS-Dp110DN/+; EP-dFOXO25/+; (e,f) y w ey-flp/y w; FRT82/FRT82 cl3R3 w+ (left); y w ey-flp/y
w; FRT82 EP-dFOXO21/FRT82 cl3R3 w+ (right); (g) y w hs-flp/y w; FRT82 EP-dFOXO21/FRT82 w+.
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The growth-deficient phenotypes of DInr, chico,
Dp110 and dPKB mutants are significantly
suppressed by loss of dFOXO
We performed genetic epistasis experiments to examine
whether the growth phenotypes of DInr-signaling mutants
are dependent on dFOXO function. For this purpose, we
either generated double-mutant flies or investigated the
double-mutant effect only in the head using the ey-Flp/FRT
system. In contrast to the absence of a growth phenotype in
single dFOXO mutant flies, lack of dFOXO significantly sup-
presses the growth-deficient phenotype observed in flies
mutant for the insulin receptor substrate (IRS) homolog
chico (Figure 4). Flies mutant for chico are smaller because
they have fewer and smaller cells [45]. Loss of one dFOXO
copy dominantly suppresses the cell-number reduction in
chico mutant flies without affecting cell size. The suppression
is more pronounced when both copies of dFOXO are
removed in a chico mutant background. In this situation, the
chico small body-size phenotype is partially suppressed.
Homozygous chico-dFOXO double-mutant flies have more,
and even slightly smaller, cells than homozygous chico single
mutants. It seems that removal of dFOXO accelerates the cell
cycle at the expense of cell size in a chico background.
We next asked whether dFOXO interacts with other compo-
nents of the Drosophila insulin-signaling pathway. The ey-
Flp/FRT system was used to generate heterozygous
insulin-signaling mutant flies with heads homozygous for
each mutation. Removal of DInr, Dp110 or dPKB leads to a
characteristic ‘pinhead’ phenotype, which is substantially
suppressed by the presence of a dFOXO loss-of-function
allele on the same FRT chromosome as the insulin-signaling
mutation. In all three cases, we observed a partial rather
than a complete rescue of the tissue growth repression, con-
sistent with the finding that dFOXO mutations affect only
the cell-number aspect of the chico phenotype. Surprisingly,
loss of dFOXO dramatically delays lethality in dPKB
mutants. Complete loss of dPKB leads to larval lethality in
the early third instar, but homozygous dPKB-dFOXO double
mutants are able to develop into pharate adults of reduced
size, most of which fail to eclose (Figure 5l). The lethality
associated with the complete loss of dPKB is therefore
largely due to hyperactivation of dFOXO.
We also observed that dFOXO interacts with the tumor sup-
pressors dTSC1 and dPTEN. Tissue-specific removal of either
gene from the head leads to a bighead phenotype
(Figure 5h,j). The dTSC1-/- bighead phenotype is enhanced
by loss of dFOXO (Figure 5i). This observation is consistent
with the recently reported negative feedback loop between
dS6K and dPKB. Mutant dTSC1 larvae have elevated levels
of dS6K activity, which in turn downregulates dPKB activity
[31]. This reduction in dPKB activity probably leads to
enhanced activation of dFOXO, which in turn partially miti-
gates the overgrowth phenotype by slowing down prolifera-
tion. The dTSC1 phenotype can therefore be enhanced by
loss of the inhibitory function of dFOXO. Unexpectedly, the
dPTEN-/- bighead phenotype was slightly suppressed by
dFOXO mutations (Figure 5k). From the current model, it
would be expected that in a dPTEN mutant dPKB activity is
high and dFOXO is to a large extent inactive in the cyto-
plasm. Thus, removal of dFOXO function should have no
effect on the dPTEN phenotype. At present, we can only spec-
ulate about possible explanations for this observation. In a
parallel study, it has been shown that dFOXO can induce
transcription of DInr [52]. It may be that in a dPTEN-mutant
background dFOXO activates DInr expression in a negative-
feedback loop. In this model, concomitant loss of dFOXO
would alleviate the dPTEN overgrowth phenotype by lower-
ing DInr levels. Another possible explanation is that dFOXO
has additional functions when localized to the cytoplasm or
during its nuclear export, such as interacting with other pro-
teins. Loss of dFOXO might affect the function of interaction
partners that have a role in dPTEN signaling. 
In summary, our epistasis analysis provides strong genetic
evidence that dFOXO is required to mediate the organismal
growth arrest that is elicited in insulin-signaling mutants.
dFOXO upregulates transcription of the d4E-BP
gene
We have shown previously that Drosophila embryonic Kc167
cells respond to insulin stimulation with upregulated activi-
ties of dPKB and dS6K [53,54]. We performed mRNA profil-
ing experiments using the Affymetrix GeneChip system to
measure on a genome-wide scale the transcriptional
changes induced by insulin in these cells. On the basis of
the currently held model that FOXO transcription factors
are transcriptional activators that are negatively regulated by
insulin, we expected potential dFOXO target genes to be
repressed in Kc167 cells upon insulin stimulation. Figure 6a
shows a selection of dFOXO target gene candidates that are
transcriptionally downregulated by a factor of two or more
upon insulin stimulation and whose promoter regions
contain one or more conserved forkhead-response elements
(FHREs) with the consensus sequence (G/A)TAAACAA [55].
Three of these candidate gene products are each involved in
one of two biological processes known to be negatively reg-
ulated by insulin, namely gluconeogenesis (PEPCK) and
lipid catabolism (CPTI and long-chain-fatty-acid-CoA-
ligase). The remaining candidates are involved in stress
responses (cytochrome P450 enzymes), DNA repair (DNA
polymerase iota), transcription and translation control
(d4E-BP and CDK8), and cell-cycle control (centaurin
gamma and CG3799). Several of the insulin-repressed genes
have been reported to be transcriptionally induced in
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Drosophila larvae under conditions of complete starvation
(d4E-BP and PEPCK) or sugar-only diet (CPTI and long-
chain-fatty-acid-CoA-ligase) [41,56].
We chose d4E-BP for further investigation, because it has previ-
ously been reported to be insulin-regulated at the level of
protein phosphorylation, but not at the level of gene expression
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Figure 4
Loss of dFOXO suppresses the cell-number reduction in chico mutants. (a-e) Partial rescue of the chico phenotype by mutations in dFOXO. Bar sizes
are 100 m (low magnification) and 20 m (high magnification). Each graph displays the variation of a single parameter between the five genotypes
shown in (a–e): (f) body weight, (g) cell number in the eye, (h) cell size in the eye, (i) wing area, (j) cell number in the wing, and (k) cell size in the
wing. (f) dFOXO-/- partially suppresses the low-body-weight phenotype of chico-/-. The suppression is less pronounced in the wing (i), because dFOXO-
null mutants have significantly smaller wings than control flies, although their body weight is the same. In a chico-/- background, loss of dFOXO leads
to increased cell numbers in the eye (g) and in the wing (j) compared to the chico single mutant. Although organ and tissue size is increased, cell size
significantly decreases in the chico-dFOXO double mutant both in the eye (h) and in the wing (k). It seems that loss of dFOXO in a chico-/- background
leads to increased proliferation rates. All values are shown ± SD. Genotypes are: (a) y w;; EP-dFOXO/EP-dFOXO; (b) y w;; EP-dFOXO21/EP-dFOXO25; (c)
y w; chico1/chico2; EP-dFOXO21/+; (d) y w; chico1/chico2; EP-dFOXO21/ EP-dFOXO25; (e) y w; chico1/chico2.
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[57]. The d4E-BP gene encodes a translational repressor and
was initially identified as the immune-compromised Thor
mutant in a genetic screen for genes involved in the innate
immune response to bacterial infection [58,59]. Figure 6b
shows the presence of several FHREs in the genomic region
around the d4E-BP locus. The d4E-BP protein is negatively
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Figure 5
Growth-deficient phenotypes of DInr, Dp110 and dPKB mutants are suppressed by loss of dFOXO. (a) Control fly. (b) Selective removal of DInr
from the head leads to a pinhead phenotype, which is partially suppressed by the loss of dFOXO (c). The same suppression is observed in Dp110-,
and dPKB-pinheads (d-g). The TSC1-/- bighead phenotype (h) is enhanced by mutations in dFOXO (i), but the dPTEN-/- bighead (j) is slightly
suppressed (k). (l) Living without PKB. In contrast to the larval lethality of dPKB null mutants, dPKB-dFOXO double mutants develop into small
pharate adults, most of which fail to eclose. Bar sizes are 200 m (low magnification) and 20 m (high magnification). Genotypes are: (a) y w ey-flp/y
w; FRT82/FRT82 cl3R3 w+; (b) y w ey-flp/y w; FRT82 DInr304/FRT82 cl3R3 w+; (c) y w ey-flp/y w; FRT82 DInr304 EP-dFOXO25/FRT82 cl3R3 w+; (d) y w ey-flp/y
w; FRT82 Dp1105W3/FRT82 cl3R3 w+; (e) y w ey-flp/y w; FRT82 Dp1105W3 EP-dFOXO25/FRT82 cl3R3 w+; (f) y w ey-flp/y w; FRT82 dPKB1/FRT82 cl3R3 w+;
(g) y w ey-flp/y w; FRT82 dPKB1 EP-dFOXO25/FRT82 cl3R3 w+; (h) y w ey-flp/y w; FRT82 dTSC1Q87X/FRT82 cl3R3 w+; (i) y w ey-flp/y w; FRT82 dTSC1Q87X EP-
dFOXO25/FRT82 cl3R3 w+; (j) y w ey-flp/y w; FRT40 dPTEN117-4/FRT40 cl2L3 w+; (k) y w ey-flp/y w; FRT40 dPTEN117-4/FRT40 cl2L3 w+; FRT82 EP-
dFOXO25/FRT82 cl3R3 w+; (l) y w;; EP-dFOXO21/EPdFOXO25 (left), y w;; dPKB1 EP-dFOXO21/dPKB1 EP-dFOXO25 (middle), dPKB1/dPKB1 (right).
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regulated by insulin through LY294002- and rapamycin-sensi-
tive phosphorylation [57], suggesting involvement of the
Dp110 and dTOR signaling pathways. Phosphorylation of
d4E-BP leads to the dissociation of d4E-BP from its binding
partner, the translation initiation factor deIF4E, which then
participates in the formation of a functional initiation complex.
Positive transcriptional regulation of d4E-BP by dFOXO, which
corresponds to negative transcriptional regulation by insulin,
would be a complementary mechanism of regulation.
We then investigated whether overexpression of endogenous
dFOXO could induce transcriptional upregulation of the
d4E-BP gene. On the basis of our overexpression results, we
chose the Dp110DN-dFOXO coexpression to efficiently acti-
vate dFOXO. Eye imaginal discs from Dp110DN-expressing
third instar larvae display a low level of basal d4E-BP transcrip-
tion throughout the disc, which is not induced by the driver
construct alone (Figure 6d). Coexpression of dFOXO elicited a
dramatic upregulation of d4E-BP transcription posterior to the
morphogenetic furrow (Figure 6e). Consistent with this obser-
vation, we were able to induce expression of the d4E-BP
enhancer trap line Thor1 with human FOXO3a-TM (Figure 6f-
h). It remained unclear, however, whether regulation of d4E-
BP expression by dFOXO is of physiological relevance. 
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Figure 6
dFOXO regulates transcription of the d4E-BP gene. (a) A selection of microarray-identified genes that are transcriptionally downregulated after 2 h
of insulin stimulation in Kc167 cells and contain forkhead response elements (FHREs) in their genomic upstream or intronic sequences. (b) FHREs
(red) at the d4E-BP locus; black boxes are exons. (c,d) Overexpression of Dp110DN alone does not induce transcription of d4E-BP in imaginal discs,
but (e) coexpression of dFOXO strongly upregulates the gene. (f-h) Expression of human FOXO3a-TM induces expression of the d4E-BP enhancer
trap line Thor1. (i) d4E-BP and dPKB interact genetically. The Thor1 mutation increases the ommatidial number in dPKB-mutants by 9% without
affecting cell size. Values are shown ± SD. Genotypes are: (c) y w; GMR-Gal4 UAS-Dp110DN/+; (d) y w; GMR-Gal4 UAS-Dp110DN/+; (e) y w; GMR-Gal4
UAS-Dp110DN/+; EP-dFOXO/+; (f) y w; (g) y w; Thor1/+; (h) y w; Thor1/GMR-Gal4; UAS-hFOXO3a-TM/+; (i) from right to left: y w;; dPKB3/dPKB1, y w;
Thor1/+; dPKB3/dPKB1, y w; Thor1/Thor1; dPKB3/dPKB1.
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It has been previously reported that overexpression of d4E-
BP partially suppresses the dPKB overexpression phenotype
[57], but as ectopic expression experiments have to be inter-
preted with some caution, we assessed whether loss of d4E-
BP function suppresses the cell-number reduction in
insulin-signaling mutants as does loss of dFOXO function.
We generated double-mutant flies for dPKB and d4E-BP and
observed that the Thor1 mutation slightly but significantly
suppressed the reduced cell-number phenotype in a dose-
dependent manner. The Thor1 mutation itself had no effect
on ommatidial number compared to wild-type flies (data
not shown), so we can rule out additive effects of d4E-BP
and dPKB. These observations strongly argue that under
conditions of reduced insulin-signaling activity the dFOXO-
dependent reduction in cell number is in part mediated by
the transcriptional upregulation of its target d4E-BP.
Microarray studies in both mammalian [23] and Drosophila
[52] cells imply that FOXO transcription factors exert their
physiological functions by modulating expression of large
sets of target genes.
Discussion
Forkhead transcription factors of the FOXO subfamily
mediate insulin-regulated gene expression in C. elegans and
mammals. In this study, we provide genetic evidence that
the Drosophila FOXO/DAF-16 homolog dFOXO is an impor-
tant downstream effector of Drosophila insulin signaling and
a regulator of stress resistance. 
dFOXO is a critical target of dPKB but mediates
only part of its function
Genetic studies in C. elegans and Drosophila have led to two
models regarding the output of the insulin pathway. First,
the complete epistasis of daf-16 over the insulin pathway
mutants daf-2, age-1, akt-1 and akt-2 suggests that the
primary function of PKB is to inactivate FOXO transcription
factors [60]. Second, it has been proposed that the TSC
tumor suppressor complex is the major target of PKB
[61,62] in the regulation of cell growth in Drosophila. Our
analysis of Drosophila FOXO indicates that it is indeed a crit-
ical PKB target, but that it mediates only one aspect of PKB
function. Several lines of evidence support this model.
Firstly, the effects of ectopic overexpression of dFOXO and
hFOXO3a in the developing Drosophila eye are altered by
Dp110 and dPKB signaling as well as by nutrient levels.
Under conditions of lowered insulin signaling, the pheno-
types resulting from expression of dFOXO and hFOXO3a
were dramatically enhanced. This situation was mimicked
by expressing a dPKB-insensitive phosphorylation mutant,
suggesting that endogenous dPKB signaling is required to
mitigate the effects of ectopically expressed dFOXO and
hFOXO3a. Secondly, the physiological relevance of dFOXO
in dPKB signaling is most vividly demonstrated by our
observation that the larval lethality associated with the com-
plete loss of dPKB is rescued by dFOXO mutations to the
extent that some flies develop to pharate adults. The lethal-
ity associated with loss of dPKB function is therefore to a
large extent due to the hyperactivation of dFOXO. Thirdly,
loss of dFOXO function suppresses the effects of insulin-
signaling mutations only partially; dFOXO mediated a
reduction in cell number but not in cell size in response to
reduced insulin signaling. 
dFOXO controls the reduction in cell number in
body-size mutants
Genetic analysis of the control of body size in Drosophila has
revealed two classes of mutations. Flies carrying mutations
in chico or viable allelic combinations of DInr, Dp110, and
dPKB are reduced in body size by up to 50% owing to a
reduction in both cell size and cell number. Conversely,
flies mutant for dS6K exhibit a more moderate reduction in
body size, caused almost exclusively by a reduction in cell
size [36]. This suggests that the pathways controlling cell
number and cell size bifurcate at or below dPKB. Although
dFOXO single mutants have no obvious size phenotype,
loss of dFOXO substantially suppresses the cell-number
reduction observed in insulin-signaling mutants. It appears
that dFOXO mediates the repression of proliferation in flies
mutant for DInr, chico, Dp110, and dPKB without being
required for the reduction in cell size. Chico-dFOXO double
mutant flies even have slightly smaller cells than chico
mutants, suggesting that removal of dFOXO permits cell-
cycle acceleration under conditions of impaired insulin sig-
naling. The pathway controlling body size in response to
insulin therefore bifurcates at the level of dPKB: dPKB con-
trols cell number by inhibiting dFOXO function and dPKB
controls cell size, at least under some conditions, by regulat-
ing S6K activity by phosphorylation of dTSC2 [29]. 
The signaling systems controlling cell size and cell number
are tightly interconnected. Genetic and biochemical analy-
ses have revealed five different links between the dTSC-
dTOR-dS6K pathway and the DInr-dPKB-dFOXO pathway.
First, under conditions of unnaturally high insulin-signaling
activity (that is, following the oncogenic activation of
dPKB) dPKB phosphorylates and inactivates dTSC2, result-
ing in increased activation of dS6K [29]. Under normal
culture conditions this regulation does not seem critical,
however, loss of dPKB function does not lower dS6K activ-
ity in larval extracts [54]. Second, under physiological con-
ditions, dPDK1 regulates dPKB as well as dS6K [63]. Third,
dS6K itself downregulates dPKB activity in a negative feed-
back loop [31]. Fourth, under severe starvation conditions,
nuclear dFOXO presumably activates target genes that
reduce cell proliferation. One of these target genes is
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d4E-BP, which encodes an inhibitor of translation initiation.
When conditions improve, the insulin and TOR signaling
pathways can stimulate translation by disrupting the 4E-
BP/eIF4E complex via phosphorylation of 4E-BP, and in par-
allel by repressing FOXO-dependent 4E-BP expression. Fifth,
under even more severe starvation or stress conditions, full
activation of dFOXO upregulates expression of the insulin
receptor itself, thus rendering the cell hypersensitive to low
insulin levels (see [52]). These multiple positive and nega-
tive interactions ensure a continuous fine adjustment of the
growth rate to changing environmental conditions.
Evolutionary conservation of insulin signaling and
FOXO function
Genetic dissection of signaling by insulin and its target
DAF-16 has been pioneered in C. elegans and has helped to
unravel the role of this pathway in dauer formation and
longevity. Our analysis shows that the same pathway with
the homologous nuclear targets operates in flies in the
control of cell growth and proliferation, processes that do
not involve insulin signaling in worms. Dauer formation
and possibly longevity affect the entire organism and do not
depend on cell-autonomous functions of the insulin signal-
ing pathway [64]. The cell-growth phenotype in Drosophila,
however, depends on the cell-autonomous functioning of
the insulin-signaling cascade [45]. Insects enter diapause in
response to diverse environmental cues (nutrients, day
length or temperature) and arrest development or the aging
process in a manner similar to dauer formation in worms
[65]. Ageing, and possibly diapause, is also under the
control of the insulin pathway in Drosophila [65,66]. It has
recently been shown that heterozygous IGF-1R mutant mice
also exhibit a prolonged lifespan [3]. It therefore appears
that the function of the insulin pathway, its components,
and possibly at least some of its targets, have been con-
served throughout evolution.
dFOXO may integrate different forms of cellular
stress
The longevity phenotype of IGF-1R-deficient mice is associ-
ated with enhanced resistance to oxidative stress [3]. It is
likely that this phenomenon is due to hyperactivation of
FOXO proteins, as several studies have shown that FOXO
transcription factors play a role in the oxidative-stress
response in mammalian cells [16,17] as well as in C. elegans
[49]. Our observation that dFOXO mutant flies are hyper-
sensitive to oxidative stress confirms that, in addition to
their role in insulin signaling, the role of FOXO proteins in
protecting against cellular stress is highly conserved. The
mechanism by which dFOXO confers oxidative-stress resis-
tance is not yet known. In our microarray experiment, we
identified several genes encoding cytochrome P450
enzymes as dFOXO target gene candidates (Figure 6a). As it
has been shown that cytochrome P450 enzymes reduce the
toxic effects of paraquat in mice [67], they might partially
mediate the protective effect of dFOXO. Furthermore, it
remains to be established whether the regulation of dFOXO
by insulin is required for dFOXO’s protective properties. It
is tempting to speculate that distinct stress-induced signal-
ing pathways activate dFOXO under conditions of cellular
stress, in addition to the negative input from the insulin
cascade, as several stress-induced phosphorylation sites are
conserved between hFOXO3a and dFOXO (A Brunet and
ME Greenberg, personal communication). This view is sup-
ported by our observation that overexpression of a FOXO
variant that cannot be inactivated by PKB elicits cell death,
a phenotype not observed in larval tissues lacking insulin-
signaling components [45]. This result argues that dFOXO
induces cellular responses that are independent of insulin. 
The emerging model postulates that positive and negative
inputs converge on FOXO proteins in response to different
environmental conditions, making them central and impor-
tant integrators controlling cellular (cell-cycle progression)
and organismal adaptations (dauer formation, diapause
and longevity; see Figure 7). Elucidating the positive inputs
that converge on FOXO, by mutating conserved phosphory-
lation sites in the single Drosophila homolog of this class,
should help us to better understand dFOXO’s integrator
function. 
Materials and methods
Identification of dFOXO
We searched the Drosophila genome [68] using a TBLASTN
algorithm for sequences with homology to the DNA-
binding domain of human FOXO3a (amino acids 157-
251). The resultant matches were further assessed for the
presence of consensus PKB phosphorylation sites R-X-R-X-
X-S/T [37].
We used a genomic DNA stretch flanking the only identified
region fulfilling these criteria to search a collection of
Drosophila expressed sequence tags [69], which eventually
identified two clones (LD05569 and LD18492) containing
identical full-length cDNA sequences of 3.7 kb length. The
dFOXO gene is annotated in FlyBase [70] (FBgn0038197)
under the name foxo.
Generation of plasmids and transgenic flies
The cDNA clone LD05569 contains the full-length dFOXO
cDNA within the pBS-SK(+/-) vector (Stratagene [71]). To
generate a triple PKB phosphorylation mutant of dFOXO, we
used PCR-based site-directed mutagenesis (QuickChange,
Stratagene) to introduce the three point mutations T44A,
S190A and S259A. Primer sequences are available upon
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request. The mutated sequence was confirmed by double-
stranded DNA sequencing. To generate UAS constructs, the
cDNA inserts from both wild-type dFOXO and triple-mutant
dFOXO were subcloned from pBS-SK(+/-) into the pUAST
transformation vector [72] as EcoRI-Asp718 fragments. The
corresponding UAS constructs containing the cDNA encod-
ing wild-type and triple-mutant hFOXO3a [12] were gener-
ated by subcloning the inserts from pECE-HA-hFOXO3a and
pECE-HA-hFOXO3a-TM (generous gifts of Anne Brunet)
into pUAST as BglII-XbaI fragments. Fragments were excised
from the pECE clones via complete digestion with XbaI fol-
lowed by partial BglII digestion. All sequences were con-
firmed by double-stranded DNA sequencing. The four
resultant UAS constructs are referred to as UAS-dFOXO,
UAS-dFOXO-TM, UAS-hFOXO3a and UAS-hFOXO3a-TM.
To generate transgenic Drosophila lines, P-element-mediated
germline transformation was carried out as described
previously [73]. Several independent transformant lines
were recovered for each construct with the exception of
UAS-dFOXO-TM, for which we did not obtain a viable
transformant line.
EMS reversion mutagenesis
To generate dFOXO loss-of-function mutants, homozygous
y w;; EP35-147 males were mutagenized with 27 mM ethyl
methanesulfonate (EMS) according to standard procedures
[74]. Mutagenized males were mated to homozygous y w;
GMR-Gal4 UAS-Dp110DN virgins. Roughly 60,000 F1
progeny were screened for suppression of semilethality and
the eye phenotype shown in Figure 3b. F1 revertants were
retested for transmission of the reversion to F2 and positive
candidate lines were then balanced over TM3 Sb Ser. To
characterize the mutations, the dFOXO open reading frame
from each individual mutagenized chromosome was ampli-
fied by RT-PCR and sequenced. The cDNA derived from the
unmutagenized EP35-147 chromosome was used as a refer-
ence sample to identify mutations. Promising mutations
were verified by double peak analysis of PCR fragments
amplified from genomic DNA using the Sequencher
program (Gene Codes Corporation [75]).
Drosophila strains
The EP-35-147 line was kindly provided by Konrad Basler,
the GMR-Gal4 driver was a gift from M. Freeman. The GMR-
Gal4, UAS-Dp110DN line was obtained from Sally Leevers,
the eiger mutants from Masayuki Miura, and the Thor1 line
from Paul Lasko.
Phenotype analyses
All phenotypes were analyzed in females raised at 25°C
unless indicated otherwise. Body weight, cell size and cell
number were determined as described previously [5]. The
body weight experiment was performed in duplicate, and
male and female flies were measured separately (n = 12 for
each gender and genotype; the highest and lowest values
were excluded from the analysis). Flies were reared under
identical, non-crowding conditions and were of identical
age (2 d) at the time of the experiment. The sizes of omma-
tidia and rhabdomeres were quantified with the program
NIH Image 1.61. [76].
Clonal analysis
To induce loss-of-function clones, we used the Flp/FRT and
ey-Flp systems to generate mosaic flies by mitotic recombi-
nation [47,77]. Overexpression clones were generated as
described [63].
In situ hybridizations
In situ hybridizations to eye imaginal discs was performed
as described [78,79]. The d4E-BP cDNA was PCR-amplified
with Pfu polymerase from Promega [80] from total double-
stranded cDNA derived from adult y w flies and cloned
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Figure 7
dFOXO may be an integrator of cellular stress. We propose a model in
which dFOXO senses different forms of cellular stress (that is, nutrient
deprivation or reactive oxygen species) and induces cellular responses,
such as proliferation arrest, in part by repressing translation via
upregulation of d4E-BP. The various signaling proteins shown in the
figure are discussed in the text. 
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into the pCAPS vector (PCR blunt-end cloning kit from
Roche [81]). Insert orientation was determined by sequenc-
ing. Vector-specific PCR primers flanking the multiple
cloning site (MCS) and containing either T7 or SP6 RNA
polymerase promoters were used to synthesize double-
stranded DNA templates for the labeling in vitro transcrip-
tion reaction. The sense probe was transcribed with T7 and
the antisense probe with SP6 RNA polymerase. 
Cell culture
Drosophila embryonic Kc167 cells were maintained as
described elsewhere [53]. Briefly, cells were grown at 25°C
in Schneider’s Drosophila medium (Gibco/Invitrogen [82])
supplemented with 10% heat-inactivated fetal calf serum,
FCS. Cells were split and diluted to a density of 1x106 per
ml twice a week. For the microarray experiment, cells were
grown into the stationary phase for 7 d and then stimulated
with 100 nM bovine insulin for 2 h. 
Microarray experiment
The microarray experiment was performed at the Functional
Genomics Center Zürich (FGCZ) using the Affymetrix
GeneChipTM system [83]. Total RNA was extracted from
untreated control cells and insulin-treated cells 2 h after
stimulation using the RNeasy Mini kit (Qiagen [84])
according to the manufacturer’s instructions. From each cell
population, three independent samples were taken,
processed in parallel and hybridized to three separate
microarrays. Synthesis of cDNA and labeled cRNA, array
hybridization and scanning were performed according to
the standard Affymetrix protocols. The .chp files for the
individual scanned microarrays were imported into the
Affymetrix Data Mining ToolTM software for data analysis. 
Stress treatments
Stress-resistance experiments were performed with 3-day-
old adult flies, and males and females were assayed sepa-
rately. For bacterial infection experiments, adult flies were
pricked with a thin needle which had been dipped in a con-
centrated bacterial culture [85]. Bacterial strains tested were
the Gram-negative Erwinia carotovora carotovora and the
Gram-positive Micrococcus luteus. Heat shock was performed
by continuous exposure to 37°C. Resistance to heavy metals
during development was assayed by rearing flies on food
containing either 2.5 mM copper, 6 mM zinc or 200 M
cadmium. For the starvation test, flies were transferred from
normal food to empty vials closed with a wet foam stopper.
For oxidative-stress challenge, flies were starved in empty
vials for 6 h and then transferred to vials containing a gel of
phosphate-buffered saline (PBS), 10% sucrose, 0.8% low-
melt agarose and the respective oxidative agent (either 5%
H2O2 or 20 mM paraquat). The oxidant was added to the
solution after cooling to 40°C. A control population of flies
was placed in vials containing the PBS-sucrose gel without
oxidant. Dead flies were counted every 12 h (n = 80 for each
gender and genotype). The hydrogen peroxide and paraquat
experiments were each done in triplicate. Larval starvation
was performed by rearing larvae on normal fly food until 80
h after egg deposition, then floating them in 30% glycerol,
washing with water and transfering batches of 30-40 larvae
to vials containing a gel of either PBS, 20% sucrose and
0.8% agarose (sugar condition) or PBS-agarose only (com-
plete starvation).
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Diet-Dependent Effects of the Drosophila
Mnk1/Mnk2 Homolog Lk6 on Growth via eIF4E
was also identified in a misexpression screen as a puta-
tive negative regulator ofRas/MAPKsignaling [10]. How-
ever, no physiological role has been assigned to Lk6 in
Jan H. Reiling,1 Kathrin T. Doepfner,1
Ernst Hafen,* and Hugo Stocker
Zoologisches Institut
Universita¨t Zu¨rich Drosophila so far.
EPLk6-mediated Lk6 overexpression not only sup-Winterthurerstrasse 190
CH-8057 Zu¨rich pressed the overgrowth phenotype elicited by coex-
pression of PKB and PDK1, but it also attenuated theSwitzerland
eye overgrowth caused by the overproduction of the
insulin receptor (Inr) and of the small GTPase Rheb (Ras
homolog enriched in brain) aswell as an S6 kinase (S6K)-Summary
dependent bent-downwing phenotype (see Figure S1 in
the Supplemental Data available with this article online;The control of cellular growth is tightly linked to the
regulation of protein synthesis. A key function in trans- data not shown). Ubiquitous expression of Lk6 (by
means of daGal4) resulted in smaller flies (weight reduc-lation initiation is fulfilled by the 5 cap binding eukary-
otic initiation factor 4E (eIF4E), and dysregulation of tion of 10% in females and 9% in males, respectively;
Figure 1B). The reduced wing size (10%) was broughteIF4E is associatedwithmalignant transformation and
tumorigenesis [1, 2]. In mammals, the activity of eIF4E about by a decrease in cell number (10% decrease in
females) but not in cell size (Figure 1C). Likewise, theis modulated by phosphorylation at Ser209 by mito-
gen-activated protein kinases (MAPK)-interacting ki- observed reduction in overall eye size was caused by
a diminution in cell number (data not shown).nases 1 and 2 (Mnk1 and Mnk2) [3–5], which them-
selvesare activated byERKandp38MAPK in response eIF4E is regulated bybindingof eIF4Ebindingproteins
(4E-BPs), which in their hypophosphorylated form inhibitto mitogens, cytokines or cellular stress [6]. Whether
phosphorylation of eIF4E at Ser209 exerts a positive or cap-dependent translation, and by direct phosphoryla-
tion [11]. Themammalian Lk6 homologsMnk1 andMnk2inhibitory effect on translation efficiency has remained
controversial. Herewe provide a genetic characteriza- are the physiological kinases responsible for the phos-
phorylation of eIF4E at Ser209 [3–5]. Flies lacking eIF4Etion of the Drosophila homolog of Mnk1/2, Lk6. Lk6
function is dispensable under a high protein diet, con- function die during early larval stages. A genomic eIF4E
construct containing anamino acid exchangeat positionsistent with the recent finding that mice lacking both
Mnk1 and Mnk2 are not growth-impaired [4]. Interest- 251 (Ser251→Ala, corresponding to Ser209 in mamma-
lian eIF4E) is capable of rescuing eIF4E null mutants toingly, loss of Lk6 function causes a significant growth
reduction when the amino acid content in the diet is adulthood. However, the rescued animals have a re-
duced viability, develop more slowly, and are smallerreduced. Overexpression of Lk6 also results in growth
inhibition in an eIF4E-dependent manner. We propose than control flies, indicating an important role for Ser251
phosphorylation in assuring normal growth during de-a model of eIF4E regulation that may reconcile the
contradictory findings with regard to the role of phos- velopment [12]. To genetically test whether the effects
of Lk6 are mediated by phosphorylation of eIF4E atphorylation by Mnk1/2.
Ser251, we overexpressed Lk6 with daGal4 in an eIF4E-
deficient background provided with an eIF4ESer251AlaResults and Discussion
transgene. Strikingly, the effects of Lk6 overexpression
were completely abrogated in this genetic context (Fig-Lk6 Overexpression Inhibits Growth
through eIF4E ure 1D). Thus, at least under overexpression conditions,
eIF4E-Ser251 is required for Lk6 to affect growth.In search of novel growth effectors acting downstream
of Protein kinase B (PKB, also called Akt) and 3-phos-
phoinositide-dependent kinase-1 (PDK1), we set out to
Lk6 Is Dispensable for Normal Growthidentify genes whose expression is capable of modulat-
and Developmenting an overgrowth phenotype caused by the cooverex-
The functional significance of eIF4E-Ser209 phosphory-pression of PKB and PDK1. To this end, we performed
lation is still under debate [13]. It is widely accepteda UAS (upstream activating sequences)/Gal4-based EP
that eIF4E phosphorylation is increased in response to(enhancer/promoter) screen [7, 8] to coexpress random
growth factors, hormones, cytokines, and mitogenicgenes together with PKB/PDK1. EP30.18 strongly sup-
stimuli that activate translation [11]. However, differentpressed the hyperplastic phenotype (Figure 1A), and
studies demonstrated a negligible role—or even an in-plasmid rescue revealed Lk6 as the gene driven by the
hibitory effect—for eIF4E-Ser209 phosphorylation inEP insertion (henceforth termed EPLk6).
translation initiation [14, 15]. Moreover, published dataLk6 encodes the single Drosophila homolog of Mnk1
concerning the affinity of phosphorylated eIF4E forand Mnk2. It has previously been described as a micro-
capped mRNA are also contradictory [16–18]. Thus, ittubule- and centrosome-associated protein [9], and it
is essential to study the physiological function of eIF4E
phosphorylation in a genetically tractable model organ-*Correspondence: hafen@zool.unizh.ch
1These authors contributed equally to this work. ism such as Drosophila. We generated mutations in Lk6
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Figure 1. Overexpression of Lk6, the Drosophila Mnk1/2 Homolog, Inhibits Growth via Phosphorylation of eIF4E
(A) Overexpression of Lk6 (achieved by EPLk6) suppresses a PKB/PDK1-dependent big-eye phenotype. Dorsal view of Drosophila adult heads
of genotypes y w;GMR-Gal4 UAS-PKB/;EPPDK1/ (left) and y w;GMR-Gal4 UAS-PKB/;EPPDK1/EPLk6 (right).
(B) Ubiquitous expression of Lk6 (with daGal4 as driver line) gives rise to smaller flies. Quantitative analysis shows a weight reduction of 10%
in females and 9% in males (n  33, p  0.05; student’s t test).
(C) The reduced wing size (n  10, p  0.05; student’s t test) is attributable to fewer cells.
(D) Flies overexpressing Lk6 in an eIF4E phosphorylation site mutant background (white bars) do not display any weight reduction as compared
to control flies (black and gray bars; n  19). Consistently, neither number nor size of ommatidia in the adult eye of females is altered (right;
n  4). Thus, Lk6 exerts its effect via phosphorylation of eIF4E at Ser251. Measurements were performed according to Bohni et al. [22]. All
error bars represent the standard deviation.
by feeding EPLk6 males with ethylmethane sulphonate the kinase domain (Figure 2A). All mutant combinations
gave rise to viable and fertile flies without obvious(EMS) and crossing them to Act5CGal4 driver females.
Because the overexpression of Lk6 is lethal at the pupal growth defects (Figure 2B). Clones of Lk6 mutant cells
were induced in imaginal discs during larval stages tostage, only flies carrying a lesion in the Lk6 gene (or in
an essential downstream gene) could survive. In this investigate whether loss of Lk6 affects growth of mutant
cells when juxtaposed to wild-type cells. The growthway, we obtained five loss-of-function alleles of Lk6
(Figure 2A). Fourmutations (Lk615, Lk625, Lk626, and Lk636) behavior of marked Lk6 mutant clones was indistin-
guishable from their neighboring twin spot clones (Fig-are located in the region encoding the evolutionarily
conserved kinase domain. Lk638 results in a premature ure 2C). Accordingly, no differences in cell size could
be observed in clones of Lk6 mutant cells in the adultstop at amino acid position 474, located C-terminal to
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Figure 2. Loss of Lk6 Does Not Lead to Growth Abnormalities under Standard Culture Conditions
(A) Alignment of the highly conserved kinase domain of Lk6 with its human (H.s.), mouse (M.m.), and C. elegans (C.e.) homologs (Mnk1 and
Mnk2 in mammals; alignment only shown for Mnk1). The red stars indicate the positions of the sequence changes caused by the EMS-induced
Lk6 mutations. Lk636: His to Arg at position 154; Lk626: Gly to Arg at position 186; Lk625: Ser to Leu at position 265; and Lk615: frame shift, at
position 360, leading to translation termination after nine additional amino acids (GGRVARCQR). Lk638 results in a truncation at position 474
after the kinase domain.
(B) Lk6 mutant flies are normal in size. The weight of mutant female and male flies (four different alleles) is not significantly altered compared
to control flies.
(C and D) Clonal analyses in imaginal wing discs (C) and in the adult eye (D) do not reveal any growth impairment of Lk6 mutant cells. Mitotic
recombination was induced by a heatshock 48–72 hr after egg deposition. Mutant cells aremarked by the absence of GFP and red pigmentation,
respectively. Genotypes are y w hs-Flp;FRT82 Lk615/FRT82 Ubi-GFP (C) and y w hs-Flp;FRT82 Lk615/FRT82 w (D).
compound eye (Figure 2D). Thus, Lk6 is dispensable for adult wings (Figure 3B). Consistently, the number of
ommatidia in the compound eye was also reduced (8%normal development and growth under standard culture
conditions. fewer ommatidia in females; data not shown). Further
reduction of the yeast content (20% yeast) led to an
even more pronounced weight loss of the Lk6 mutantsLk6 Is Limiting under Conditions of Reduced
(15% in males, 29% in females), but it also decreasedDietary Protein and Oxidative Stress
the weight of control flies by up to 6% in males (FigureA comparison with the results of another study on the
3A). Interestingly, the size reduction of the Lk6 mutantfunction of Lk6 ([19], published online along with this
flies at 20% yeast is caused by a reduction in both cellpaper) revealed surprising differences because these
size and cell number. Strikingly, Lk6 mutant cell clonesauthors observed a significant growth reduction of Lk6
induced in larval imaginal discs grew poorly at 20%mutant flies.We reasoned that thedifference couldorigi-
yeast as compared to their wild-type sibling clones, innate fromunequal culture conditions and testedwhether
sharp contrast to the normal growth at 100% yeastthe requirement for Lk6 function depends on the diet.
(compare Figure 3C with Figure 2C). We conclude thateIF4E is regulated both by phosphorylation andby direct
Lk6 is a positive growth regulator that becomes limitingbinding to 4E-BPs. The activity of 4E-BPs is intimately
only under poor nutrient supply.linked to nutrient availability because TOR, the kinase
We initially identified Lk6 as a negative growth regula-that is part of a nutrient-sensing complex [20], phos-
tor capable of suppressing, upon overexpression, a big-phorylates 4E-BP under nutrient-rich conditions, lead-
eye phenotype. Moreover, ubiquitous overexpression ofing to the dissociation of 4E-BP from eIF4E [21]. Lk6
Lk6 at 100% yeast resulted in a growth reduction (seefunction might become limiting when amino acid levels
above, Figures 1B and 1C). The results of the loss-of-are reduced. Lk6 mutant as well as control larvae were
function analysis suggest that Lk6overexpression underreared on food with a reduced content in yeast (and
our standard conditions acts in a dominant-negativetherefore limited amino acid supply) to test this hypothe-
manner. We wondered whether the negative effects onsis. At 30% yeast, control flies did not show any weight
growth were also contingent on amino acid availability.loss when compared to flies reared at 100% yeast (our
At 30% and 20% yeast, Lk6-overexpressing flies werestandard fly medium). In contrast, Lk6 mutants were
no longer reduced in weight when compared to controlsignificantly smaller at 30% yeast (weight reduction of
flies (Figure 3D). Furthermore, the lethality caused by9% in males and 20% in females; Figure 3A; data not
Act5CGal4-mediated Lk6 overexpression at 100%yeastshown). The reduced size resulted from a diminution in
cell number because cell size was not affected in the (only 16% and 2% survivors for females and males,
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Figure 3. Reducing Dietary Yeast Reveals a
Growth Function for Lk6
(A) Differential effects of reducing the yeast
content in the food. Whereas control flies are
of normal size when reared at 30% yeast, Lk6
mutants are significantly smaller. Depending
on the allelic combination, the weight reduc-
tion ranges from 9% to 17% in males and
from 15% to 20% in females (p  0.001; stu-
dent’ s t test). At 20% yeast, control flies are
also slightly reduced in size (2%–6% inmales,
3%–7% in females). Flies lacking Lk6 function
are further reduced (15%–26% in males,
17%–29% in females). Theweight of homozy-
gous Lk615 males is shown as an example.
Heterozygous Lk615/ and EPLk6/ males
serve as controls. n  30–50 for all measure-
ments. A comparison of female Lk6 mutant
flies reared at 100% and 20% yeast, respec-
tively, is shown below.
(B) Closer examination of adult wings reveals
a predominant effect on cell number. Cell size
is only affected at 20% yeast, both in the Lk6
mutant and control flies. Ten wings of female
flies were analyzed for each experimental
condition, andmean values are displayed rel-
ative to the respective sizes at 100% yeast.
(C) At 20% yeast, clones of Lk6 mutant cells
(markedby the absenceofGFP) bear a severe
growth disadvantage in comparison to the
wild-type sister clones (bright green). Geno-
type is the same as indicated in Figure 2C.
(D) The negative effects caused by ubiquitous
overexpression of Lk6 on growth are dimin-
ished by reducing the yeast content in the
food.
(E) Measurement of lipid levels in 3 day-old
females and males (according to Bohni et al.
[22]) reveals elevated lipid contents in Lk6-
overexpressing flies (y w;daGal4/EPLk6; n 
10, p  0.05) as well as in homozygous Lk6
mutants (Lk615; n  9, p  0.05 for females).
(F) Both loss and gain of Lk6 function lead to
an increase in the average lifespan of adult
flies, as compared to control flies, under com-
plete starvation (n 100). Similar results were
obtained with different Lk6 alleles.
respectively) was substantially suppressed by rearing Measurement of the lipid content in adult flies revealed
significantly increased lipid levels in the mutant animalsthe animals on low-yeast food (74% and 16% survival
ratio at 30%yeast, 58%and8%at 20%yeast for females (31% [loss-of-function] and54% [overexpression] in
females; 13% [loss-of-function] and 59% [overex-and males, respectively). From these overexpression
experiments, we conclude that the activity of Lk6 is also pression] in males; Figure 3E), consistent with the notion
that the enriched lipid stores can bemobilized to endureregulated by amino acid availability.
Loss of Chico, the Drosophila homolog of vertebrate periods of starvation. Notably, lifespan of Lk6 mutants
was prolonged only under starvation conditions. Underinsulin receptor substrate 1-4 proteins (IRS1-4), results
in flies with proportionally reduced body size [22]. These normal culture conditions, Lk6mutant flies lived shorter
than control flies (data not shown).chico mutant flies have increased lipid levels and are
more resistant to starvation than wild-type flies [23]. We p38 MAPK is activated by diverse stress stimuli, in-
cluding oxidative stress [6]. We therefore askedwhethertherefore tested Lk6 mutant animals for their behavior
under starvation conditions and for changes in their Lk6, as a p38 downstream effector, might be important
for survival in response to oxidative stress. Adult Lk6lipid metabolism. The effect to sustain starvation (i.e.,
a water-only diet) was more pronounced in females: mutants and control flies were subjected to an oxidative
stress regime by feeding them a sucrose/paraquat mix-Adult Lk615 mutant females lived nearly 50% longer than
control flies, Lk638 mutant females 33% longer (Figure ture, which leads to the generation of reactive oxygen
species whenmetabolized. Lk6mutants weremore sus-3F; data not shown). Male Lk615 and Lk638 mutants
showed an increase in lifespan of 22%and 13%, respec- ceptible to paraquat feeding than control flies (Figure
S2), indicating that Lk6 is critical for survival under oxi-tively. Flies overexpressing Lk6 displayed a similar life-
span extension under fasting conditions (Figure 3F). dative stress conditions.
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Figure 4. Effect of the Diet and Lk6 Dosage
on Growth
TOR activity is stimulated under rich nutrient
conditions (high amino acids), resulting in the
phosphorylation of 4E-BP. This leads to an
increase in the pool of free eIF4E (represented
by dots), which assembles into functional
translation initiation complexes. The transla-
tion efficiency is further modulated by phos-
phorylation of eIF4E by Lk6 (red dots symbol-
ize phosphorylated eIF4E). A high amount of
Lk6 results in complete phosphorylation of
eIF4E and impairs growth because of prema-
ture eIF4E phosphorylation and/or a reduc-
tion of the affinity of phosphorylated eIF4E to
capped mRNA. On the other hand, the loss of
Lk6 is without impact on translation initiation
under favorable conditions because phos-
phorylation of eIF4E is not essential as long
as the pool of free eIF4E is sufficiently large.
Under dietary restricted conditions, however,
the absence of Lk6 leads to impaired transla-
tion efficiency. Lk6 activity is presumably also
regulated in response to amino acid availabil-
ity. See text for further details.
Conclusions eIF4E, which dampens the rate of translation. It is likely
that the predominant mechanism of eIF4E regulation isOur genetic analysis shows that Lk6 is dispensable un-
der standard culture conditions (rich amino acid source), achieved by TOR/4E-BP activity, and that the phosphor-
ylation of eIF4Eby Lk6/Mnk imposes a translational fine-commensurate with the recent finding that Mnk1 and
Mnk2 are not essential for cell growth and development tuning that becomes rate limiting only under adverse
food conditions. Lacking Lk6 function in addition to di-in the mouse [4]. Under adverse food conditions, how-
ever, Lk6 is required for normal growth. It is interesting to minished eIF4E availability impinges on translation effi-
ciency, which results in the observed body size re-note that Lk6 expression has been reported to be upregu-
lated upon starvation during larval development [24]. duction.
Alternatively, high TOR activity caused by a diet richWe have also provided evidence that Lk6 exerts its
function via phosphorylation of eIF4E because the ef- in amino acids could enable the activation of another
(unidentified) eIF4E kinase that acts redundantly to Lk6/fects of Lk6 overexpression are strictly dependent on
the presence of Ser251 in eIF4E. This conclusion is Mnk. However, this is rather unlikely because mice lack-
ing Mnk1 and Mnk2 do not show any residual eIF4E-strongly supported by the finding that eIF4E phosphory-
lation is diminished in ovaries of Lk6 mutant flies [19]. Ser209 phosphorylation, strongly arguing against an un-
characterized eIF4E kinase [4].Therefore, flies lacking Lk6 function can be expected
to display the same phenotype as eIF4E mutant flies Overexpression of Lk6 under standard food condi-
tions consistently resulted in a suppression of growth.rescued by a P{eIF4ESer251Ala} transgene. However, the
rescuedeIF4Emutants grow to a smaller size evenunder Furthermore, another EP insertion in the Lk6 locus
(EP3344; see Experimental Procedures), which pro-our standard culture conditions. Although they contain
significantly fewer cells, the size reduction is predomi- motes lower expression levels as compared to EPLk6,
yielded qualitatively similar but milder phenotypes (datanantly caused by smaller cells [12]. In contrast, the loss
of Lk6 function primarily affects cell number. Whether not shown), suggesting that the dosage of Lk6 expres-
sion is important for its ability to regulate growth. Con-these discrepancies reflect a qualitative difference be-
tween eIF4E mutant flies rescued by a P{eIF4ESer251Ala} centration-dependent effects of Mnk1 have also been
described by Knauf et al. [15], who suggested a negativetransgene and Lk6 mutants is currently unknown.
We speculate that the net result of Lk6/Mnk activity role of Mnk1/2 for cap-dependent translation. It is con-
ceivable that overexpressed Lk6 exerts a dominant-neg-(i.e., whether translation is inhibited or promoted) is not
determined by the absolute levels of Lk6/Mnk, but rather ative effect on translation efficiency by reducing the
affinity of phosphorylated eIF4E for cappedmRNA, lead-by the ratio of activated Lk6/Mnk and free eIF4E (i.e.,
not bound by 4E-BPs), the limiting factor for translation ing to a precocious disassembly of the eIF4F complex.
Reducing the amino acid supply abolished the nega-initiation (see Figure 4). Under our standard culture con-
ditions (high protein), a larger fraction of eIF4E assem- tive effects of Lk6overexpression ongrowth, suggesting
that the activity of Lk6 is also regulated in response tobles into functional eIF4F complexes because of high
TOR activity, thereby promoting translation. Under re- nutrients. The mechanism for this additional layer of
regulation is unknown but is likely to involve phosphory-duced conditions (e.g., 30% yeast), TOR pathway activ-
ity is lowered, and, thus, more 4E-BP binds and inhibits lation by the upstream kinases ERK and/or p38. Consis-
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sequencing, and members of the Basler and Hafen laboratories fortently, the p38 homolog in fission yeast, Sty1/Spc1, is
participating in the generation of the EP lines.regulated in response to nutrient limitation and osmotic
stress [25].
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Why is an elephant bigger than a mouse? Why, luckily, are our arms precisely the same 
size? While developmental genetics 
over the past 20 years has provided 
us with fascinating insights into how 
segments form, limbs bud, and axons 
ﬁ nd their targets, we have made little 
progress towards answering these 
obvious questions in biology. Rather 
than attempting to provide the answers, 
we will try to frame the questions in a 
developmental context and highlight 
some approaches towards answering 
them. Somewhat artiﬁ cially, we will 
consider separately the mechanisms of 
cell, organ, and body size control.
What Controls the Size of 
Eukaryotic Cells?
The size of a cell depends on 
intrinsic and extrinsic factors. For 
example, cell size can vary dramatically 
with cell type—some neurons or glia 
cells are up to 1,000 times larger 
than epithelial cells. Cell size is also 
inﬂ uenced by the number of genome 
sets (ploidy). A haploid Drosophila 
epithelial cell is only about half the 
size of a diploid cell. A polyploid 
salivary gland cell, on the other hand, 
is more than 1,000 times larger than 
a diploid cell. Amongst the extrinsic 
factors, the availability of nutrients and 
temperature are well known for their 
effect on cell size. Starvation not only 
prolongs the cell doubling time in yeast 
and in Drosophila cells, it also reduces 
the size at which they divide. 
Work from Zetterberg (Killander 
and Zetterberg 1965) in mammalian 
ﬁ broblasts and subsequently from 
Nurse and Hartwell in yeast provided 
evidence for a cell size checkpoint 
(Nurse 1975; Johnston et al. 1977). 
In budding yeast, the protein Cln3p 
acts as a sizer. Cells only initiate the 
critical cell cycle step from G1 phase 
to S phase, when Cln3p has reached a 
certain threshold. The accumulation 
of Cln3p is, in turn, dependent on 
efﬁ cient translation of the Cln3 mRNA, 
which is inefﬁ ciently translated until 
sufﬁ cient numbers of ribosomes 
have been generated (Polymenis 
and Schmidt 1997). In this way, the 
presence of an efﬁ cient translation 
machinery is a prerequisite for passing 
the cell size checkpoint. Indeed, in 
a whole-genome survey of mutants 
affecting cell size in budding yeast, 
many size mutants exhibited defects in 
ribosome biogenesis (Jorgensen et al. 
2002).
Ribosome biogenesis also appears 
to be an important regulator of 
cell size in multicellular organisms. 
Phosphorylation of the ribosomal 
protein S6 by S6 kinase (S6K) results 
in the preferential translation of 
ribosomal proteins and thus in the 
replenishment of the protein synthesis 
machinery. Drosophila cells lacking 
functional S6K grow more slowly and 
are smaller than normal cells, possibly 
because of the earlier accumulation of 
a cell sizer analogous to Cln3p in yeast 
(Thomas 2000).
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Unsolved Mysteries discuss a topic of biological 
importance that is poorly understood and in need of 
attention.
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But is there a need for a cell 
size checkpoint in multicellular 
organisms? One would assume so, 
because otherwise cells would either 
become progressively smaller or 
larger. However, it has been suggested 
that this may be a problem for 
exponentially growing cells like yeast, 
but that mammalian cell growth is 
linear and, under these conditions, 
the need for a cell size checkpoint 
may be less stringent. Indeed, Conlon 
and Raff (2003) did not observe a cell 
size checkpoint in rat Schwann cells 
grown under different growth factor 
conditions (see also Grewal and Edgar 
2003). Furthermore, the existence of 
cell size checkpoints may be cell-type 
dependent and stage speciﬁ c. During 
Drosophila imaginal disc development, 
for example, cells are larger at the 
beginning of imaginal disc growth 
and become progressively smaller 
during later stages (Madhavan and 
Schneiderman 1977). 
Until recently, more emphasis has 
been placed on understanding the 
genetic control of cell cycle progression 
than on the mechanisms regulating 
cell growth. This has often led to 
the use of cell proliferation and cell 
growth as synonymous terms. Analysis 
in Drosophila imaginal discs using cell 
clones either deﬁ cient in cell cycle 
progression or expressing cell cycle 
regulators that accelerate or slow down 
the cell cycle, however, have shown 
clearly that cell cycle progression alone 
is not sufﬁ cient to promote growth 
(Weigmann et al. 1997; Neufeld et al. 
1998). In summary, cell size is altered 
by changing ploidy, by uncoupling cell 
cycle progression from cell growth, 
and by pathways regulating cell growth 
such as the insulin (see below) and 
S6K pathways. Of these three, only the 
modulation of cell growth has an effect 
on overall growth at the next level, the 
organ. 
How Is the Size of Organs 
Controlled?
Changes in organ size are only 
partly due to changes in cell size. In 
Drosophila, the reduction in wing size 
in S6K mutant ﬂ ies or in ﬂ ies raised 
at higher temperature is caused by 
a reduction in cell size (Partridge et 
al. 1994; Montagne et al. 1999); in 
contrast, starvation or mutations in 
genes coding for insulin signaling 
components that mediate the 
starvation response affect body size 
and organ size by reducing cell size 
and cell number (Garofalo 2002). 
The effect of insulin pathway activity 
on growth is largely autonomous to 
cells and multicellular regions, called 
compartments. Speciﬁ c reduction of 
dAkt function, an essential component 
of the insulin signaling pathway, in 
either the anterior or the posterior 
compartment of the wing imaginal 
disc results in a severe reduction of the 
respective compartment. Astonishingly, 
the small compartment is properly 
patterned and the size and patterning 
of the adjacent compartment remain 
untouched (Figure 1), demonstrating 
that the insulin pathway has a profound 
effect on the ﬁ nal size of an organ 
without interfering with the patterning 
mechanism. 
Recently, a novel signaling complex 
that restricts organ size by controlling 
both proliferation arrest and apoptosis 
has been discovered (Ryoo and Steller 
2003). Mutations in either hippo, 
salvador, or warts result in a failure of 
cell cycle exit and in a protection from 
cell death, thus leading to massively 
overgrown organs. How an organ 
knows when it has reached its ﬁ nal size, 
however, is still mysterious and thus 
challenging. 
It is clear that autonomous and 
nonautonomous factors control organ 
size, but their relative contribution 
varies depending on organ type and 
species. Multiple transplanted fetal 
thymus glands each grow to their 
normal size while multiple transplanted 
fetal spleens grow collectively to the 
size of one spleen (reviewed in Conlon 
and Raff 1999). In Drosophila, immature 
imaginal discs (larval structures that 
undergo metamorphosis and develop 
into structures such as legs, wings, and 
eyes in the adult) transplanted into 
a third instar larva do not undergo 
metamorphosis until they reach the 
ﬁ nal size (Bryant and Simpson 1984). 
But the size of insect appendages is 
not only controlled autonomously. 
Ablation of the hind wing discs in 
butterﬂ ies increases the size of the fore 
wings (Nijhout and Emlen 1998). 
The Role of Cell Competition
Based on experiments in mammalian 
systems, it has been suggested that 
the competition for limiting growth 
or survival factors may be a general 
mechanism for organ size control 
(Conlon and Raff 1999). In Drosophila, 
cell competition is observed in 
imaginal discs. Slowly growing cells are 
eliminated when they are next to cells 
that grow at a normal rate (Simpson 
and Morata 1981). The slowly growing 
cells in these studies were heterozygous 
at one of several Minute (M) loci, some 
of which encode ribosomal proteins. 
Recently, a link has been established 
DOI: 10.1371/journal/pbio.0000086.g001
Figure 1. The Insulin Signaling Activity 
Controls Organ Size in a Compartment-Specifi c 
Manner
Mosaic Drosophila wings with 
compartment-speciﬁ c manipulations of 
dAkt function display striking size defects 
but normal patterning. 
(A) Selective reduction of dAkt function 
in the posterior compartment by means 
of FLP-mediated mitotic recombination 
in posterior cells (using engrailed–Gal4 to 
drive the expression of UAS–Flp) results in 
a small P compartment largely consisting 
of dAkt3 mutant cells. The smaller 
compartment size is due to fewer and 
smaller cells. 
(B) Wild-type wing for comparison. 
(C) Expression of dAkt in posterior cells 
(engrailed–Gal4 UAS–dAkt) of wings with 
reduced dAkt function (dAkt3) restores 
the size of the P compartment, whereas 
the A compartment remains small. The 
red lines mark the anterior–posterior 
compartment boundary. Note that 
similar results in the wing disc have been 
obtained by Teleman and Cohen (2000).
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between cell competition and signaling 
by the secreted factor Decapentaplegic 
(Dpp) (Moreno et al. 2002). The 
elimination of slowly growing M/+ 
cells is preceded by the upregulation 
of the gene brinker (brk), which 
triggers cell death. Expression of brk 
is downregulated by high Dpp levels. 
As in M/+ cells, brk upregulation and 
cell elimination by apoptosis are also 
triggered in cells close to the Dpp 
source that are unresponsive to Dpp 
because they lack the Dpp receptor 
Thickveins (Tkv). Slowly growing cells 
may be outcompeted because they may 
be less efﬁ cient in internalizing Dpp 
via endocytosis and thus receive fewer 
survival signals. The problem with this 
simple model is that cells away from 
the anterior–posterior boundary—the 
site of Dpp production—possess high 
levels of Brk but do not die and grow 
at the same rate as cells close to the 
Dpp source. Indeed, tkv mutant clones 
also survive in these regions (Burke 
and Basler 1996). Therefore, brk levels 
do not correlate with the growth 
and survival potential of cells in all 
circumstances. 
An alternative explanation for 
the observed parallels between the 
elimination of tkv mutant cells and 
M/+ cells is that the juxtaposition 
of cells with different cell surface 
properties is the trigger for elimination. 
The upregulation of brk in M/+ cells 
may trigger different surface properties 
(positional identities) in the same 
way as in tkv mutant cells. Thus, cell 
competition may be a cell-policing 
mechanism that eliminates cells that 
for various reasons do not ﬁ t into the 
community. Whether this mechanism 
of cell competition plays a major role in 
organ size control is still unclear.
How Are Pattern Formation and 
Growth Connected?
Organ size is coupled to pattern 
formation. Interfering with patterning 
mechanisms, for example, by 
implanting a bead soaked in the 
secreted factor Sonic hedgehog (Shh) 
into the anterior of the chick wing 
bud or by the ectopic expression 
of Hedgehog (Hh) or Dpp in the 
Drosophila wing, causes pattern 
duplications and concomitant growth. 
Conversely, partial loss-of-function 
mutations in dpp reduce wing size 
(Potter and Xu 2001) (Figure 2). 
In contrast to the effects caused by 
modulating insulin pathway activity, 
the stimulation of growth by Dpp 
appears to be tightly linked with 
pattern formation. How is patterning 
coupled to growth? This is one of the 
major unsolved questions in the ﬁ eld. 
It does not appear that the patterning 
morphogens like Dpp act by directly 
promoting growth since the cell 
division rates are the same in regions 
of high and low Dpp concentrations 
(Milan et al. 1996).
An attractive hypothesis put 
forward based on a previous 
model of regeneration postulates 
that the individual cells of an 
organ primordium measure the 
concentration gradients of speciﬁ c 
signaling molecules, such as Dpp in 
the Drosophila wing disc and Shh in 
the vertebrate limb bud (Day and 
Lawrence 2000). In immature small 
primordia, the gradients are steep 
and cells continue to grow and divide. 
Since the source of the gradient 
stays approximately constant, its 
concentration gradient ﬂ attens as the 
tissue grows. When the difference 
in the morphogen concentration 
sensed by the two ends of the cells 
along the axis of the gradient falls 
below a certain threshold, the cells 
stop growing. Although this model 
could explain why cell growth and 
division are not concentrated around 
DOI: 10.1371/journal/pbio.0000086.g002
Figure 2. Changing the Patterning 
Mechansims during Wing Development 
Affects Growth
Compared with a wild-type wing (A), 
loss of Dpp function results in reduced 
growth and loss of pattern elements (B). 
Ectopic expression of Dpp in a clone 
of cells results in pattern duplications 
associated with massive extra growth (C). 
The region of Dpp expression in (A) 
and (C) is indicated by the green color. 
(Zecca et al. 1995; pictures courtesy of B. 
Müller and K. Basler.)
DOI: 10.1371/journal/pbio.0000086.g003
Figure 3. Model for the Coordinated Control 
of Growth and Patterning in the Drosophila 
Wing Disc
A schematic representation of a growing 
(left) and a mature (right) wing disc 
is shown at the top. Corresponding 
cross-sections through the wing blade 
region are depicted below. The wing 
disc originates from the infolding of 
the embryonic ectoderm and consists 
of pseudostratiﬁ ed epithelial cells 
containing a basal–lateral side (yellow) 
and an apical side (red). The apical 
surface faces the disc lumen that is 
formed by the epithelium and the 
overlaying peripodial membrane (black), 
consisting of squamous epithelial cells. 
The morphogen and growth factor Dpp 
(yellow) is secreted basal–laterally by the 
Dpp-producing cells located anterior 
to the anterior–posterior compartment 
boundary (line through centre of wing 
disc). The Dpp concentration gradient 
from the anterior–posterior boundary 
to the periphery provides the anterior–
posterior patterning cues. In addition, 
Dpp is also secreted apically into the disc 
lumen where is can diffuse freely. The 
model proposes that luminal Dpp acts as 
a growth-promoting factor stimulating 
disc growth in young discs. As the disc 
grows, a hypothetical growth inhibitor 
(blue dots) is also secreted apically and 
antagonizes the growth promoting activity 
of Dpp. Once the concentration of the 
inhibitor has reached a certain threshold, 
proliferation of wing imaginal disc cells 
ceases.
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sources of morphogens, experimental 
evidence does not support it. Clones of 
cells expressing a constitutively active 
version of the Dpp receptor Tkv show 
increased growth when surrounded by 
cells of low Tkv activity. Furthermore, 
constant overexpression of activated 
Tkv in the entire disc also promotes 
growth, arguing against growth being 
induced by a differential of Tkv activity 
across the cell (Lecuit et al. 1996; 
Nellen et al. 1996). 
How then does normal graded Tkv 
activity produce homogenous growth? 
One possible solution to this problem 
comes from the observation that Dpp 
in the Drosophila wing is secreted 
basal–laterally as well as apically 
(Figure 3). While Dpp secreted on the 
basal–lateral side in the epithelium 
has been detected in a concentration 
gradient (Teleman and Cohen 2000), 
Dpp secreted on the apical side 
accumulates in the disc lumen formed 
by the disc epithelium proper and the 
peripodial membrane, whose cells also 
secrete Dpp (Gibson et al. 2002). It is 
tempting to speculate that Dpp in the 
lumen functions as a general growth-
promoting factor, while Dpp secreted 
in a graded fashion from the basal–
lateral side induces pattern formation. 
A growth-promoting function has been 
suggested for the luminally produced 
Dpp (Gibson et al. 2002). This model 
implies that Dpp received on the apical 
side of the cell triggers a different 
cellular response (growth, survival, 
or both) than Dpp received on the 
basal–lateral side (patterning) and 
would probably require an unequal 
distribution of Dpp receptors or 
signaling components along the apical–
basal axis of the cell. 
At present, the most attractive 
hypothesis for how intrinsic control of 
organ size is achieved postulates that 
a secreted growth-promoting factor 
accumulates in the organ primordium 
and that its function is counteracted by 
an inhibitor accumulating with a delay 
(Nijhout 2003). Once the inhibitor 
reaches a certain threshold and/or 
the growth factor is consumed, organ 
growth stops (Figure 3). Although 
hypothetical, activator and inhibitor 
models have been postulated for many 
patterning processes. Dpp and related 
transforming growth factor  (TGF) 
molecules provide a particularly well-
established case. TGF agonists and 
antagonists are involved in patterning 
the dorsal–ventral axis in the Drosophila 
embryo and the left–right asymmetry in 
the vertebrate embryos (Capdevila and 
Belmonte 1999). Further genetic and 
biochemical experiments are needed 
to identify the components involved in 
intrinsic organ growth control. 
Which Growth Promoting Path-
ways Are Regulated by Secreted 
Factors with Patterning Functions? 
Although little is known about the 
connection between patterning factors 
and growth pathways, a few potential 
links have been described. For 
example, in the Drosophila eye imaginal 
disc, Hh regulates growth directly by 
controlling the expression of cyclin 
E, a promoter of the G1/S transition, 
and by cyclin D, a promoter of cell 
growth (Duman-Scheel et al. 2002). 
Whether this is a general mechanism 
by which Hh controls cell growth and 
cell division is unclear, however, since 
in the wing disc at least, the effect of 
Hh appears to be mediated by Dpp. 
Comprehensive surveys of target genes 
regulated by these patterning factors 
in the speciﬁ c developing tissues using 
microarray technology may provide 
further insight into how they control 
cell growth directly or indirectly.
How Is Body Size Controlled?
Can the question of body size 
regulation be reduced to simply 
summing up the mechanisms that 
regulate the size of individual organs? 
In contrast to organ size control 
that involves local cell interactions, 
locally produced growth factors as 
well as systemic growth factors, overall 
body size is controlled primarily by 
systemic factors. Vertebrate body size 
is controlled by growth hormone and 
the subordinate insulin-like growth 
factors (IGFs) (Butler and Roith 2001). 
In invertebrates, growth and body size 
are also regulated by the insulin/IGF 
system in response to nutrients. In 
addition, ﬁ nal body size in insects is 
determined by the number of molting 
cycles, and these are under the control 
of the steroid hormone ecdysone and 
the sesquiterpenoid juvenile hormone 
(Nijhout 2003). Nevertheless, changing 
ecdysone or insulin-like peptide levels 
in invertebrates or overproducing 
growth hormone in vertebrates 
can increase body size only within 
a certain range. It is obviously not 
possible to turn a mouse into the size 
of an elephant, although the recent 
identiﬁ cation of fossils of Phoberomys 
pattersoni indicates that rodents were 
once a great deal larger than they 
are today (Sanchez-Villagra et al. 
2003). In addition to the hormonal 
control of body size, there are intrinsic 
genetic constraints to organ and body 
size. Understanding the mechanism 
underlying these constraints will be 
another challenge for the future. 
Conclusions
In contrast to the control of cell 
fate, segment number, or patterning, 
which is largely determined by genetic 
regulatory mechanisms, the control 
of size is inﬂ uenced by genetic, 
hormonal, and environmental inputs. 
Understanding this phenomenon 
requires a combination of 
developmental genetic, physiological, 
and evolutionary approaches. Given 
the signiﬁ cant interest that has been 
generated in growth control, it should 
not be long before some of these old 
mysteries in biology are explained. 
This will not only reward us with a 
better understanding of this important 
aspect of developmental biology, but 
it will also provide better insight into 
human diseases, such as cancer, that 
are associated with a misregulation of 
cellular growth. 
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Drosophila melanogaster – a model system to study growth
How is cellular growth regulated? What mechanisms ensure that growth is in tune
with environmental conditions? At which size does a cell have to divide? How do
organs know when they have reached their appropriate size? Who conducts the
orchestra of cell birth and cell death during the development of multicellular
organisms? While some of these issues have been addressed in cell culture
experiments, there is doubtlessly an immediate need for genetically amenable model
organisms to gain insight into the mysteries of growth control. Drosophila
melanogaster appears to be well suited for this purpose. The development of the
imaginal discs provides an ideal setup for the analysis of growth processes. Imaginal
discs are single-layered epidermal tissues that grow during larval development to
eventually give rise to the adult appendages. Importantly, imaginal disc cells remain
diploid (in contrast to most larval cells), and their cell cycles include G1 and G2
phases (Edgar and Lehner, 1996), much as mammalian cells do. Furthermore, the
cell division patterns during imaginal disc development appear to be rather random,
sharply contrasting the situation in another simple genetic model organism,
Caenorhabditis elegans. In this nematode, development follows a relatively strict cell
lineage. As a result, the number of cells in an adult animal is astonishingly constant,
suggesting that C. elegans mainly governs growth by controlling the cell divisions.
Therefore, the control of growth in imaginal discs of Drosophila resembles the
mammalian situation much closer. What are the advantages of Drosophila over the
mouse system? One striking difference is the relative ease with which genetic
analyses can be performed in the fly. Not only is the generation time of Drosophila
considerably shorter, but fly geneticists also have many more sophisticated tools in
hands. Moreover, redundancy appears to be less of a problem in Drosophila as
compared to mammals. For instance, while three structurally and functionally related
insulin receptor-like receptor tyrosine kinases exist in the mouse (IR, IGF-IR, and
IRR), there is only one fly ortholog (Inr). The four mammalian IRS molecules also
have a unique Drosophila counterpart. In the case of Akt, the single fly kinase has
three orthologs in the mouse. The discrepancy in genetic complexity is further
increased by the apparently much greater variety of protein isoforms derived from
mammalian genes. Therefore, genetic investigations in the low-complexity system
(Drosophila) are much more promising, whereas analyses in the mouse are
inherently ambiguous. On the other hand, it can be argued that the simple setup of
Drosophila might not adequately reflect the multilayered control mechanisms
governing mammalian development. The hope of the fly geneticists is, therefore, that
the signaling pathways emerging from their studies constitute the heart of an
evolutionarily conserved system, which is partially covered by additional layers of
control in higher organisms such as mammals.
Akt/PKB is the major effector of PI3K signaling during Drosophila development
One goal of the present work was to clarify the role of the proto-oncogene Akt during
Drosophila development. In light of the wealth of studies on Akt function in
mammalian cell culture systems, this analysis might appear to be superfluous.
However, most cell culture experiments suffer from severe disadvantages. One
obvious drawback is the isolation of cells from their natural context. Such isolation
might for instance have a tremendous impact on the ability to survive under delicate
conditions. Moreover, cell culture studies are often based on overexpression of
particular protein variants. The inherent danger of overexpression experiments is that
the expression level might exceed physiological concentrations, thereby possibly
causing unwanted side effects. In the case of so-called dominant negative protein
variants, the mechanism of action often remains obscure, further complicating the
interpretation of the observed effects. Thus, an in vivo analysis of the gene function
by genetic means is imperative.
Akt function has been investigated in the nematode C. elegans. It could be shown
that the two Akt genes (akt-1 and akt-2) act in the insulin receptor pathway
downstream of the PI3K ortholog AGE-1 (Paradis and Ruvkun, 1998). Since a
mutation in the forkhead transcription factor DAF-16 relieves the requirement for Akt
activity, the akt genes primarily function to antagonize DAF-16 (Paradis and Ruvkun,
1998), indicating that the signaling pathway downstream of the insulin receptor DAF-
2 might be rather linear in C. elegans. While these studies in C. elegans confirm the
participation of Akt in the insulin receptor signaling cascade, they do not tell us
anything about Akt’s role in growth control.
Akt function has also been analyzed in knockout mice. Mice lacking Akt1 (PKBα)
displayed defects in embryonic and postnatal growth (Chen et al., 2001; Cho et al.,
2001b), whereas a loss of Akt2 (PKBβ) function resulted in metabolic defects
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consistent with a role of Akt2 in insulin action (Cho et al., 2001a). Therefore, the
functions of the different Akt isoforms appear to be complementary rather than
redundant. Surprisingly, the effects of Akt knockouts on cell survival were mild. Only
in some tissues (testis, thymus) of mice devoid of Akt1, increased spontaneous
apoptosis could be observed (Chen et al., 2001). Akt1 -/- mouse embryonic
fibroblasts (MEFs) were more susceptible to cell death triggered by various inducers
(Chen et al., 2001). The unexpectedly weak apoptosis phenotype could be explained
in two ways. Either Akt’s anti-apoptotic function is redundant (shared by at least two
of the three isoforms), or the results of various cell culture experiments were
overstated. Double knockout mice for Akt1 and Akt2 have been reported only
recently (Peng et al., 2003). They are severely growth-impaired and die shortly after
birth, displaying similar phenotypes as IGF-IR knock out mice (defects in skin and
bone development and severe skeletal muscle atrophy), suggesting that Akt1/2 are
the major downstream effectors of IGF-1R.
Redundancy should not perturb genetic analyses in Drosophila, as the fly genome
contains a single gene encoding an Akt homolog. However, two isoforms with
apparent molecular weights of 66 and 85 kDa, respectively, are generated by the
alternative usage of an upstream non-AUG translational initiation signal (Andjelkovic
et al., 1995). It is presently unclear whether the less abundant longer isoform (with an
addition of 81 amino acids at its NH2-terminus) exerts functions distinct from those of
the more common shorter isoform.
Flies lacking Akt function were shown to die during larval stages, and removal of the
maternal contribution led to excessive cell death during embryogenesis (Staveley et
al., 1998). A closer look at Akt’s function during larval development revealed that Akt
is not essential for cellular survival, but for cellular growth. Clones consisting of cells
devoid of functional Akt remain tiny, but, importantly, they are not out-competed by
surrounding faster dividing cells. Contrary to the expectation, these cells are
somehow protected from apoptosis and they are even able to properly differentiate.
Flies with reduced Akt activity develop slowly and emerge as small adults. They
consist of fewer cells of reduced size. This phenotype is reminiscent of the effects of
starvation (Simpson, 1979).
In another series of experiments, it could be demonstrated that the activity of the
insulin receptor signal not only dictates growth and size at the level of single cells,
but also at the levels of compartments and organs. For instance, reducing Akt
function specifically in the posterior (P) compartment of the developing wing gives
rise to an adult wing with a smaller P compartment, while the anterior compartment
remains unaffected (Hafen and Stocker, 2003). Although much reduced in size, the P
compartment exhibits a surprisingly normal wing vein pattern. It is difficult to explain
how the same source of the morphogen Dpp is able to elicit fundamentally different
responses in the two compartments. Further experimentation will be needed to
address this issue. Removal of Akt function from the entire eye-antennal imaginal
discs (by means of the ey-flp technique (Newsome et al., 2000)) results in flies with
tiny eyes and heads on bodies of normal size. Thus, whole organs grow to a size that
is in accordance with the signal strength of the insulin receptor pathway within the
organ, irrespective of the other organs.
The characterization of a hypomorphic Akt allele (in collaboration with Mirjana
Andjelkovic, FMI, Basel) revealed a reduced affinity of the mutant kinase for PIP3
due to a single amino acid exchange in the PH domain. This mutation was
instrumental in testing the importance of Akt as a mediator of the growth-stimulating
effects caused by the loss of the tumor suppressor PTEN. In the absence of PTEN
function, the concentration of the second messenger PIP3 raises. Accumulation of
PIP3 is believed to recruit a variety of proteins containing PIP3-interacting domains
(such as the PH domain) to the plasma membrane. In many cases, the relocalization
of the protein is expected to result in a stimulation of its activity. Therefore, it was
generally assumed that the simultaneous activation of numerous effectors would sum
up to the complete response elicited by the loss of PTEN function. A simple genetic
experiment proved the contrary, at least in Drosophila. Flies devoid of PTEN function
and with measurably increased PIP3 concentrations can readily survive if only the
affinity of Akt for PIP3 is reduced. The generalization of this finding will certainly be
questioned. Possibly, signaling downstream of the second messenger PIP3 is far
less complicated in the fly than it is in mammals. For instance, a number of PH
domain-containing proteins (e.g. DAPP1, TAPP1, and TAPP2) are not encoded by
the Drosophila genome. Alternatively, it could equally well be that the importance of
other potential effectors has been overestimated. The severe phenotype of Akt1 Akt2
double knockout mice is suggesting that Akt also plays a major role in IGF-IR
mediated growth in mammals.
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The genetic identification of novel insulin signaling components
The highly characteristic pinhead phenotype of flies lacking Akt function specifically
in the progenitor cells of the head and the eye laid the foundations for a mutagenesis
screen aiming at the identification of novel components of insulin receptor signaling
as well as of other genes involved in growth control. Using the elegant ey-flp
technique developed by Barry Dickson (Newsome et al., 2000), mutations in growth-
regulating genes could be easily identified in the first generation by virtue of the
resultant abnormal head size phenotype. The right arm of the third chromosome was
screened to saturation, and numerous flies displaying a pinhead phenotype were
isolated. Interestingly, flies exhibiting the opposite phenotype did also emerge.
Larger than normal heads can form if the function of a negative regulator of a growth-
promoting signal is impaired, or if a proliferation-blocking signal is missing.
The focus of the screen was on the potential novel components of the insulin
receptor pathway. We found six complementation groups that fulfill the crucial criteria
for positive insulin signaling components (the mutant tissue grows poorly but can
properly differentiate). Three of the candidate groups correspond to the backbone of
the signal transduction cascade: The receptor (Inr), the lipid kinase PI3K that
produces the second messenger PIP3, and the major effector of PIP3, Akt/PKB.
Alleles of the three other groups carry mutations in the genes encoding the small
GTPase Rheb (see below), MASK and Lnk, respectively. MASK (multiple ankyrin
repeats, single KH domain) is a huge protein with an RNA binding domain (KH
domain). MASK mutations have also been isolated as dominant enhancers of a
phenotype caused by the expression of dominant-negative Corkscrew (Smith et al.,
2002). Corkscrew encodes a protein tyrosine phosphatase that is required for
signaling downstream of receptor tyrosine kinases such as Sevenless and the
epidermal growth factor receptor (EGFR). Consistently, clones of MASK mutant cells
displayed phenotypes reminiscent of reduced EGFR signaling (impaired proliferation,
differentiation and survival). Interestingly, the mutations identified in our screen do
not severely impinge on photoreceptor differentiation. Either our mutations represent
hypomorphic alleles, or they specifically compromise a particular (growth) function of
MASK while leaving other functions (differentiation) intact. The identification of the
molecular lesions might help in resolving this issue.
All heteroallelic combinations of Lnk alleles are viable and yield flies of reduced size,
reminiscent of (although milder than) the chico mutant phenotype (Bohni et al.,
1999). The mammalian Lnk family of adaptor proteins consists of Lnk, APS (adaptor
protein with a PH domain and an SH2 domain) and SH2-B. Besides the
characteristic PH and SH2 domains, all family members (including Drosophila Lnk)
contain potential tyrosine phosphorylation sites that serve as docking sites for the
adaptor molecule Grb2 as well as proline-rich stretches. By virtue of binding to
phosphatidylinositols, the PH domain directs the adaptors to membranes where the
SH2 domain mediates binding to phospho-tyrosines, e.g. motifs in
autophosphorylated receptor tyrosine kinases. Not only is the modular composition of
Lnk family members strikingly similar to that of the IRS proteins, but APS and SH2-B
have also been shown to function as an insulin receptor substrates (Ahmed et al.,
1999; Kotani et al., 1998; Moodie et al., 1999). They could, therefore, be functionally
redundant with IRS proteins. APS binds the activated IR much stronger than SH2-B,
and expression of APS or SH2-B correlates with sustained signaling activity (Ahmed
and Pillay, 2003). It has been speculated that APS and SH2-B might stabilize the
active conformation of the IR, or they might prevent its dephosphorylation (Ahmed
and Pillay, 2003). The generation of knockout mice revealed functions of APS and
SH2-B in insulin signaling. Mice devoid of functional SH2-B were slightly growth-
retarded and failed to build proper genital organs (Ohtsuka et al., 2002).
Furthermore, they developed insulin resistance and glucose intolerance during aging
(Duan et al., 2004), suggesting that SH2-B is a physiological enhancer of insulin
receptor activity. Surprisingly, the disruption of the APS gene resulted in increased
insulin sensitivity (Minami et al., 2003), which could be explained by the increased
serum levels of leptin and adiponectin in these mice. These strikingly different
knockout phenotypes demonstrate that APS and SH2-B cannot functionally
substitute each other in vivo. In Drosophila, the IRS homolog Chico is the only
adaptor protein binding to Inr described so far. Interestingly, chico is not an essential
gene, in contrast to the genes encoding Inr, Dp110/PI3K and Akt/PKB. This could be
explained in two ways. Either basal PI3K activation occurs via the COOH-terminal
extension of the Drosophila Inr, or the signal is mediated by another adaptor protein.
Lnk is an obvious candidate for the latter case. Interestingly, flies lacking chico are
no longer able to survive if they carry one mutant copy of Lnk, indicative of a strong
genetic interaction between chico and Lnk. It is also tempting to speculate that Lnk
might bridge between the Inr and Ras-MAPK signaling via interaction with Drk/Grb2.
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Although the Inr loss-of-function phenotype is not indicative of a reduction in Ras-
MAPK signal strength, the overexpression of Inr results in phosphorylation of MAPK
(Brogiolo et al., 2001). It will be interesting to test whether this crosstalk depends on
functional Lnk.
Negative regulators of insulin signaling are expected to result in a bighead phenotype
in the ey-flp assay. An example is the tumor suppressor PTEN: Loss of PTEN in
mosaic animals gives rise to enlarged cells and tissues (Gao et al., 2000; Goberdhan
et al., 1999; Huang et al., 1999). All the novel mutations that displayed a very similar
phenotype fell into a single complementation group corresponding to the Tsc1 locus.
The TSC1 (Tuberous sclerosis complex 1, also called hamartin) and TSC2
(Tuberous sclerosis complex 2, also known as tuberin) tumor suppressor proteins
are both required to form a functional complex, and mutations in both genes are
linked to a hamartomas syndrome called tuberous sclerosis (hence the names).
Whereas TSC2 bears a GAP (GTPase activating protein) domain, TSC1 hooks the
complex to the membrane via its transmembrane domain. Studies on Tsc1/2 function
in Drosophila implied this tumor suppressor as a component of the insulin receptor
signal transduction cascade or of a pathway acting in parallel (Gao and Pan, 2001;
Potter et al., 2001; Tapon et al., 2001). Furthermore, a negative role of Tsc1/2 in the
regulation of TOR (target of Rapamycin) activity was reported (Gao et al., 2002; Inoki
et al., 2002), and a direct link between Inr signaling and the Tsc1/2 complex via
phosphorylation of Tsc2 by Akt was suggested  (Inoki et al., 2002; Potter et al.,
2002). However, a recent study suggests that this phosphorylation is not a
physiological event, but rather occurs under high insulin signaling activity only (Dong
and Pan, 2004).
Is Tsc2 the only target of Akt/PKB? Data from mammalian cell culture suggest that
members of the FOXO family of transcription factors are excluded from the nucleus
upon phosphorylation by Akt (Kops et al., 1999). In fact, the only Drosophila FOXO
homolog gets phosphorylated by Akt upon insulin treatment, leading to an increased
expression of 4EBP and Inr (Junger et al., 2003; Puig et al., 2003). The expression of
Inr constitutes a novel feedback regulation of unknown function (Puig et al., 2003). A
genetic analysis of FOXO mutants did not reveal any growth defects in flies with
otherwise normal insulin signaling. It was only when insulin signaling activity was
lowered (e.g. by chico or hypomorphic Akt mutations) that the loss of FOXO exerted
positive effects on growth, resulting in a partial suppression of the growth deficit
(Junger et al., 2003). Interestingly, the suppressive effect was solely due to an effect
on cell number. Moreover, flies lacking Akt function could almost survive in the
absence of functional FOXO, indicating that FOXO is indeed a critical target of Akt
(Junger et al., 2003). How can these findings be reconciled with the notion that Akt
signals primarily via Tsc2 (Potter et al., 2002)? It is conceivable that the primary
target of Akt depends on signaling strength. Whereas abnormally high signaling
activity results in hyperactivation of Akt and subsequent inactivation of the Tsc1/Tsc2
complex, physiological levels of Akt activity are required to keep FOXO in check.
The small GTPase Rheb is negatively regulated by the tumor suppressors
Tsc1/Tsc2 and controls TOR activity
Mutations in the gene encoding the homolog of the small GTPase Rheb (Ras
homolog enriched in brain) were isolated based on the resulting pinhead phenotype.
Hypomorphic Rheb mutants (in certain heteroallelic combinations) were reduced in
size, and the females were sterile. Rheb mutant cells grew poorly but they were
capable of properly differentiating. Conversely, overexpression of Rheb promoted
cellular growth. All these characteristics also apply to insulin signaling components
such as Inr, Dp110/PI3K and Akt/PKB. Therefore, it was reasonable to assume that
Rheb is a component of the insulin signaling cascade. A detailed epistasis analysis
placed Rheb downstream of Tsc1/2 and upstream of TOR and S6K. The fact that
flies lacking Tsc1 function can be rescued by reducing Rheb activity suggests that
the inactivation of Rheb is the main task of Tsc1/2. These genetic findings were
corroborated by the demonstration that Tsc2 is the Rheb GAP (Garami et al., 2003;
Inoki et al., 2003a; Tee et al., 2003; Zhang et al., 2003), and that S6K activity
critically depends on Rheb. Our observation that Rheb is also epistatic over PTEN is
consistent with Akt talking to Tsc2 under conditions of elevated PIP3 levels.
The regulation of Rheb mainly occurs via its GAP, Tsc2. No Rheb GEF has been
reported so far. How is the activity of Tsc2 controlled? Phosphorylation at various
regulatory sites appears to be key. Besides Akt/PKB, other kinases such as AMPK
(Inoki et al., 2003b) and MK2 (Li et al., 2003) can also phosphorylate Tsc2. Since
AMPK is activated by low cellular energy levels (and thereby increased AMP
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concentration), AMPK provides a link between energy status of the cell and TOR
activity. Interestingly, full AMPK activation depends on phosphorylation by LKB1, a
tumor suppressor mutated in patients with Peutz-Jeghers syndrome, establishing a
link between the tumor suppressors LKB1 and TSC1/2 (Corradetti et al., 2004; Shaw
et al., 2004a; Shaw et al., 2004b). Therefore, TSC2 appears to be an integrator of
diverse signals, coupling cellular conditions to the activation of TOR.
Rheb function correlates with the activity of S6K, a well-established (direct?)
downstream target of TOR. This raises the question how Rheb regulates TOR, a
huge multidomain (NH2-terminal HEAT domains) serine/threonine kinases that is
inhibited by the drug rapamycin (Schmelzle and Hall, 2000). Genetic analyses in the
fly demonstrated that the loss of TOR gives rise to similar growth effects as seen for
Rheb mutants (Neufeld, 2004; Oldham et al., 2000; Zhang et al., 2000), consistent
with the idea that the activation of TOR is the main outcome of Rheb action. In
Saccharomyces cerevisiae, TOR exists in high molecular weight complexes of two
flavors (Loewith et al., 2002). TOR Complex 1 (TORC1), which is Rapamycin
sensitive, contains TOR1 or TOR2, KOG1 and LST8, whereas TOR Complex 2
(TORC2), which is not inhibited by rapamycin, is composed of TOR2, AVO1-3 and
LST8. TORC2 is not implicated in growth regulation; it rather acts on the actin
cytoskeleton. In mammals, two similar complexes appear to exist (although higher
eukaryotes have only one TOR). Raptor (regulatory associated protein of mTOR)
that shares homology with KOG1 is essential for TOR’s growth function (Hara et al.,
2002; Kim and Sabatini, 2004; Kim et al., 2002). The mammalian homolog of LST8,
mLST8 or GßL, is also part of the TOR complex (Kim et al., 2003). It strongly binds
to the kinase domain of mTOR and stabilizes the interaction of Raptor with mTOR.
Interestingly, the sensitivity to nutrients and rapamycin depends on the presence of
GßL in the complex (Kim et al., 2003). Recently, a mammalian counterpart of AVO3
was shown to be part of a TOR complex. Rictor (rapamycin-insensitive companion of
mTOR) forms a complex with mTOR that neither contains Raptor, nor is it sensitive
to rapamycin (Sarbassov dos et al., 2004). The Rictor-mTOR complex also signals to
the actin cytoskeleton, raising the possibility that the TORC2 is conserved from yeast
to man. In this context, it is noteworthy that clones of Rheb mutant cells display
unusual elongated shapes, a behavior that could be explained by the tendency of
Rheb mutant cells to minimize contact to each other. It is tempting to speculate that
the altered adhesion behavior is mediated by TORC2. Future experiments will be
directed towards the identification of Rheb’s effectors that contribute to the regulation
of the two TOR complexes.
How conserved are the insulin and TOR signaling pathways?
Signaling triggered by the activation of the insulin receptor appears to be a highly
conserved signal transduction pathway that regulates growth in accordance with
environmental conditions. In the nematode C. elegans, the cascade headed by the
insulin-receptor DAF-2 controls development and longevity. Under adverse
environmental conditions (food shortage, high temperature or high population
density), the worms arrest development in the dauer stage. This diapause state
allows long-term survival, and the subsequent adult lifespan is not affected by the
period spent in the dauer stage. Mutations in the positively acting components of the
insulin receptor pathway result in a dauer-constitutive phenotype, whereas worms
lacking DAF-18/PTEN never enter the dauer stage. Hypomorphic mutations in daf-2
or age-1 significantly extend the adult lifespan (Kenyon et al., 1993), and the focus of
insulin receptor signaling in the control of lifespan was shown to reside in the CNS
(Apfeld and Kenyon, 1998; Wolkow et al., 2000). The ability of insulin receptor
signaling to coordinate development with environmental conditions also applies to
Drosophila. The phenotype of flies with reduced Inr signaling activity is
indistinguishable from that of flies reared under adverse conditions (small body size,
delay in development). Recently, a direct influence of amino acid deprivation on the
formation of the second messenger PIP3 could be demonstrated (Britton et al.,
2002). Does the functional conservation of insulin receptor signaling extend further?
The situation in mammals appears to be more complex. Clearly, insulin plays a
crucial role in the regulation of glucose homeostasis and metabolism, whereas the
IGFs are primarily involved in growth regulation. It is conceivable that the mammalian
ligands have adopted more specialized functions during evolution. Nevertheless,
there are striking parallels between insulin secretion in the pancreatic ß-cells and the
production of several DILPs in neurosecretory cells of the Drosophila brain (Ikeya et
al., 2002; Rulifson et al., 2002), and this analogy has recently been further extended
to the glucose sensing mechanism and the production of the insulin antagonist
glucagon (Kim and Rulifson, 2004). Therefore, the picture in lower metazoans might
highlight the ancient functions of the insulin signal transduction cascade. This raises
55
the question whether a similar mechanism can already be found in lower organisms
such as yeast. The fact that no orthologs of the insulin receptor or of PI3K are
encoded by the yeast genomes suggests that no similar signaling pathway involving
the second messenger PIP3 exists. However, recent findings by Fabrizio and
colleagues are very intriguing (Fabrizio et al., 2001). They identified mutations in
SCH9, the yeast ortholog of Akt, based on their resistance to heat and oxidative
stress in mutant nondividing cells. This could indicate that the downstream
components of the insulin receptor signaling cascade are more highly conserved as
compared to the top of the hierarchy. A similar constellation has been proposed for
the sex determining pathways across species (Wilkins, 1995). In fact, the TOR
signaling branch is highly conserved from yeast to man (see above). Rheb also
exists in yeast, and it has been implicated in the regulation of amino acid uptake
(Urano et al., 2000). In Schizosaccharomyces pombe, the TSC1/2 complex
negatively regulates Rheb to control arginine uptake (Van Slegtenhorst et al., 2004).
It remains to be determined whether the activity of the TSC1/2 complex in yeast is
regulated by kinases with homology to Akt, AMPK and MK2.
The high evolutionary conservation of insulin signaling in higher eukaryotes also has
medical implications. Deregulation of insulin signaling causes severe diseases such
as diabetes and cancer. In fact, the tumor suppressor PTEN is frequently lost in a
variety of cancer types (Cantley and Neel, 1999; Simpson and Parsons, 2001).
Therefore, the identification of novel signaling components in model organisms such
as C. elegans and Drosophila melanogaster might enhance the understanding of
human diseases and eventually lead to novel therapeutic interventions. From the
data presented in this thesis, it can be deduced that many tumors could potentially
be attacked in two ways: Either by molecules specifically disturbing the interaction of
Akt’s PH domain with the second messenger PIP3, or by the inhibition of Rheb
activity (e.g. by farnesyltransferase inhibitors).
Drosophila has told us a great deal about growth control. There are, however,
numerous unsolved issues to be addressed in the future. How does the fly sense
nutrients? Do the DILPs respond to energy levels? Which aspects of insulin receptor
signaling are (non)autonomous? Do we know all the target genes of Akt’s kinase
activity? How are the insulin and TOR signaling pathways connected? What is the
mechanism of TOR activation by Rheb? How do amino acids regulate the TOR
complex? These are some of the questions that immediately arise from the findings
of our recent research. In the long term, more complex issues like the enigmatic
relationship of patterning and growth control will attract our attention. Drosophila
promises to be the leading edge in this exciting field of research.
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